metronidazole has been researched along with Duodenal Ulcer in 302 studies
Metronidazole: A nitroimidazole used to treat AMEBIASIS; VAGINITIS; TRICHOMONAS INFECTIONS; GIARDIASIS; ANAEROBIC BACTERIA; and TREPONEMAL INFECTIONS.
metronidazole : A member of the class of imidazoles substituted at C-1, -2 and -5 with 2-hydroxyethyl, nitro and methyl groups respectively. It has activity against anaerobic bacteria and protozoa, and has a radiosensitising effect on hypoxic tumour cells. It may be given by mouth in tablets, or as the benzoate in an oral suspension. The hydrochloride salt can be used in intravenous infusions. Metronidazole is a prodrug and is selective for anaerobic bacteria due to their ability to intracellularly reduce the nitro group of metronidazole to give nitroso-containing intermediates. These can covalently bind to DNA, disrupting its helical structure, inducing DNA strand breaks and inhibiting bacterial nucleic acid synthesis, ultimately resulting in bacterial cell death.
Duodenal Ulcer: A PEPTIC ULCER located in the DUODENUM.
| Excerpt | Relevance | Reference |
|---|---|---|
| "To assess the efficacy and safety of omeprazole given with the new single capsule of bismuth, metronidazole and tetracycline (OBMT) compared with quadruple treatment consisting of omeprazole, bismuth, amoxicillin and clarithromycin (OBAC) for Helicobacter pylori eradication in duodenal ulcer patients." | 9.27 | New single capsule of bismuth, metronidazole and tetracycline given with omeprazole versus quadruple therapy consisting of bismuth, omeprazole, amoxicillin and clarithromycin for eradication of Helicobacter pylori in duodenal ulcer patients: a Chinese pro ( Chen, Y; Du, Y; Li, Y; Liu, D; Lv, N; Pan, X; Wang, H; Wang, J; Wu, K; Xie, Y; Xu, J; Zeng, Z; Zhang, G, 2018) |
| "Levofloxacin-tinidazole-based triple therapy was highly effective and safe as a first-line regimen in Indian patients with gastroduodenal ulcer disease associated with H." | 9.17 | Safety and efficacy of 1-week levofloxacin-based triple therapy in first-line treatment for Helicobacter pylori-related peptic ulcer disease in Kashmir, India. ( Gulzar, GM; Javid, G; Khan, BA; Khan, MA; Saif, R; Shah, A; Shoukat, A; Sodhi, JS; Teli, F; Yattoo, GN; Zargar, SA, 2013) |
| "To investigate the effect of Helicobacter pylori eradication on endothelin-1 (ET-1) and nitric oxide (NO) in duodenal ulcer (DU) patients." | 9.11 | Response of blood endothelin-1 and nitric oxide activity in duodenal ulcer patients undergoing Helicobacter pylori eradication. ( Chang, FY; Chen, CY; Lee, SD; Lu, CL; Lu, RH; Luo, JC, 2005) |
| "Comparison of two treatment regimens of eradication treatment of duodenal ulcer (DU) associated with Helicobacter pylori based on fromilid (clarithromycin)." | 9.10 | [Fromilid (clarithromycin) in eradication patients in patients with duodenal ulcer associated with Helicobacter pylori (comparison of two treatment variations)]. ( Firsanova, VIu; Kolomiets, EV; Vasil'ev, IuV; Zvenigorodskaia, LA, 2002) |
| "One hundred and forty-nine consecutive patients with active duodenal ulcer were randomized to receive omeprazole (20 mg b." | 9.10 | Omeprazole triple therapy versus omeprazole quadruple therapy for healing duodenal ulcer and eradication of Helicobacter pylori infection: a 24-month follow-up study. ( Amberiadis, P; Archavlis, E; Chiotakakou, E; Christoforidis, P; Kourtessas, D; Mantzaris, GJ; Petraki, K; Triantafyllou, G, 2002) |
| "This multicenter, randomized, active-controlled trial assessed efficacy of bismuth-based quadruple therapy with omeprazole, bismuth biskalcitrate, metronidazole, and tetracycline (OBMT) using a single-triple capsule of BMT compared with triple therapy with omeprazole, amoxicillin, and clarithromycin (OAC) in treatment of patients with Helicobacter pylori infection and duodenal ulcers." | 9.10 | Bismuth-based quadruple therapy using a single capsule of bismuth biskalcitrate, metronidazole, and tetracycline given with omeprazole versus omeprazole, amoxicillin, and clarithromycin for eradication of Helicobacter pylori in duodenal ulcer patients: a ( El-Zimaity, H; Hunt, R; Laine, L; Nguyen, B; Osato, M; Spénard, J, 2003) |
| "To investigate the efficacy of two omeprazole triple therapies for the eradication of Helicobacter pylori, ulcer healing and ulcer relapse during a 6-month treatment-free period in patients with active duodenal ulcer." | 9.09 | The DU-MACH study: eradication of Helicobacter pylori and ulcer healing in patients with acute duodenal ulcer using omeprazole based triple therapy. ( Bayerdörffer, E; Bradette, M; Farley, A; Leddin, D; Lind, T; O'Morain, C; Sinclair, P; Sipponen, P; Spiller, RC; Unge, P; Wrangstadh, M; Zanten, SJ; Zeijlon, L, 1999) |
| " pylori-positive duodenal ulcer were allocated randomly to receive one of four regimens: metronidazole, 200 mg; amoxicillin, 250 mg; and colloidal bismuth subcitrate (CBS), 120 mg (group 1), or CBP, 100 mg qid (group 2) for 2 weeks, then continued CBS, 240 mg, or CBP, 200 mg bid for a further 2 weeks." | 9.09 | Colloidal bismuth pectin: an alternative to bismuth subcitrate for the treatment of Helicobacter pylori--positive duodenal ulcer. ( Dai, S; Du, H; Li, Q; Li, Y; Nie, Y; Sha, W; Wang, H; Wu, H, 1999) |
| " Our main objective was to study the outcome of a non-metronidazole and omeprazole-based antibiotic regimen in eradicating Helicobacter pylori in patients with duodenal ulcer." | 9.09 | The outcome of a 2-week treatment of Helicobacter pylori-positive duodenal ulcer with omeprazole-based antibiotic regimen in a region with high metronidazole resistance rate. ( Abdulle, AM; Adeyemi, EO; Benedict, S; Danial, MF; Helal, T, 1999) |
| "To compare two lansoprazole-based non-clarithromycin triple therapies and one dual therapy in a prospective double-blind placebo-controlled study of Helicobacter pylori eradication and duodenal ulcer healing." | 9.09 | Comparison of lansoprazole-based triple and dual therapy for treatment of Helicobacter pylori-related duodenal ulcer: an Asian multicentre double-blind randomized placebo controlled study. ( Carpio, RE; Fock, KM; Ho, J; Hu, FL; Hu, PJ; Huang, NX; Kachintorn, U; Kullavanijaya, P; Lam, SK; Lesmana, L; Li, YY; Manan, C; Perez, JY; Phornphutkul, K; Qian, SC; Wong, BC; Xiao, SD, 2000) |
| "The aim of this study was to compare in an open, controlled and prospective trial the efficacy of one-week regimen using either lansoprazole (2 x 30 mg) + 2 x 500 mg metronidazole + 2 x 250 mg clarithromycin (group I, 60 cases) or ranitidine bismuth citrate (2 x 400 mg) + 2 x 500 mg metronidazole + 2 x 250 mg clarithromycin (group II, 61 cases) on the eradication of Hp infection in duodenal ulcer patients." | 9.09 | [Lansoprazole versus ranitidine bismuth citrate containing triple regimens for Helicobacter pylori eradication in patients with duodenal ulcer]. ( Buzás György, M; Illyés, G; Székely, E; Széles, I, 2000) |
| " pylori-positive duodenal ulcers were randomized to receive either lansoprazole 30 mg, clarithromycin 500 mg, and metronidazole 400 mg twice daily for 7 days (LCM-7) or lansoprazole 30 mg, clarithromycin 500 mg, metronidazole 400 mg, and bismuth subcitrate 240 mg twice daily for 3 days (LCMB-3)." | 9.09 | Three-day lansoprazole quadruple therapy for Helicobacter pylori-positive duodenal ulcers: a randomized controlled study. ( Chan, CK; Chu, KM; Fung, FM; Hu, FL; Hu, WH; Hui, WM; Kung, NN; Lai, KC; Lam, SK; Lau, GK; Liu, XG; Wang, WH; Wong, BC; Wong, WM; Yuen, MF, 2001) |
| " pylori positive duodenal ulcer were enrolled and randomly allocated into one of the five treatment groups: 1) group A: received lansoprazole 30 mg once daily for 2 weeks plus amoxicillin (AM) 500 mg and metronidazole (MZ) 500 mg twice daily for one week in the first week; 2) group B: the AM in group A was replaced by clarithromycin (CM) 250 mg; 3) group C: the MZ in group A was replaced by CM 250 mg; 4) group D: the AM and CM in group C was used for 2 wk; 5) group E: the CM in group D was doubled to 500 mg twice daily." | 9.09 | A multicenter study on eradication of Helicobacter pylori infection in patients with duodenal ulcer by lansoprazole-antibiotics combined therapy. ( Hsu, CT; Kuo, CF; Wang, CS; Wang, TH; Yang, JC; Yang, KC, 1999) |
| " The aim of this controlled, randomized, prospective study was to compare the effect of these two regimens and a further regimen for metronidazole-resistant patients on duodenal ulcer healing, H." | 9.08 | Effect of triple therapy or amoxycillin plus omeprazole or amoxycillin plus tinidazole plus omeprazole on duodenal ulcer healing, eradication of Helicobacter pylori, and prevention of ulcer relapse over a 1-year follow-up period: a prospective, randomized ( Dehbashi, N; Etaati, H; Fattahi, M; Javan, A; Massarrat, S; Saberi-Firoozi, M; Zare, S, 1995) |
| "To establish the efficacy of omeprazole combined with two antibiotics for Helicobacter pylori eradication and duodenal ulcer relapse." | 9.08 | Efficacy of omeprazole combined with antibiotics for Helicobacter pylori eradication and duodenal ulcer recurrence. ( Bargiggia, S; Bianchi Porro, G; Lazzaroni, M; Maconi, G; Minguzzi, M, 1995) |
| "To investigate differences between omeprazole and Helicobacter pylori eradication in patients with duodenal ulcers refractory to H2-receptor antagonists and to compare the recurrence rates after the two treatments." | 9.08 | Refractory duodenal ulcer healing and relapse: comparison of omeprazole with Helicobacter pylori eradication. ( Avsar, E; Gültekin, O; Kalayci, C; Kiziltas, S; Lawrence, R; Tözün, N; Ulusoy, NB, 1996) |
| "To determine the effect of Helicobacter pylori eradication with omeprazole and amoxycillin, with or without metronidazole, on the 12-month course of duodenal ulcer disease." | 9.08 | Symptomatic and endoscopic duodenal ulcer relapse rates 12 months following Helicobacter pylori eradication treatment with omeprazole and amoxycillin with or without metronidazole. ( Axon, AT; Bate, CM; Bell, GD; Martin, JL; Richardson, PD; Taylor, MD; Tildesley, G, 1996) |
| "Eighty patients with endoscopically proven active duodenal ulcer were randomized to take ranitidine or lansoprazole for 4-8 wk, together with clarithromycin 250 mg b." | 9.08 | Triple therapy with ranitidine or lansoprazole in the treatment of Helicobacter pylori-associated duodenal ulcer. ( Bargiggia, S; Bianchi Porro, G; Lazzaroni, M, 1997) |
| "This double-blind, randomized, phase III clinical trial was carried out in two parallel groups to assess the efficacy of ebrotidine (N-[(E)-[[2-[[[2-[(diaminomethylene) amino]-4-thiazolyl]methyl]thio]ethyl]amino] methylene]-4-bromo-benzenesulfonamide, CAS 100981-43-9, FI-3542) 400 mg and ranitidine 300 mg given in single evening dose, combined with amoxicillin 750 mg and metronidazole 500 mg three times daily for 14 days, in the eradication of Helicobacter pylori in patients with duodenal ulcer." | 9.08 | Efficacy of ebrotidine and ranitidine combined with amoxicillin and metronidazole in the eradication of Helicobacter pylori in patients with duodenal ulcer. ( Fillat, O; Herrero, E; Karcz, D; Kulig, J; Márquez, M; Ortiz, JA; Popiela, T; Tabor, J; Torres, J, 1997) |
| "In patients with active duodenal ulcer, a 10-day course of amoxycillin-clarithromycin-based triple therapy without additional acid suppression is highly effective in eradicating H." | 9.08 | Short-course therapy with amoxycillin-clarithromycin triple therapy for 10 days (ACT-10) eradicates Helicobacter pylori and heals duodenal ulcer. ACT-10 Study Group. ( Archambault, A; Archimandritis, A; Bazzoli, F; Fedorak, R; Hentschel, E; Megraud, F; Mora, P; Rodrigo, L; Rokkas, T; Skandalis, N; Stamler, D; Wurzer, H, 1997) |
| "To estimate and compare the efficacy of 'triple' 1-week regimens--omeprazole, clarithromycin and a nitroimidazole (metronidazole or ornidazole)--followed by omeprazole, for an additional 3 weeks, on Helicobacter pylori eradication and duodenal ulcer (DU) healing, in a country with a high resistance rate of H." | 9.08 | One-week therapy with omeprazole, clarithromycin and metronidazole or ornidazole, followed by 3 weeks' treatment with omeprazole, eradicates Helicobacter pylori equally and heals duodenal ulcer. ( Archimandritis, A; Balatsos, V; Davaris, P; Delis, V; Kanellopoulou, E; Manika, Z; Skandalis, N; Souyioultzis, S; Tzivras, M, 1997) |
| "Both treatment regimens, the 1-h topical method and amoxycillin with omeprazole, have low eradication rates in patients with duodenal ulcer." | 9.08 | Randomized comparison of 1-hour topical method vs. amoxycillin plus omeprazole for eradication of Helicobacter pylori in duodenal ulcer patients. ( Butruk, E; Dziurkowska-Marek, A; Hennig, E; Kohut, M; Marek, T; Nowak, A; Ostrowski, J; Przytulski, K; Regula, J, 1998) |
| "A total of 101 patients with proven duodenal ulcer and a positive urease test were randomized into two groups: one group received the classic triple therapy (bismuth subnitrate 3 x 375 mg for 4 weeks + tetracycline 3 x 500 mg + metronidazole 3 x 250 mg daily, both for 2 weeks ), the other group received dual therapy comprising amoxicillin 2 x 1000 mg + omeprazole 2 x 20 mg daily, both for 2 weeks." | 9.08 | Continuous and more effective duodenal ulcer healing under therapy with bismuth and two antibiotics than with dual therapy comprising omeprazole and amoxicillin. ( Kashifard, M; Malekzadeh, R; Massarrat, S; Mikaeli, J; Siavoshi, F, 1998) |
| "Two 4-week triple-therapy treatment regimens, metronidazole+tetracycline+bismuth subcitrate and omeprazole+amoxycillin+bismuth subcitrate, were compared in a randomly allocated double-blind trial for their efficacy in eradicating Helicobacter pylori from the gastric mucosa of patients with gastritis and/or peptic ulcer disease." | 9.07 | Pharmacological effects of metronidazole+tetracycline+bismuth subcitrate versus omeprazole+amoxycillin+bismuth subcitrate in Helicobacter pylori-related gastritis and peptic ulcer disease. ( Hahm, JS; Kim, HJ; Park, KN, 1994) |
| " In study II 22 duodenal ulcer patients were given bismuth subnitrate, oxytetracycline, and metronidazole (triple therapy) for 2 weeks to eradicate H." | 9.07 | Effects of omeprazole and eradication of Helicobacter pylori on gastric and duodenal mucosal enzyme activities and DNA in duodenal ulcer patients. ( Aase, S; Andersen, KJ; Mowinckel, P; Schrumpf, E; Vetvik, K, 1994) |
| "To determine the distribution of Helicobacter pylori in the antral and duodenal mucosa of patients with duodenal ulcers refractory to 12 wk of treatment with cimetidine and to evaluate the effect of adding antimicrobial agents to cimetidine on the healing of refractory duodenal ulcers." | 9.07 | Helicobacter pylori and refractory duodenal ulcers: cross-over comparison of continued cimetidine with cimetidine plus antimicrobials. ( Boyd, EJ; Boyd, HK; Chinzon, D; Eisig, JN; Iriya, K; Laudanna, AA; Zaterka, S, 1994) |
| "A controlled, prospective clinical trial of colloidal bismuth subcitrate (CBS), ranitidine and ranitidine plus metronidazole for the treatment of duodenal ulcer (DU) is reported here, with evaluation of the possible pathogenic role of Helicobacter pylori (HP) on DU in a six-month follow-up." | 9.07 | Colloidal bismuth subcitrate, ranitidine, and ranitidine plus metronidazole in the treatment of duodenal ulcer and Helicobacter pylori infection: a controlled and prospective study. ( Chen, GH; Huang, CK, 1993) |
| "Duodenal ulcer relapse rates after therapy with sucralfate or bismuth are lower than those after H2-receptor antagonist therapy." | 9.07 | Triple therapy with sucralfate is as effective as triple therapy containing bismuth in eradicating Helicobacter pylori and reducing duodenal ulcer relapse rates. ( Jaskiewicz, K; Lastovica, A; Le Roux, E; Louw, JA; Lucke, W; Marks, IN; Winter, T; Zak, J, 1992) |
| " pylori agents and ranitidine was superior to ranitidine alone for duodenal ulcer healing." | 9.07 | Effect of triple therapy (antibiotics plus bismuth) on duodenal ulcer healing. A randomized controlled trial. ( Evans, DG; Evans, DJ; Graham, DY; Klein, PD; Lew, GM, 1991) |
| "Omeprazole heals most duodenal ulcers after 4 weeks of treatment but relapse is common." | 7.68 | Short report: treatment of Helicobacter pylori-associated duodenal ulcer with omeprazole plus antibiotics. ( Beattie, S; Collins, R; Hamilton, H; McCarthy, CJ; O'Morain, C, 1993) |
| "The histamine concentration of the oxyntic mucosa was determined in Helicobacter pylori-positive patients with duodenal ulcer before and after antimicrobial therapy and in H." | 7.68 | Histamine content of the oxyntic mucosa from duodenal ulcer patients: effect of Helicobacter pylori eradication. ( Coelho, LG; Cunha-Melo, JR; Lima Júnior, GF; Mendes, EN; Moura, SB; Oliveira, CA; Passos, MC; Queiroz, DM; Resende, LM; Rocha, GA, 1993) |
| "60 patients with recurrent duodenal ulcers were treated with bismuth subnitrate, oxytetracycline and metronidazole." | 7.68 | [Treatment of stomach ulcer with bismuth subnitrate, oxytetracycline and metronidazole]. ( Berstad, A; Berstad, K; Hundal, O; Wilhelmsen, I, 1992) |
| "pylori on the recurrence of duodenal ulcer, we treated 104 patients with H." | 6.67 | Effect of ranitidine and amoxicillin plus metronidazole on the eradication of Helicobacter pylori and the recurrence of duodenal ulcer. ( Brandstätter, G; Dragosics, B; Hentschel, E; Hirschl, AM; Nemec, H; Schütze, K; Taufer, M; Wurzer, H, 1993) |
| "To assess the efficacy and safety of omeprazole given with the new single capsule of bismuth, metronidazole and tetracycline (OBMT) compared with quadruple treatment consisting of omeprazole, bismuth, amoxicillin and clarithromycin (OBAC) for Helicobacter pylori eradication in duodenal ulcer patients." | 5.27 | New single capsule of bismuth, metronidazole and tetracycline given with omeprazole versus quadruple therapy consisting of bismuth, omeprazole, amoxicillin and clarithromycin for eradication of Helicobacter pylori in duodenal ulcer patients: a Chinese pro ( Chen, Y; Du, Y; Li, Y; Liu, D; Lv, N; Pan, X; Wang, H; Wang, J; Wu, K; Xie, Y; Xu, J; Zeng, Z; Zhang, G, 2018) |
| "Levofloxacin-tinidazole-based triple therapy was highly effective and safe as a first-line regimen in Indian patients with gastroduodenal ulcer disease associated with H." | 5.17 | Safety and efficacy of 1-week levofloxacin-based triple therapy in first-line treatment for Helicobacter pylori-related peptic ulcer disease in Kashmir, India. ( Gulzar, GM; Javid, G; Khan, BA; Khan, MA; Saif, R; Shah, A; Shoukat, A; Sodhi, JS; Teli, F; Yattoo, GN; Zargar, SA, 2013) |
| "248 patients with Hp-associated active duodenal ulcer confirmed by endoscopy, 193 males and 55 females, were randomized to receive OAC(250): omeprazole (0." | 5.11 | [Effects of different triple therapies on duodenal ulcer-associated Helicobacter pylori infection and a one-year follow-up study]. ( , 2004) |
| "To investigate the effect of Helicobacter pylori eradication on endothelin-1 (ET-1) and nitric oxide (NO) in duodenal ulcer (DU) patients." | 5.11 | Response of blood endothelin-1 and nitric oxide activity in duodenal ulcer patients undergoing Helicobacter pylori eradication. ( Chang, FY; Chen, CY; Lee, SD; Lu, CL; Lu, RH; Luo, JC, 2005) |
| "Comparison of two treatment regimens of eradication treatment of duodenal ulcer (DU) associated with Helicobacter pylori based on fromilid (clarithromycin)." | 5.10 | [Fromilid (clarithromycin) in eradication patients in patients with duodenal ulcer associated with Helicobacter pylori (comparison of two treatment variations)]. ( Firsanova, VIu; Kolomiets, EV; Vasil'ev, IuV; Zvenigorodskaia, LA, 2002) |
| "To assess and compare the efficacy and safety of two triple regimes: A) metronidazole, amoxicillin and omeprazole, which is still widely used in Russia, and B) azithromycin, amoxicillin and omeprazole in healing active duodenal ulcer and H." | 5.10 | Azithromycin in a triple therapy for H.pylori eradication in active duodenal ulcer. ( Bondarenko, OY; Fedchenko, VI; Grigoriev, PY; Gulyaev, PV; Ivashkin, VT; Lapina, TL; Sklanskaya, OA; Vasiliev, YV; Yakovenko, EP, 2002) |
| "One hundred and forty-nine consecutive patients with active duodenal ulcer were randomized to receive omeprazole (20 mg b." | 5.10 | Omeprazole triple therapy versus omeprazole quadruple therapy for healing duodenal ulcer and eradication of Helicobacter pylori infection: a 24-month follow-up study. ( Amberiadis, P; Archavlis, E; Chiotakakou, E; Christoforidis, P; Kourtessas, D; Mantzaris, GJ; Petraki, K; Triantafyllou, G, 2002) |
| "This multicenter, randomized, active-controlled trial assessed efficacy of bismuth-based quadruple therapy with omeprazole, bismuth biskalcitrate, metronidazole, and tetracycline (OBMT) using a single-triple capsule of BMT compared with triple therapy with omeprazole, amoxicillin, and clarithromycin (OAC) in treatment of patients with Helicobacter pylori infection and duodenal ulcers." | 5.10 | Bismuth-based quadruple therapy using a single capsule of bismuth biskalcitrate, metronidazole, and tetracycline given with omeprazole versus omeprazole, amoxicillin, and clarithromycin for eradication of Helicobacter pylori in duodenal ulcer patients: a ( El-Zimaity, H; Hunt, R; Laine, L; Nguyen, B; Osato, M; Spénard, J, 2003) |
| "To determine the value of Helicobacter pylori (Hp) serology in diagnosis of active Hp infection in patients with documented duodenal ulcer (DU) and to directly compare the efficacy and side-effects profiles of metronidazole or tinidazole in a triple therapy regimen to eradicate active Hp infection." | 5.10 | Diagnosis and eradication of Helicobacter pylori in patients with duodenal ulceration in the community. ( Abbas, AB; Abbas, SZ; Crawshaw, A; Dalton, HR; English, J; McGovern, D; Shaw, S; Vivian, G, 2003) |
| "To investigate the efficacy of two omeprazole triple therapies for the eradication of Helicobacter pylori, ulcer healing and ulcer relapse during a 6-month treatment-free period in patients with active duodenal ulcer." | 5.09 | The DU-MACH study: eradication of Helicobacter pylori and ulcer healing in patients with acute duodenal ulcer using omeprazole based triple therapy. ( Bayerdörffer, E; Bradette, M; Farley, A; Leddin, D; Lind, T; O'Morain, C; Sinclair, P; Sipponen, P; Spiller, RC; Unge, P; Wrangstadh, M; Zanten, SJ; Zeijlon, L, 1999) |
| " pylori-positive patients with endoscopically defined peptic ulcer [DU (n = 65), GU (n = 12)] or non-ulcer dyspepsia (NUD, n = 43) were randomized to receive a 1-week course of twice daily omeprazole 20 mg, clarithromycin 250 mg and either metronidazole 400 mg (OCM) or tinidazole 500 mg (OCT) in a double-blind fashion." | 5.09 | Randomized controlled comparison of nitroimidazoles for the eradication of Helicobacter pylori and relief of ulcer-associated and non-ulcer dyspepsia. ( Goddard, AF; Lawes, S; Logan, RP; Spiller, RC, 1999) |
| " pylori-positive duodenal ulcer were allocated randomly to receive one of four regimens: metronidazole, 200 mg; amoxicillin, 250 mg; and colloidal bismuth subcitrate (CBS), 120 mg (group 1), or CBP, 100 mg qid (group 2) for 2 weeks, then continued CBS, 240 mg, or CBP, 200 mg bid for a further 2 weeks." | 5.09 | Colloidal bismuth pectin: an alternative to bismuth subcitrate for the treatment of Helicobacter pylori--positive duodenal ulcer. ( Dai, S; Du, H; Li, Q; Li, Y; Nie, Y; Sha, W; Wang, H; Wu, H, 1999) |
| " Our main objective was to study the outcome of a non-metronidazole and omeprazole-based antibiotic regimen in eradicating Helicobacter pylori in patients with duodenal ulcer." | 5.09 | The outcome of a 2-week treatment of Helicobacter pylori-positive duodenal ulcer with omeprazole-based antibiotic regimen in a region with high metronidazole resistance rate. ( Abdulle, AM; Adeyemi, EO; Benedict, S; Danial, MF; Helal, T, 1999) |
| "To compare two lansoprazole-based non-clarithromycin triple therapies and one dual therapy in a prospective double-blind placebo-controlled study of Helicobacter pylori eradication and duodenal ulcer healing." | 5.09 | Comparison of lansoprazole-based triple and dual therapy for treatment of Helicobacter pylori-related duodenal ulcer: an Asian multicentre double-blind randomized placebo controlled study. ( Carpio, RE; Fock, KM; Ho, J; Hu, FL; Hu, PJ; Huang, NX; Kachintorn, U; Kullavanijaya, P; Lam, SK; Lesmana, L; Li, YY; Manan, C; Perez, JY; Phornphutkul, K; Qian, SC; Wong, BC; Xiao, SD, 2000) |
| "To compare the eradication rates of Helicobacter pylori, ulcer healing rates and side-effects of three regimens of omeprazole triple therapy in patients with duodenal ulcer from South-East Asia and to study the impact of metronidazole resistance." | 5.09 | Triple therapy in the eradication of Helicobacter pylori in patients with duodenal ulcer disease: results of a multicentre study in South-East Asia. South-East Asia Multicenter Study Group. ( Chelvam, P; Fock, KM; Lim, SG, 2000) |
| "To compare the efficacy of either omeprazole or ranitidine in a second-line quadruple regimen in patients with duodenal ulcer or erosive duodenitis." | 5.09 | Randomized study comparing omeprazole with ranitidine as anti-secretory agents combined in quadruple second-line Helicobacter pylori eradication regimens. ( Balta, A; Bouzakis, H; Broutet, N; Kralios, N; Michopoulos, S; Tsibouris, P; Vougadiotis, J, 2000) |
| " pylori eradication and duodenal ulcer healing in this region despite the high metronidazole resistance rate." | 5.09 | Randomized trial of omeprazole and metronidazole with amoxycillin or clarithromycin for Helicobacter pylori eradication, in a region of high primary metronidazole resistance: the HERO study. ( Adamthwaite, D; Davidson, G; Katelaris, PH; Lambert, J; Midolo, P; Yeomans, ND, 2000) |
| "For this open study, 331 patients with duodenal ulcer were screened and randomly allocated to either pantoprazole 40 mg b." | 5.09 | Eradication of Helicobacter pylori with pantoprazole and two antibiotics: a comparison of two short-term regimens. ( Daake, H; Frevel, M; Janisch, HD; Kellner, HU; Krezdorn, HG; Tanneberger, D; Wack, R, 2000) |
| "The aim of this study was to compare in an open, controlled and prospective trial the efficacy of one-week regimen using either lansoprazole (2 x 30 mg) + 2 x 500 mg metronidazole + 2 x 250 mg clarithromycin (group I, 60 cases) or ranitidine bismuth citrate (2 x 400 mg) + 2 x 500 mg metronidazole + 2 x 250 mg clarithromycin (group II, 61 cases) on the eradication of Hp infection in duodenal ulcer patients." | 5.09 | [Lansoprazole versus ranitidine bismuth citrate containing triple regimens for Helicobacter pylori eradication in patients with duodenal ulcer]. ( Buzás György, M; Illyés, G; Székely, E; Széles, I, 2000) |
| " pylori alone with the present bismuth-based triple therapy in patients with duodenal ulcer hemorrhage did not result in significant reduction in further bleeding episodes, although a trend was seen for the group that was given triple therapy." | 5.09 | Treatment of Helicobacter pylori in patients with duodenal ulcer hemorrhage--a long-term randomized, controlled study. ( Ching, CK; Hu, WH; Hui, WM; Lai, KC; Lam, SK; Wong, BC; Wong, WM, 2000) |
| "Patients with active duodenal ulcer were randomized either to omeprazole, 20 mg twice daily until healing, followed by omeprazole, 20 mg/ day for 1 year, or to eradication therapy (metronidazole, amoxicillin, and omeprazole for 2 weeks) followed by placebo for 1 year." | 5.09 | Eradication of Helicobacter pylori compared with long-term acid suppression in duodenal ulcer disease. A randomized trial with 2-year follow-up. The Danish Ulcer Study Group. ( Aalykke, C; Bekker, C; Bonnevie, O; Bytzer, P; Eriksen, J; Gjørup, T; Hansen, J; Justesen, T; Kjaergaard, J; Kromann-Andersen, H; Rask-Madsen, J; Rune, S; Teglbjaerg, PS; Vilien, M; Vyberg, M; Weywadt, L, 2000) |
| " pylori-positive duodenal ulcers were randomized to receive either lansoprazole 30 mg, clarithromycin 500 mg, and metronidazole 400 mg twice daily for 7 days (LCM-7) or lansoprazole 30 mg, clarithromycin 500 mg, metronidazole 400 mg, and bismuth subcitrate 240 mg twice daily for 3 days (LCMB-3)." | 5.09 | Three-day lansoprazole quadruple therapy for Helicobacter pylori-positive duodenal ulcers: a randomized controlled study. ( Chan, CK; Chu, KM; Fung, FM; Hu, FL; Hu, WH; Hui, WM; Kung, NN; Lai, KC; Lam, SK; Lau, GK; Liu, XG; Wang, WH; Wong, BC; Wong, WM; Yuen, MF, 2001) |
| "To investigate Helicobacter pylori eradication in duodenal ulcer patients with a new regimen, lansoprazole 30 mg daily for one or four weeks plus twice daily tetracycline 500 mg, clarithromycin 250 mg, and metronidazole 400 mg." | 5.09 | Quadruple therapy for symptomatic spontaneous duodenal ulcer disease. ( Bateson, MC, 2001) |
| " pylori positive duodenal ulcer were enrolled and randomly allocated into one of the five treatment groups: 1) group A: received lansoprazole 30 mg once daily for 2 weeks plus amoxicillin (AM) 500 mg and metronidazole (MZ) 500 mg twice daily for one week in the first week; 2) group B: the AM in group A was replaced by clarithromycin (CM) 250 mg; 3) group C: the MZ in group A was replaced by CM 250 mg; 4) group D: the AM and CM in group C was used for 2 wk; 5) group E: the CM in group D was doubled to 500 mg twice daily." | 5.09 | A multicenter study on eradication of Helicobacter pylori infection in patients with duodenal ulcer by lansoprazole-antibiotics combined therapy. ( Hsu, CT; Kuo, CF; Wang, CS; Wang, TH; Yang, JC; Yang, KC, 1999) |
| " The aim of this controlled, randomized, prospective study was to compare the effect of these two regimens and a further regimen for metronidazole-resistant patients on duodenal ulcer healing, H." | 5.08 | Effect of triple therapy or amoxycillin plus omeprazole or amoxycillin plus tinidazole plus omeprazole on duodenal ulcer healing, eradication of Helicobacter pylori, and prevention of ulcer relapse over a 1-year follow-up period: a prospective, randomized ( Dehbashi, N; Etaati, H; Fattahi, M; Javan, A; Massarrat, S; Saberi-Firoozi, M; Zare, S, 1995) |
| "To establish the efficacy of omeprazole combined with two antibiotics for Helicobacter pylori eradication and duodenal ulcer relapse." | 5.08 | Efficacy of omeprazole combined with antibiotics for Helicobacter pylori eradication and duodenal ulcer recurrence. ( Bargiggia, S; Bianchi Porro, G; Lazzaroni, M; Maconi, G; Minguzzi, M, 1995) |
| ") in eradicating Helicobacter pylori in patients with duodenal ulcer successfully healed with omeprazole or ranitidine; second, to examine the influence of the eradication on duodenal ulcer recurrence rate after 12 months." | 5.08 | Triple therapy eradicated H. pylori equally in patients pretreated with omeprazole or ranitidine. A 12-month follow-up. ( Archimandritis, A; Balatsos, V; Delis, V; Kastanas, K; Mentis, A; Scandalis, N, 1995) |
| "In this double-blind trial, conducted in 19 hospitals, 119 patients with symptomatic duodenal ulcer disease were randomized to receive either 14 days treatment with omeprazole 40 mg daily, amoxycillin 500 mg t." | 5.08 | Addition of metronidazole to omeprazole/amoxycillin dual therapy increases the rate of Helicobacter pylori eradication: a double-blind, randomized trial. ( Axon, AT; Bate, CM; Bell, GD; Emmas, CE; Green, JR; Kerr, GD; Taylor, MD; Tildesley, G, 1995) |
| "The combined therapy with amoxycillin, metronidazole, and omeprazole is highly effective in both HP eradication and prevention of duodenal ulcer recurrence." | 5.08 | Omeprazole coupled with two antibiotics for Helicobacter pylori eradication and prevention of ulcer recurrence. ( Alvisi, C; Bargiggia, S; Bianchi Porro, G; Cesana, B; Fiocca, R; Franceschi, M; Lazzaroni, M; Luinetti, O; Maconi, G; Perego, M; Solcia, E; Trespi, E; Villani, L, 1996) |
| "To investigate differences between omeprazole and Helicobacter pylori eradication in patients with duodenal ulcers refractory to H2-receptor antagonists and to compare the recurrence rates after the two treatments." | 5.08 | Refractory duodenal ulcer healing and relapse: comparison of omeprazole with Helicobacter pylori eradication. ( Avsar, E; Gültekin, O; Kalayci, C; Kiziltas, S; Lawrence, R; Tözün, N; Ulusoy, NB, 1996) |
| " Sixty duodenal ulcer patients were randomised to receive either standard triple therapy (tripotassium dicitrato bismuthate 120 mg qds+tetracycline 500 mg qds+metronidazole 400 mg qds), quadruple therapy A (triple therapy+omeprazole 20 mg od) or quadruple therapy B (triple therapy+omeprazole 40 mg od), for 7 days." | 5.08 | One week treatment for Helicobacter pylori infection: a randomised study of quadruple therapy versus triple therapy. ( Griffiths, AE; Halliday, D; Jacyna, MR; Phull, PS, 1995) |
| "To determine the effect of Helicobacter pylori eradication with omeprazole and amoxycillin, with or without metronidazole, on the 12-month course of duodenal ulcer disease." | 5.08 | Symptomatic and endoscopic duodenal ulcer relapse rates 12 months following Helicobacter pylori eradication treatment with omeprazole and amoxycillin with or without metronidazole. ( Axon, AT; Bate, CM; Bell, GD; Martin, JL; Richardson, PD; Taylor, MD; Tildesley, G, 1996) |
| " pylori-positive gastritis with or without peptic ulcer, and compared with the classic 'Bazzoli regimen' (OCT: omeprazole, clarithromycin, tinidazole) in 60 matched patients." | 5.08 | Short-term low-dose triple therapy with azithromycin, metronidazole and lansoprazole appears highly effective for the eradication of Helicobacter pylori. ( Alvisi, V; Caselli, M; Gasbarrini, G; Gaudenzi, P; Luzzi, I; Ruina, M; Sartori, S; Trevisani, L; Tursi, A, 1997) |
| " After 2 weeks duodenal ulcer healing was confirmed in 91% (95% CI = 80-100%) of patients treated with omeprazole and in 76% (95% CI = 60-91%) in the placebo group (P = 0." | 5.08 | One-week low-dose triple therapy for Helicobacter pylori is sufficient for relief from symptoms and healing of duodenal ulcers. ( Adamek, RJ; Börsch, G; Idström, JP; Labenz, J; Peitz, U; Tillenburg, B, 1997) |
| "Eighty patients with endoscopically proven active duodenal ulcer were randomized to take ranitidine or lansoprazole for 4-8 wk, together with clarithromycin 250 mg b." | 5.08 | Triple therapy with ranitidine or lansoprazole in the treatment of Helicobacter pylori-associated duodenal ulcer. ( Bargiggia, S; Bianchi Porro, G; Lazzaroni, M, 1997) |
| "This double-blind, randomized, phase III clinical trial was carried out in two parallel groups to assess the efficacy of ebrotidine (N-[(E)-[[2-[[[2-[(diaminomethylene) amino]-4-thiazolyl]methyl]thio]ethyl]amino] methylene]-4-bromo-benzenesulfonamide, CAS 100981-43-9, FI-3542) 400 mg and ranitidine 300 mg given in single evening dose, combined with amoxicillin 750 mg and metronidazole 500 mg three times daily for 14 days, in the eradication of Helicobacter pylori in patients with duodenal ulcer." | 5.08 | Efficacy of ebrotidine and ranitidine combined with amoxicillin and metronidazole in the eradication of Helicobacter pylori in patients with duodenal ulcer. ( Fillat, O; Herrero, E; Karcz, D; Kulig, J; Márquez, M; Ortiz, JA; Popiela, T; Tabor, J; Torres, J, 1997) |
| "A randomised, double blind placebo controlled trial was performed to study the efficacy of an antibiotic only regimen consisting of 300 mg metronidazole, 500 mg amoxycillin, and 250 mg clarithromycin, each given four times daily for two weeks, in the healing of duodenal ulcer as assessed by endoscopy." | 5.08 | Does treatment of Helicobacter pylori with antibiotics alone heal duodenal ulcer? A randomised double blind placebo controlled study. ( Chan, CK; Ching, CK; Lai, CL; Lai, KC; Lam, SK; Ong, L; Wong, BC, 1997) |
| "In patients with active duodenal ulcer, a 10-day course of amoxycillin-clarithromycin-based triple therapy without additional acid suppression is highly effective in eradicating H." | 5.08 | Short-course therapy with amoxycillin-clarithromycin triple therapy for 10 days (ACT-10) eradicates Helicobacter pylori and heals duodenal ulcer. ACT-10 Study Group. ( Archambault, A; Archimandritis, A; Bazzoli, F; Fedorak, R; Hentschel, E; Megraud, F; Mora, P; Rodrigo, L; Rokkas, T; Skandalis, N; Stamler, D; Wurzer, H, 1997) |
| " pylori-infected patients with endoscopically documented duodenal ulcer either currently or within the past year were randomized to 14 days of (1) lansoprazole, 30 mg bid, plus amoxicillin, 1 gm tid; (2) lansoprazole, 30 mg tid, plus amoxicillin, 1 gm tid; (3) lansoprazole, 30 mg tid alone; or (4) amoxicillin, 1 gm tid alone." | 5.08 | Double-blind, multicenter evaluation of lansoprazole and amoxicillin dual therapy for the cure of Helicobacter pylori infection. ( Arora, A; Graham, D; Haber, M; Harford, W; Lanza, F; Rose, P; Siepman, N; Weissfeld, A, 1996) |
| " Patients (n = 787) with proved duodenal ulcer disease were randomized to treatment twice daily for 1 week with omeprazole, 20 mg (O), plus either placebo (P) or combinations of two of the following antimicrobials: amoxicillin, 1 gm (A), clarithromycin, 250 or 500 mg (C250, C500), or metronidazole, 400 mg (M)." | 5.08 | Eradication of Helicobacter pylori using one-week triple therapies combining omeprazole with two antimicrobials: the MACH I Study. ( Bardhan, KD; Bayerdörffer, E; Bradette, M; Cederberg, C; Chiba, N; Idström, JP; Lind, T; O'Morain, C; Spiller, R; Unge, P; Veldhuyzen van Zanten, S; Wrangstadh, M, 1996) |
| " pylori-positive peptic ulcer received omeprazole 20 mg twice daily in combination with metronidazole 400 mg twice daily and clarithromycin 500 mg twice daily for seven days." | 5.08 | One week triple therapy for Helicobacter pylori: does high-dose clarithromycin confer additional benefit? ( Bhutta, AS; Bindel, H; Cunnane, K; Loane, J; O'Connor, HJ, 1997) |
| "To estimate and compare the efficacy of 'triple' 1-week regimens--omeprazole, clarithromycin and a nitroimidazole (metronidazole or ornidazole)--followed by omeprazole, for an additional 3 weeks, on Helicobacter pylori eradication and duodenal ulcer (DU) healing, in a country with a high resistance rate of H." | 5.08 | One-week therapy with omeprazole, clarithromycin and metronidazole or ornidazole, followed by 3 weeks' treatment with omeprazole, eradicates Helicobacter pylori equally and heals duodenal ulcer. ( Archimandritis, A; Balatsos, V; Davaris, P; Delis, V; Kanellopoulou, E; Manika, Z; Skandalis, N; Souyioultzis, S; Tzivras, M, 1997) |
| "To compare the efficacy of two "new" one-week triple therapies (with omeprazole, metronidazole and clarithromycin or amoxycillin) for the eradication of Helicobacter pylori and healing duodenal ulcer." | 5.08 | [new one-week triple therapies with metronidazole for the eradication of Helicobacter pylori: clarithromycin or amoxycillin as the second antibiotic]. ( Abraira, V; Boixeda, D; García Plaza, A; Gisbert, JP; Martín de Argila, C; Moreno, L; Redondo, C, 1998) |
| "Both treatment regimens, the 1-h topical method and amoxycillin with omeprazole, have low eradication rates in patients with duodenal ulcer." | 5.08 | Randomized comparison of 1-hour topical method vs. amoxycillin plus omeprazole for eradication of Helicobacter pylori in duodenal ulcer patients. ( Butruk, E; Dziurkowska-Marek, A; Hennig, E; Kohut, M; Marek, T; Nowak, A; Ostrowski, J; Przytulski, K; Regula, J, 1998) |
| "Ninety patients with active duodenal ulcer disease and H pylori infection, proven with the 13C-urea breath test and CLO test (Campylobacter-like organism test) were treated randomly in three therapeutic groups: Group A, DeNol 120 mg, amoxicillin 500 mg and metronidazole 250 mg four times a day orally for 14 days; Group B, omeprazole 20 mg plus clarithromycin 500 mg twice a day and amoxicillin 500 mg four times a day for 14 days; Group C, omeprazole 20 mg, clarithromycin 250 mg and metronidazole 500 mg twice a day for seven days." | 5.08 | New one-week, low-dose triple therapy for the treatment of duodenal ulcer with Helicobacter pylori infection. ( Ho, AS; Hsu, CT; Huang, WH; Lee, MM; Lee, SC; Shyu, RY, 1998) |
| "A total of 101 patients with proven duodenal ulcer and a positive urease test were randomized into two groups: one group received the classic triple therapy (bismuth subnitrate 3 x 375 mg for 4 weeks + tetracycline 3 x 500 mg + metronidazole 3 x 250 mg daily, both for 2 weeks ), the other group received dual therapy comprising amoxicillin 2 x 1000 mg + omeprazole 2 x 20 mg daily, both for 2 weeks." | 5.08 | Continuous and more effective duodenal ulcer healing under therapy with bismuth and two antibiotics than with dual therapy comprising omeprazole and amoxicillin. ( Kashifard, M; Malekzadeh, R; Massarrat, S; Mikaeli, J; Siavoshi, F, 1998) |
| "Three hundred seventy four patients with duodenal ulcers and Helicobacter pylori infections were given a four-week treatment of bismuth or ranitidin." | 5.08 | [The treatment of chronic duodenal ulcer with accompanying Helicobacter pylori infection]. ( Kabala, A; Pawłowski, W; Petsch, B, 1998) |
| "Two 4-week triple-therapy treatment regimens, metronidazole+tetracycline+bismuth subcitrate and omeprazole+amoxycillin+bismuth subcitrate, were compared in a randomly allocated double-blind trial for their efficacy in eradicating Helicobacter pylori from the gastric mucosa of patients with gastritis and/or peptic ulcer disease." | 5.07 | Pharmacological effects of metronidazole+tetracycline+bismuth subcitrate versus omeprazole+amoxycillin+bismuth subcitrate in Helicobacter pylori-related gastritis and peptic ulcer disease. ( Hahm, JS; Kim, HJ; Park, KN, 1994) |
| "Seventy-four patients with three endoscopically verified duodenal ulcers during the past 2 years received triple treatment consisting of bismuth subnitrate, oxytetracycline, and metronidazole for 14 days." | 5.07 | Quality of life and relapse of duodenal ulcer before and after eradication of Helicobacter pylori. ( Berstad, A; Wilhelmsen, I, 1994) |
| " In study II 22 duodenal ulcer patients were given bismuth subnitrate, oxytetracycline, and metronidazole (triple therapy) for 2 weeks to eradicate H." | 5.07 | Effects of omeprazole and eradication of Helicobacter pylori on gastric and duodenal mucosal enzyme activities and DNA in duodenal ulcer patients. ( Aase, S; Andersen, KJ; Mowinckel, P; Schrumpf, E; Vetvik, K, 1994) |
| " Forty-six consecutive patients (suffering from either peptic ulcer or non-ulcer dyspepsia) with helicobacter pylori infection were randomly allocated to one of the following two groups: group 1 (n = 23) 2 weeks of treatment with bismuth subcitrate tablets (120 mgx4) + amoxycillin capsules (500 mgx4) + metronidazole tablets (250 mgx4); group 2 (n = 23) 2 weeks of treatment with amoxycillin capsules (500 mgx4) + metronidazole tablets (250 mgx4)." | 5.07 | Evaluation of two therapeutic regimens for the treatment of Helicobacter pylori infection. ( Corinaldesi, R; De Giorgio, R; Gasperoni, S; Paparo, GF; Poli, L; Stanghellini, V; Tucci, A; Varoli, O, 1994) |
| "To determine the distribution of Helicobacter pylori in the antral and duodenal mucosa of patients with duodenal ulcers refractory to 12 wk of treatment with cimetidine and to evaluate the effect of adding antimicrobial agents to cimetidine on the healing of refractory duodenal ulcers." | 5.07 | Helicobacter pylori and refractory duodenal ulcers: cross-over comparison of continued cimetidine with cimetidine plus antimicrobials. ( Boyd, EJ; Boyd, HK; Chinzon, D; Eisig, JN; Iriya, K; Laudanna, AA; Zaterka, S, 1994) |
| " pylori-positive duodenal ulcers were randomized to receive either triple therapy for 1 wk plus omeprazole for 4 wk (Triple+OMP) (n = 78), or omeprazole alone (OMP) for 4 wk (N = 77)." | 5.07 | One-year follow-up of duodenal ulcers after 1-wk triple therapy for Helicobacter pylori. ( Cheng, AF; Chung, SC; Hosking, SW; Li, AK; Ling, TK; Sung, JJ; Yung, MY, 1994) |
| "A total of 104 patients with recurrent duodenal ulcer were treated with either ranitidine plus amoxicillin plus metronidazole or ranitidine plus placebo." | 5.07 | Kinetics of specific IgG antibodies for monitoring the effect of anti-Helicobacter pylori chemotherapy. ( Brandstätter, G; Dragosics, B; Hentschel, E; Hirschl, AM; Kundi, M; Rotter, ML; Schütze, K; Taufer, M, 1993) |
| "A controlled, prospective clinical trial of colloidal bismuth subcitrate (CBS), ranitidine and ranitidine plus metronidazole for the treatment of duodenal ulcer (DU) is reported here, with evaluation of the possible pathogenic role of Helicobacter pylori (HP) on DU in a six-month follow-up." | 5.07 | Colloidal bismuth subcitrate, ranitidine, and ranitidine plus metronidazole in the treatment of duodenal ulcer and Helicobacter pylori infection: a controlled and prospective study. ( Chen, GH; Huang, CK, 1993) |
| "In this study, 26 patients with duodenal ulcers refractory to treatment with H2-receptor antagonists for 8-12 weeks were randomly assigned to eight weeks of treatment with colloidal bismuth subcitrate (120 mg four times a day) alone (N = 12) or in combination with tetracycline hydrochloride (500 mg four times a day, days 0-14) and metronidazole (500 mg three times a day, days 15-28)." | 5.07 | Prospective, randomized, investigator-blind trial of Helicobacter pylori infection treatment in patients with refractory duodenal ulcers. Healing and long-term relapse rates. ( Hatzis, A; Mantzaris, GJ; Petraki, K; Spiliades, C; Tamvakologos, G; Triadaphyllou, G, 1993) |
| "A one week regimen of bismuth, tetracycline, and metronidazole is safe and effective in eradicating H pylori and reduces the number of duodenal ulcers four weeks after completing treatment." | 5.07 | Randomised controlled trial of short term treatment to eradicate Helicobacter pylori in patients with duodenal ulcer. ( Cheng, A; Chung, SC; Hosking, SW; Leung, JW; Li, AK; Ling, TK; Yung, MY, 1992) |
| "Duodenal ulcer relapse rates after therapy with sucralfate or bismuth are lower than those after H2-receptor antagonist therapy." | 5.07 | Triple therapy with sucralfate is as effective as triple therapy containing bismuth in eradicating Helicobacter pylori and reducing duodenal ulcer relapse rates. ( Jaskiewicz, K; Lastovica, A; Le Roux, E; Louw, JA; Lucke, W; Marks, IN; Winter, T; Zak, J, 1992) |
| " pylori-positive patients with (n = 42) or without (n = 42) duodenal ulcer were randomized to receive ranitidine, bismuth, or bismuth plus antibiotics." | 5.07 | Surface hydrophobicity of gastric mucosa in Helicobacter pylori infection: effect of clearance and eradication. ( Corbishley, CM; Goggin, PM; Jackson, PA; Marrero, JM; Northfield, TC; Spychal, RT, 1992) |
| "The probability of recurrence for patients who received triple therapy plus ranitidine was significantly lower than that for patients who received ranitidine alone: for patients with duodenal ulcer, 12% (95% CI, 1% to 24%) compared with 95% (CI, 84% to 100%); for patients with gastric ulcer, 13% (CI, 4% to 31%) compared with 74% (44% to 100%)." | 5.07 | Effect of treatment of Helicobacter pylori infection on the long-term recurrence of gastric or duodenal ulcer. A randomized, controlled study. ( Evans, DG; Evans, DJ; Graham, DY; Klein, PD; Lew, GM; Malaty, HM; Saeed, ZA, 1992) |
| " pylori agents and ranitidine was superior to ranitidine alone for duodenal ulcer healing." | 5.07 | Effect of triple therapy (antibiotics plus bismuth) on duodenal ulcer healing. A randomized controlled trial. ( Evans, DG; Evans, DJ; Graham, DY; Klein, PD; Lew, GM, 1991) |
| "50 patients with intractable duodenal ulcer were randomly assigned to 4 weeks of treatment with colloidal bismuth subcitrate (CBS) alone (26 patients) or with amoxicillin and metronidazole (24 patients)." | 5.06 | Cure of duodenal ulcer associated with eradication of Helicobacter pylori. ( Rauws, EA; Tytgat, GN, 1990) |
| " pylori eradication is achieved; (5) the eradication rates seem to be higher in peptic ulcer than in nonulcer dyspepsia; (6) in areas where the prevalence of metronidazole resistance is high, triple therapy including a PPI, clarithromycin, and amoxicillin is the best option, and (7) quadruple therapy (PPI, bismuth, tetracycline, and metronidazole) is the recommended second-line therapy after PPI-clarithromycin-amoxicillin failure, although replacing the PPI and the bismuth compound by ranitidine bismuth citrate achieves also good results." | 4.81 | Helicobacter pylori therapy: first-line options and rescue regimen. ( Gisbert, JP; Pajares, JM, 2001) |
| "46 patients having exacerbation of duodenal ulcer in the presence of Helicobacter pylori (HP) were studied for efficacy of HP eradication treatment which comprised omeprazole (40 mg/day), colloid bismuth subcitrate (480 mg/day) and metronidazole (1000 mg/day) for 2 weeks." | 3.72 | [Effectiveness of eradication anti-helicobacter therapy in patients with duodenal ulcer in different drug dosage regimens]. ( Nurbaev, FE; Orziev, ZM; Rakhimova, GSh, 2003) |
| "To study the long-term curative effects of suture plus proximal gastric vagotomy (PGV) and suture plus triad-therapy (omeprazole, amoxycillin and flagyl taken orally) for the treatment of duodenal ulcer with acute perforation." | 3.71 | [Long-term curative effects of suture plus proximal gastric vagotomy or triad-therapy for duodenal ulcer with acute perforation]. ( Fang, L; Huang, S; Jiang, K; Jiang, X; Lin, N; Pan, W; Wan, Y; Xu, R, 2002) |
| "We describe a 54-year-old man with Helicobacter pylori (+) duodenal ulcer who developed Clostridium difficile associated colitis, 5 days after commencing a 'triple' regimen consisting of omeprazole 20 mg b." | 3.70 | Clostridium difficile colitis associated with a 'triple' regimen, containing clarithromycin and metronidazole, to eradicate Helicobacter pylori. ( Archimandritis, A; Katsorida, M; Souyioultzis, S; Tzivras, M, 1998) |
| " pylori-infected patients with duodenal ulcer were treated with either omeprazole or famotidine plus two antibiotics for 2 wk." | 3.70 | The long-term reinfection rate and the course of duodenal ulcer disease after eradication of Helicobacter pylori in a developing country. ( Acevedo, C; Duarte, I; Figueroa, C; Fuster, F; Giancaspero, R; Hola, K; Rollan, A; Schulz, M, 2000) |
| "24-h monitoring of pH of the gastric juice demonstrated that three-component therapy consisting of quamatel (20 mg/day, metronidazole (500 mg 4 times a day), amoxicillin (750 mg 3 times a day) maintains the level of intragastric acidity optimal for quick scarring of duodenal ulcer defect and led to eradication of H." | 3.70 | [24-hour monitoring of gastric juice pH in assessment of anti-ulcer treatment]. ( Andreev, NG; Ismailova, MZ; Maev, IV; Romashkina, MA; Val'tsova, ED, 2000) |
| " One hundred and thirty two patients with endoscopically confirmed H pylori positive, duodenal ulcer or antral gastritis were treated with triple therapy (colloidal bismuth/metronidazole/amoxicillin) for two weeks." | 3.69 | High Helicobacter pylori numbers are associated with low eradication rate after triple therapy. ( Bujanover, Y; Gilat, T; Hallak, A; Konikoff, FM; Moshkowitz, M; Peled, Y; Santo, M; Tiomny, E, 1995) |
| " pylori-positive duodenal ulcer patients before and 6 weeks after 'triple therapy' with bismuth, tetracycline and metronidazole." | 3.69 | Effect of eradication of Helicobacter pylori on gastric epithelial cell proliferation. ( Dhillon, AP; Fraser, AG; Pounder, RE; Sankey, EA; Sim, R, 1994) |
| "Thirty-nine Helicobacter pylori (HP) positive chronic duodenal ulcer patients completed the 4 weeks treatment of triple therapy (Denol, Metronidazole and Amoxil)." | 3.69 | Triple therapy in duodenal ulcer healing--a follow up study. ( Ahmed, W; Qureshi, H; Zuberi, SJ, 1996) |
| " and omeprazole 20 mg daily for one week, followed by 20 mg omeprazole daily for further 3 weeks) in a prospective study of 36 patients with Helicobacter pylori-associated ulcers (10 gastric ulcers, 26 duodenal ulcers)." | 3.69 | [Effectiveness of short-term triple therapy for healing Helicobacter pylori infection in ulcer disease]. ( Kobler, E; Reinhart, WH; Werth, B; Wüst, W, 1997) |
| "The in-vitro activities of omeprazole and three antimicrobial agents against 89 clinical isolates of Helicobacter pylori from a population with duodenal ulcer disease were determined by an agar dilution method." | 3.69 | In-vitro susceptibility of Helicobacter pylori to ampicillin, clarithromycin, metronidazole and omeprazole. ( Barkun, AN; De Souza, E; Fallone, CA; Lavallée, J; Loo, VG, 1997) |
| " Helicobacter pylori status and the histology of the antral and oxyntic mucosa were evaluated in 25 patients with duodenal ulcer treated with a triple schedule of furazolidone, metronidazole and amoxicillin, and in 16 patients treated only with cimetidine." | 3.68 | Histology of the mucosa of gastric antrum and body before and after eradication of Helicobacter pylori. ( Barbosa, AJ; Castro, LP; Coelho, LG; Lima Júnior, GF; Mendes, EN; Oliveira, CA; Passos, MC; Queiroz, DM; Resende, LM; Rocha, GA, 1993) |
| "Omeprazole heals most duodenal ulcers after 4 weeks of treatment but relapse is common." | 3.68 | Short report: treatment of Helicobacter pylori-associated duodenal ulcer with omeprazole plus antibiotics. ( Beattie, S; Collins, R; Hamilton, H; McCarthy, CJ; O'Morain, C, 1993) |
| "25 patients with Helicobacter pylori-associated active duodenal ulcer disease (bleeding: n = 5, penetrating: n = 1, stenosis of the bulb: n = 4, frequent ulcer relapse: n = 18) were treated with 3 x 600 mg bismuth subsalicylate (BSS), 3 x 400 mg metronidazole and 3 x 500 mg tetracycline in addition to 300 mg ranitidine." | 3.68 | [Oral triple therapy for eradication of Helicobacter pylori in duodenal ulcer disease]. ( Börsch, G; Gyenes, E; Labenz, J; Rühl, GH, 1993) |
| "The histamine concentration of the oxyntic mucosa was determined in Helicobacter pylori-positive patients with duodenal ulcer before and after antimicrobial therapy and in H." | 3.68 | Histamine content of the oxyntic mucosa from duodenal ulcer patients: effect of Helicobacter pylori eradication. ( Coelho, LG; Cunha-Melo, JR; Lima Júnior, GF; Mendes, EN; Moura, SB; Oliveira, CA; Passos, MC; Queiroz, DM; Resende, LM; Rocha, GA, 1993) |
| "Thirty-six patients with nonhealing or recurrent duodenal ulcers (DU) were treated with omeprazole; 20 mg/day for one month followed by triple therapies (metronidazole, 400 mg three times a day, tetracycline, 500 mg four times a day with either colloidal bismuth, 120 mg four times a day or sucralfate 1 g four times a day." | 3.68 | Local cellular and immune response by antral mucosa in patients undergoing treatment for eradication of Helicobacter pylori. ( Jaskiewicz, K; Louw, JA; Marks, IN, 1993) |
| "60 patients with recurrent duodenal ulcers were treated with bismuth subnitrate, oxytetracycline and metronidazole." | 3.68 | [Treatment of stomach ulcer with bismuth subnitrate, oxytetracycline and metronidazole]. ( Berstad, A; Berstad, K; Hundal, O; Wilhelmsen, I, 1992) |
| "Forty-eight patients with endoscopically proven duodenal ulcer (DU) and Helicobacter pylori infection detected by 14C-urea breath test (BT) were assigned to 5 days of treatment with furazolidone, metronidazole, and amoxicillin in addition to eventual classical anti-ulcer agents if necessary." | 3.68 | Duodenal ulcer and eradication of Helicobacter pylori in a developing country. An 18-month follow-up study. ( Brandao, MJ; Castro, LP; Chausson, Y; Coelho, LG; Costa, EL; Maia, AF; Passos, MC; Rodrigues, DC, 1992) |
| "Thirty consecutive patients with endoscopically proven duodenal ulceration who had Helicobacter pylori infection on culture and histology, were treated with tripotassium dicitrato bismuthate (1 tablet q." | 3.68 | Short report: short-term triple therapy for H. pylori-associated duodenal ulcer disease. ( Beattie, S; Keane, C; O'Morain, C; Patchett, S, 1992) |
| "We have performed a retrospective study of 103 patients with either peptic ulcer or non-ulcer dyspepsia, infected with metronidazole-sensitive strains of Helicobacter pylori (H." | 3.68 | Does a previous course of tripotassium dicitrato bismuthate affect the subsequent chances of successful Helicobacter pylori eradication? ( Bell, GD; Burridge, SM; Gant, PW; Harrison, G; Jones, PH; Powell, K; Trowell, JE; Weil, J, 1992) |
| "Nine patients with Helicobacter pylori-related antral gastritis and history of duodenal ulceration were studied before and at 1 and 7 months after eradication of the infection by a 4-week course of tripotassium dicitrato bismuthate, metronidazole, and amoxycillin." | 3.68 | Plasma gastrin, daytime intragastric pH, and nocturnal acid output before and at 1 and 7 months after eradication of Helicobacter pylori in duodenal ulcer subjects. ( Chittajalu, R; Dahill, SW; el Nujumi, AM; Fullarton, GM; Hilditch, TE; MacDonald, AM; McColl, KE, 1991) |
| "Furazolidone has been effective against Helicobacter pylori in Iran, with no resistance, but with intolerable side effects in the second week." | 2.73 | Furazolidone-based, metronidazole-based, or a combination regimen for eradication of Helicobacter pylori in peptic ulcer disease. ( Agah, S; Ajvadi, Y; Ali-Asgari, A; Ebrahimi-Dariani, N; Khatibian, M; Malekzadeh, R; Massarrat, S; Mikaeli, J; Nasseri-Moghaddam, S; Pourshams, A; Sotoudehmanesh, R; Vahedi, H; Zendehdel, N, 2007) |
| "Duodenal ulcers were healed in nine of 10 (90%) patients in the BTF group and in all patients (12/12) (100%) in the OBTM group (P = N." | 2.70 | Furazolidone-based triple 'rescue therapy' vs. quadruple 'rescue therapy' for the eradication of Helicobacter pylori resistant to metronidazole. ( Domareva, I; Ganskaya, Z; Isakov, V; Koudryavtseva, L; Maev, I, 2002) |
| "and metronidazole 500 mg b." | 2.70 | Comparison of 1-week vs. 2- or 4-week therapy regimens with ranitidine bismuth citrate plus two antibiotics for Helicobacter pylori eradication. ( Doulgeroglou, V; Kamberoglou, D; Patra, E; Polymeros, D; Sanidas, I; Savva, S; Tzias, V, 2001) |
| "pylori eradication rate and ulcer recurrence rate were compared." | 2.69 | Assessment of decisions in the treatment of Helicobacter pylori-related duodenal ulcer: a cost-effectiveness study. ( Chen, J; Chen, SY; Wang, JY; Zhang, SS; Zhang, XD, 1999) |
| "The ulcer recurrences appeared in patients with H." | 2.69 | [Reinfection with Helicobacter pylori in patients with duodenal ulcer after successful eradication]. ( Mach, T; Zahradnik-Bilska, J, 1999) |
| "With regard to ulcer recurrence, 3 independent predictors were identified: failed H." | 2.69 | Predictors of failure of Helicobacter pylori eradication and predictors of ulcer recurrence: a randomized controlled trial. ( Barkun, AN; Barkun, J; Fallone, CA; Joseph, L; Kostyk, R; Loo, V, 1999) |
| "We therefore assessed the incidence of GERD among comparable patients having undergone successful versus failed H." | 2.69 | Is Helicobacter pylori eradication associated with gastroesophageal reflux disease? ( Barkun, AN; Beech, R; Best, L; Fallone, CA; Friedman, G; Joseph, L; Loo, V; Mayrand, S, 2000) |
| "To determine the 12-month posttherapy recurrence (recrudescence) of Helicobacter pylori in patients with healed duodenal ulcer after apparent eradication of the organism with anti-H." | 2.68 | Recrudescence of Helicobacter pylori infection in patients with healed duodenal ulcer after treatment with different regimens. ( Beattie, S; Gilvarry, J; Hamilton, H; Keane, CT; O'Morain, CA; Sweeney, EC; Xia, HX, 1995) |
| "Duodenal ulcers were healed in 44 of 49 (89." | 2.68 | Dual therapy versus triple therapy for Helicobacter pylori-associated duodenal ulcers. ( Cheng, AF; Chung, SC; Lau, JY; Leung, VK; Li, AK; Ling, TK; Suen, R; Sung, JJ, 1996) |
| "91%)." | 2.68 | Low H. pylori reinfection rate after triple therapy in Chilean duodenal ulcer patients. ( Acuña, R; Albornoz, V; Figueroa, G; Portell, DP; Toledo, MS; Troncoso, M; Vigneaux, J, 1996) |
| "Cure of HP infection reduces the recurrence of peptic ulcer and of rebleeding from ulcer disease more effectively than does long-term maintenance therapy." | 2.68 | Antimicrobial therapy for Helicobacter pylori infection versus long-term maintenance antisecretion treatment in the prevention of recurrent hemorrhage from peptic ulcer: prospective nonrandomized trial on 125 patients. ( Cantero, J; Gómez-Cedenilla, A; Grávalos, RG; Pajares, JM; Santander, C, 1996) |
| "Shallow duodenal ulcers were noted in three patients at 1-year follow-up, two of whom admitted to taking non-steroidal anti-inflammatory drugs (NSAIDs); H." | 2.68 | Reinfection and duodenal ulcer relapse in south-east Asian patients following successful Helicobacter pylori eradication: results of a 2-year follow-up. ( Goh, KL; Navaratnam, P; Peh, SC, 1996) |
| "Clarithromycin is a new macrolide antibiotic which is known to be highly effective in eradicating Helicobacter pylori (H." | 2.68 | Clarithromycin in the combination therapy for the eradication of Helicobacter pylori in peptic ulcer disease. ( Lee, SD; Lin, HJ; Lo, WC; Perng, CL; Wang, K, 1997) |
| "To detect DU recurrence, the gastroscopy was performed at 6, 12, 18, and 24 months after therapy." | 2.67 | The effect of eradication of Helicobacter pylori upon the duodenal ulcer recurrence--a 24 month follow-up study. ( Choi, JH; Jung, MH; Kim, NY; Lee, KH; Oh, HS; Wee, SH, 1994) |
| "pylori) eradication and duodenal ulcer recurrence." | 2.67 | Eradication of Helicobacter pylori infection and the recurrence of duodenal ulcers. ( Chen, CY; Chen, LT; Jan, CM; Lin, SR; Liu, CS; Perng, DS; Wang, WM, 1993) |
| "pylori on the recurrence of duodenal ulcer, we treated 104 patients with H." | 2.67 | Effect of ranitidine and amoxicillin plus metronidazole on the eradication of Helicobacter pylori and the recurrence of duodenal ulcer. ( Brandstätter, G; Dragosics, B; Hentschel, E; Hirschl, AM; Nemec, H; Schütze, K; Taufer, M; Wurzer, H, 1993) |
| "Metronidazole resistance has become an increasing problem that has severely limited the usefulness of the original triple therapy." | 2.67 | Short report: a non-metronidazole triple therapy for eradication of Helicobacter pylori infection--tetracycline, amoxicillin, bismuth. ( Genta, RM; Graham, DY; Klein, PD; Lew, GM; Malaty, HM; Ramirez, FC, 1993) |
| "Duodenal ulcer recurrence and gastritis are reduced with successful Helicobacter pylori treatment." | 2.67 | Patient factors affecting Helicobacter pylori eradication with triple therapy. ( Cutler, AF; Schubert, TT, 1993) |
| "The treatment of duodenal ulcer has evolved from ineffective medical treatments through an era of surgical management, back to increasingly effective medical treatment." | 2.39 | Duodenal ulcer treatment: progress from pH to HP. ( Reilly, TG; Walt, RP, 1994) |
| "Pre-existing nonerosive gastroesophageal reflux disease, smoking, and older age are important predictors of de novo development of erosive esophagitis." | 1.36 | De novo erosive esophagitis in duodenal ulcer patients related to pre-existing reflux symptoms, smoking, and patient age, but not to Helicobacter pylori eradication: a one-year follow-up study. ( Jonaitis, L; Kiudelis, G; Kupčinskas, J; Kupčinskas, L, 2010) |
| "Meckel's diverticulum was excised." | 1.33 | Pneumatosis cystoides intestinalis associated with perforated chronic duodenal ulcer and Meckel's diverticulum. ( Ağaoğlu, N, 2005) |
| "Chronic gastritis was evaluated according to sydney system." | 1.33 | [Prospective study of 420 biopsies realised in patients with duodenal ulcer with positive Helicobacter pylori]. ( Ben Ayed, M; Ben Khelifa, H; Chedly-Debbiche, A; Gargouri, D; Ghorbel, AJ; Kharrat, J; Khayat, O; Kilani, A; Souissi, A; Zeddini, A, 2006) |
| "Gastric metaplasia was endoscopically and histologically evaluated before and after eradication of this bacterium." | 1.32 | Long-term follow-up of gastric metaplasia after eradication of Helicobacter pylori. ( Sano, T; Urakami, Y, 2003) |
| "1 year after drug therapy the recurrence of CDU is revealed in 16." | 1.31 | [Current principles of the use of laparoscopic surgery in gastroduodenal ulcer]. ( Fedorov, AV; Sazhin, VP, 2001) |
| "Lactoferrin (Lf) is an iron-binding glycoprotein present in milk, lacrimae, saliva, and gastroduodenal secretions." | 1.30 | Relation of lactoferrin levels in gastric mucosa with Helicobacter pylori infection and with the degree of gastric inflammation. ( Ikemura, N; Imoto, I; Misaki, M; Nakao, K; Shibata, T; Taguchi, Y; Takaji, S; Yamauchi, K; Yamazaki, N, 1997) |
| "After 1 year, no patient had H." | 1.30 | Duodenal ulcer relapse is not always associated with recurrence of H. pylori infection: a prospective three-year follow-up study. ( Annibale, B; D'Ambra, G; Delle Fave, G; Marcheggiano, A; Martino, G; Paoletti, M, 1999) |
| "There was no recurrence of ulcer in 17 H." | 1.29 | Long-term follow-up and serological study after triple therapy of Helicobacter pylori-associated duodenal ulcer. ( Chen, CY; Chen, LT; Jan, CM; Lin, SR; Liu, CS; Perng, DS; Wang, WM, 1994) |
| "Lansoprazole has a cytotoxic action against this organism, the MIC being 2." | 1.29 | Effect of lansoprazole in mono-, dual-, or triple therapy on Helicobacter pylori eradication. ( Kawano, S; Murakami, M; Saita, H; Tsuji, S, 1996) |
| "pylori and cured DU, there has been no recurrence of ulcer, regardless of smoking status." | 1.28 | Smoking does not contribute to duodenal ulcer relapse after Helicobacter pylori eradication. ( Andrews, P; Borody, TJ; Brandl, S; George, LL; Jankiewicz, E; Ostapowicz, N, 1992) |
| "Kinetics and bioavailability of metronidazole were studied in 17 patients admitted in our emergency care unit for gastrointestinal surgery." | 1.27 | Metronidazole kinetics and bioavailability in patients undergoing gastrointestinal surgery. ( Diquet, B; Ghesquiére, F; Levesque, C; Simon, P; Thiercelin, JF; Viars, P, 1984) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 10 (3.31) | 18.7374 |
| 1990's | 208 (68.87) | 18.2507 |
| 2000's | 72 (23.84) | 29.6817 |
| 2010's | 11 (3.64) | 24.3611 |
| 2020's | 1 (0.33) | 2.80 |
| Authors | Studies |
|---|---|
| Tseng, YY | 1 |
| Liou, JM | 1 |
| Hsu, TL | 1 |
| Cheng, WC | 1 |
| Wu, MS | 2 |
| Wong, CH | 1 |
| Vu, TB | 1 |
| Tran, TNQ | 1 |
| Tran, TQA | 1 |
| Vu, DL | 1 |
| Hoang, VT | 1 |
| Xie, Y | 1 |
| Pan, X | 1 |
| Li, Y | 2 |
| Wang, H | 2 |
| Du, Y | 1 |
| Xu, J | 1 |
| Wang, J | 1 |
| Zeng, Z | 1 |
| Chen, Y | 1 |
| Zhang, G | 1 |
| Wu, K | 1 |
| Liu, D | 1 |
| Lv, N | 1 |
| Salmanroghani, H | 1 |
| Mirvakili, M | 1 |
| Baghbanian, M | 1 |
| Salmanroghani, R | 1 |
| Sanati, G | 1 |
| Yazdian, P | 1 |
| Makobongo, MO | 1 |
| Einck, L | 1 |
| Peek, RM | 1 |
| Merrell, DS | 1 |
| Sasaki, H | 1 |
| Nagahara, A | 1 |
| Hojo, M | 1 |
| Asaoka, D | 1 |
| Matsumoto, K | 1 |
| Osada, T | 1 |
| Watanabe, S | 1 |
| Lee, HJ | 1 |
| Kim, JI | 1 |
| Lee, JS | 1 |
| Jun, EJ | 1 |
| Oh, JH | 1 |
| Cheung, DY | 1 |
| Chung, WC | 1 |
| Kim, BW | 1 |
| Kim, SS | 1 |
| Tepeš, B | 2 |
| Vujasinović, M | 1 |
| Šeruga, M | 1 |
| Stefanovič, M | 1 |
| Forte, A | 1 |
| Jeverica, S | 1 |
| Okuda, M | 1 |
| Kikuchi, S | 1 |
| Mabe, K | 1 |
| Osaki, T | 1 |
| Kamiya, S | 1 |
| Fukuda, Y | 1 |
| Kato, M | 2 |
| Ngom, G | 1 |
| Diouf, ML | 1 |
| Fall, M | 1 |
| Konaté, I | 1 |
| Sankalé, AA | 1 |
| Diop, M | 1 |
| Fall, I | 1 |
| Ndoye, M | 1 |
| El-Nakeeb, A | 1 |
| Fikry, A | 1 |
| Abd El-Hamed, TM | 1 |
| Fouda, el Y | 1 |
| El Awady, S | 1 |
| Youssef, T | 1 |
| Sherief, D | 1 |
| Farid, M | 1 |
| Feagins, LA | 1 |
| Chan, V | 1 |
| Spechler, SJ | 1 |
| Seck, A | 1 |
| Mbengue, M | 1 |
| Gassama-Sow, A | 1 |
| Diouf, L | 1 |
| Ka, MM | 1 |
| Boye, CS | 1 |
| Jonaitis, L | 1 |
| Kupčinskas, J | 1 |
| Kiudelis, G | 1 |
| Kupčinskas, L | 1 |
| Yakoob, J | 1 |
| Abid, S | 1 |
| Abbas, Z | 1 |
| Jafri, SN | 1 |
| Shah, A | 1 |
| Javid, G | 1 |
| Zargar, SA | 1 |
| Teli, F | 1 |
| Khan, BA | 1 |
| Yattoo, GN | 1 |
| Gulzar, GM | 1 |
| Sodhi, JS | 1 |
| Khan, MA | 1 |
| Shoukat, A | 1 |
| Saif, R | 1 |
| Isakov, V | 1 |
| Domareva, I | 1 |
| Koudryavtseva, L | 1 |
| Maev, I | 1 |
| Ganskaya, Z | 1 |
| Vasil'ev, IuV | 4 |
| Zvenigorodskaia, LA | 2 |
| Kolomiets, EV | 2 |
| Firsanova, VIu | 1 |
| Ivashkin, VT | 1 |
| Lapina, TL | 1 |
| Bondarenko, OY | 1 |
| Sklanskaya, OA | 1 |
| Grigoriev, PY | 1 |
| Vasiliev, YV | 1 |
| Yakovenko, EP | 1 |
| Gulyaev, PV | 1 |
| Fedchenko, VI | 1 |
| Xu, R | 1 |
| Fang, L | 1 |
| Jiang, X | 1 |
| Wan, Y | 1 |
| Huang, S | 1 |
| Jiang, K | 1 |
| Lin, N | 1 |
| Pan, W | 1 |
| Mantzaris, GJ | 2 |
| Petraki, K | 2 |
| Archavlis, E | 1 |
| Amberiadis, P | 1 |
| Christoforidis, P | 1 |
| Kourtessas, D | 1 |
| Chiotakakou, E | 1 |
| Triantafyllou, G | 1 |
| Hung, WK | 1 |
| Wong, WM | 4 |
| Wong, GS | 1 |
| Yip, AW | 1 |
| Szeto, ML | 1 |
| Lai, KC | 7 |
| Hu, WH | 6 |
| Chan, CK | 5 |
| Xia, HH | 2 |
| Yuen, MF | 2 |
| Fung, FM | 2 |
| Tong, TS | 1 |
| Ho, VY | 1 |
| Lam, SK | 8 |
| Wong, BC | 8 |
| Murakami, K | 1 |
| Sato, R | 1 |
| Okimoto, T | 1 |
| Nasu, M | 1 |
| Fujioka, T | 1 |
| Kodama, M | 1 |
| Kagawa, J | 1 |
| Schuster, MJ | 1 |
| Urakami, Y | 2 |
| Sano, T | 1 |
| Lau, CS | 1 |
| Ip, WY | 1 |
| Hui, WM | 3 |
| Wong, RW | 1 |
| Laine, L | 3 |
| Hunt, R | 1 |
| El-Zimaity, H | 1 |
| Nguyen, B | 1 |
| Osato, M | 1 |
| Spénard, J | 1 |
| Abbas, SZ | 1 |
| Abbas, AB | 1 |
| Crawshaw, A | 1 |
| Shaw, S | 1 |
| English, J | 1 |
| McGovern, D | 1 |
| Vivian, G | 1 |
| Dalton, HR | 1 |
| Orziev, ZM | 2 |
| Nurbaev, FE | 2 |
| Rakhimova, GSh | 2 |
| Rukhliada, NV | 1 |
| Nazarov, VE | 1 |
| Ermolaev, IA | 1 |
| Sjölund, M | 1 |
| Wreiber, K | 1 |
| Andersson, DI | 1 |
| Blaser, MJ | 2 |
| Engstrand, L | 1 |
| Herszényi, L | 1 |
| Malfertheiner, P | 1 |
| Kamilova, AT | 1 |
| Pazylova, SA | 1 |
| Abdullaeva, DA | 1 |
| Abduzhbarova, ZM | 1 |
| Gumurdulu, Y | 1 |
| Serin, E | 1 |
| Ozer, B | 1 |
| Kayaselcuk, F | 1 |
| Ozsahin, K | 1 |
| Cosar, AM | 1 |
| Gursoy, M | 1 |
| Gur, G | 1 |
| Yilmaz, U | 1 |
| Boyacioglu, S | 1 |
| Kirika, NV | 1 |
| Bodrug, NI | 1 |
| Butorov, IV | 1 |
| Butorov, SI | 1 |
| Xiao, SD | 2 |
| Hu, PJ | 2 |
| Wang, WH | 2 |
| Gu, Q | 1 |
| Huang, JQ | 1 |
| Wu, SM | 1 |
| Li, CJ | 1 |
| Chen, MH | 1 |
| Cui, Y | 1 |
| Chang, FY | 2 |
| Chen, CY | 3 |
| Lu, CL | 1 |
| Luo, JC | 1 |
| Lu, RH | 1 |
| Lee, SD | 3 |
| Rodríguez-Torres, M | 1 |
| Salgado-Mercado, R | 1 |
| Ríos-Bedoya, CF | 1 |
| Aponte-Rivera, E | 1 |
| Marxuach-Cuétara, AM | 1 |
| Rodríguez-Orengo, JF | 1 |
| Fernández-Carbia, A | 1 |
| Ağaoğlu, N | 1 |
| Khayat, O | 1 |
| Kilani, A | 1 |
| Chedly-Debbiche, A | 1 |
| Zeddini, A | 1 |
| Gargouri, D | 1 |
| Kharrat, J | 1 |
| Souissi, A | 1 |
| Ghorbel, AJ | 1 |
| Ben Ayed, M | 1 |
| Ben Khelifa, H | 1 |
| Tsai, SH | 1 |
| Chang, WC | 1 |
| Chu, SJ | 1 |
| Wu, CP | 1 |
| Khatibian, M | 2 |
| Ajvadi, Y | 1 |
| Nasseri-Moghaddam, S | 1 |
| Ebrahimi-Dariani, N | 1 |
| Vahedi, H | 2 |
| Zendehdel, N | 1 |
| Sotoudehmanesh, R | 1 |
| Agah, S | 1 |
| Mikaeli, J | 2 |
| Pourshams, A | 1 |
| Ali-Asgari, A | 1 |
| Malekzadeh, R | 4 |
| Massarrat, S | 6 |
| Vorob'ev, LP | 1 |
| Ponomarev, IuT | 1 |
| Samsonov, AA | 1 |
| Agibalov, IuV | 1 |
| Thiercelin, JF | 1 |
| Diquet, B | 1 |
| Levesque, C | 1 |
| Ghesquiére, F | 1 |
| Simon, P | 1 |
| Viars, P | 1 |
| Shirokova, KI | 1 |
| Filimonov, RM | 1 |
| Poliakova, LV | 1 |
| Gisbert, JP | 12 |
| Boixeda, D | 11 |
| Vila, T | 2 |
| de Rafael, L | 6 |
| Alvarez Baleriola, I | 5 |
| Martín de Argila, C | 10 |
| Bermejo, F | 3 |
| García Plaza, A | 5 |
| Labenz, J | 6 |
| Stolte, M | 4 |
| Peitz, U | 3 |
| Tillenburg, B | 3 |
| Köhl, H | 2 |
| Becker, T | 2 |
| Börsch, G | 6 |
| Schepp, W | 1 |
| Hoffenberg, P | 1 |
| Reyes, V | 1 |
| Contreras, L | 1 |
| Giglio, M | 1 |
| Ossa, P | 1 |
| Weitz, JC | 1 |
| Moshkowitz, M | 2 |
| Konikoff, FM | 2 |
| Peled, Y | 2 |
| Santo, M | 2 |
| Hallak, A | 2 |
| Bujanover, Y | 2 |
| Tiomny, E | 2 |
| Gilat, T | 2 |
| Chong, SK | 1 |
| Lou, Q | 1 |
| Asnicar, MA | 1 |
| Zimmerman, SE | 1 |
| Croffie, JM | 1 |
| Lee, CH | 1 |
| Fitzgerald, JF | 1 |
| Bell, GD | 6 |
| Powell, KU | 3 |
| Fennerty, MB | 2 |
| Xia, HX | 2 |
| Gilvarry, J | 1 |
| Beattie, S | 3 |
| Hamilton, H | 2 |
| Keane, CT | 2 |
| Sweeney, EC | 1 |
| O'Morain, CA | 2 |
| el-Omar, EM | 1 |
| Penman, ID | 1 |
| Ardill, JE | 3 |
| Chittajallu, RS | 3 |
| Howie, C | 1 |
| McColl, KE | 6 |
| Saberi-Firoozi, M | 1 |
| Zare, S | 1 |
| Fattahi, M | 1 |
| Javan, A | 1 |
| Etaati, H | 1 |
| Dehbashi, N | 1 |
| Sung, JJ | 6 |
| Leung, VK | 3 |
| Chung, SC | 6 |
| Ling, TK | 5 |
| Suen, R | 2 |
| Cheng, AF | 4 |
| Li, AK | 5 |
| Lazzaroni, M | 4 |
| Maconi, G | 2 |
| Bargiggia, S | 3 |
| Minguzzi, M | 1 |
| Bianchi Porro, G | 4 |
| O'Connor, HJ | 2 |
| Kanduru, C | 1 |
| Bhutta, AS | 2 |
| Meehan, JM | 1 |
| Feeley, KM | 1 |
| Cunnane, K | 2 |
| Qureshi, H | 2 |
| Ahmed, W | 2 |
| Syed, S | 1 |
| Lodi, TZ | 1 |
| Zuberi, SJ | 2 |
| Park, KN | 1 |
| Hahm, JS | 1 |
| Kim, HJ | 2 |
| Gormally, SM | 1 |
| Prakash, N | 1 |
| Durnin, MT | 1 |
| Daly, LE | 1 |
| Clyne, M | 2 |
| Kierce, BM | 1 |
| Drumm, B | 3 |
| Wilhelmsen, I | 2 |
| Berstad, A | 3 |
| Rune, SJ | 1 |
| Kim, NY | 1 |
| Oh, HS | 1 |
| Jung, MH | 1 |
| Wee, SH | 1 |
| Choi, JH | 1 |
| Lee, KH | 1 |
| Vetvik, K | 1 |
| Schrumpf, E | 1 |
| Mowinckel, P | 1 |
| Aase, S | 1 |
| Andersen, KJ | 1 |
| Archimandritis, A | 4 |
| Balatsos, V | 2 |
| Delis, V | 2 |
| Mentis, A | 1 |
| Kastanas, K | 1 |
| Scandalis, N | 1 |
| Adamek, RJ | 3 |
| Szymanski, C | 1 |
| Pfaffenbach, B | 1 |
| Opferkuch, W | 1 |
| Ricken, D | 1 |
| Wegener, M | 1 |
| Wang, WM | 2 |
| Jan, CM | 2 |
| Chen, LT | 2 |
| Perng, DS | 2 |
| Lin, SR | 2 |
| Liu, CS | 2 |
| Iser, JH | 1 |
| Buttigieg, RJ | 1 |
| Iseli, A | 1 |
| Hosking, SW | 3 |
| Yung, MY | 4 |
| el-Omar, E | 2 |
| Banerjee, S | 1 |
| Fraser, AG | 1 |
| Sim, R | 1 |
| Sankey, EA | 1 |
| Dhillon, AP | 1 |
| Pounder, RE | 2 |
| Lin, JT | 1 |
| Wang, JT | 1 |
| Lee, WY | 1 |
| Yang, JC | 2 |
| Wang, TH | 2 |
| Neeman, A | 1 |
| Kadish, U | 1 |
| Stölzle, L | 1 |
| Holtmann, G | 1 |
| Layer, P | 1 |
| Berstad, K | 2 |
| Sjödahl, R | 1 |
| Solcia, E | 2 |
| Villani, L | 2 |
| Fiocca, R | 2 |
| Luinetti, O | 2 |
| Boldorini, R | 1 |
| Trespi, E | 2 |
| Perego, M | 2 |
| Alvisi, C | 2 |
| Lynch, DA | 2 |
| Sobala, GM | 2 |
| Gallacher, B | 2 |
| Dixon, MF | 4 |
| Axon, AT | 5 |
| Tucci, A | 1 |
| Poli, L | 1 |
| Gasperoni, S | 1 |
| Varoli, O | 1 |
| Paparo, GF | 1 |
| De Giorgio, R | 1 |
| Stanghellini, V | 1 |
| Corinaldesi, R | 1 |
| Reilly, TG | 1 |
| Walt, RP | 1 |
| Boyd, HK | 1 |
| Zaterka, S | 1 |
| Eisig, JN | 1 |
| Chinzon, D | 1 |
| Iriya, K | 1 |
| Laudanna, AA | 1 |
| Boyd, EJ | 1 |
| Chen, TS | 1 |
| Tsay, SH | 1 |
| Resende, LM | 2 |
| Queiroz, DM | 2 |
| Barbosa, AJ | 1 |
| Mendes, EN | 2 |
| Rocha, GA | 2 |
| Coelho, LG | 4 |
| Passos, MC | 4 |
| Castro, LP | 2 |
| Oliveira, CA | 2 |
| Lima Júnior, GF | 2 |
| Schorah, CJ | 1 |
| Shires, S | 1 |
| Penman, I | 1 |
| Dorrian, CA | 1 |
| Maniatis, AG | 1 |
| Brazer, SR | 1 |
| McCarthy, CJ | 1 |
| Collins, R | 1 |
| O'Morain, C | 7 |
| Kihira, K | 1 |
| Sato, K | 1 |
| Yoshida, Y | 1 |
| Takimoto, T | 1 |
| Taniguchi, Y | 1 |
| Kimura, K | 1 |
| Thijs, JC | 2 |
| Van Zwet, AA | 1 |
| Oey, HB | 1 |
| Logan, RP | 3 |
| Gummett, PA | 1 |
| Misiewicz, JJ | 4 |
| Karim, QN | 1 |
| Walker, MM | 1 |
| Baron, JH | 2 |
| Gyenes, E | 1 |
| Rühl, GH | 1 |
| Moura, SB | 1 |
| Cunha-Melo, JR | 1 |
| Moss, SF | 2 |
| Calam, J | 5 |
| Vigneri, S | 1 |
| Savarino, V | 1 |
| Termini, R | 1 |
| Mela, GS | 1 |
| Hirschl, AM | 2 |
| Brandstätter, G | 3 |
| Dragosics, B | 3 |
| Hentschel, E | 4 |
| Kundi, M | 1 |
| Rotter, ML | 1 |
| Schütze, K | 3 |
| Taufer, M | 4 |
| Asaka, M | 1 |
| Kudo, M | 1 |
| Meguro, T | 1 |
| Kimura, T | 1 |
| Miyazaki, T | 1 |
| Inoue, K | 1 |
| Huang, CK | 1 |
| Chen, GH | 1 |
| Nemec, H | 2 |
| Wurzer, H | 3 |
| Nakanishi, T | 1 |
| Shinomura, Y | 1 |
| Kanayama, S | 1 |
| Matsuzawa, Y | 1 |
| Graham, DY | 7 |
| Lew, GM | 5 |
| Ramirez, FC | 1 |
| Genta, RM | 3 |
| Klein, PD | 5 |
| Malaty, HM | 3 |
| Cutler, AF | 1 |
| Schubert, TT | 1 |
| Jaskiewicz, K | 2 |
| Louw, JA | 2 |
| Marks, IN | 2 |
| Hatzis, A | 1 |
| Tamvakologos, G | 1 |
| Spiliades, C | 1 |
| Triadaphyllou, G | 1 |
| Hernández Ranz, F | 1 |
| Khulusi, S | 1 |
| Badve, S | 1 |
| Patel, P | 1 |
| Lloyd, R | 1 |
| Marrero, JM | 2 |
| Finlayson, C | 1 |
| Mendall, MA | 1 |
| Northfield, TC | 2 |
| Diehl, HG | 1 |
| Bate, CM | 2 |
| Tildesley, G | 2 |
| Kerr, GD | 3 |
| Green, JR | 1 |
| Emmas, CE | 1 |
| Taylor, MD | 2 |
| de Boer, WA | 2 |
| Driessen, WM | 1 |
| Vakil, N | 1 |
| Davis, S | 1 |
| Lau, JY | 1 |
| Sjöström, JE | 1 |
| Larsson, H | 1 |
| García, M | 1 |
| Redondo, C | 4 |
| Cantón, R | 1 |
| Franceschi, M | 1 |
| Cesana, B | 1 |
| Figueroa, G | 1 |
| Acuña, R | 1 |
| Troncoso, M | 1 |
| Portell, DP | 1 |
| Toledo, MS | 1 |
| Albornoz, V | 1 |
| Vigneaux, J | 1 |
| Shirotani, T | 1 |
| Okada, M | 1 |
| Murayama, H | 1 |
| Maeda, K | 1 |
| Seo, M | 1 |
| Okabe, N | 1 |
| Nakahara, T | 1 |
| Oh, K | 1 |
| Nakayama, Y | 1 |
| Hoshiko, K | 1 |
| Oda, K | 1 |
| Okumura, M | 1 |
| Stupnicki, T | 1 |
| Denk, H | 1 |
| Ratschek, M | 1 |
| Spath, P | 1 |
| Graf, K | 1 |
| Rosengren, H | 1 |
| Polson, RJ | 1 |
| Santander, C | 1 |
| Grávalos, RG | 1 |
| Gómez-Cedenilla, A | 1 |
| Cantero, J | 1 |
| Pajares, JM | 3 |
| Tsimmerman, IaS | 1 |
| Kiseleva, RP | 1 |
| Freĭnd, GG | 1 |
| Sito, E | 1 |
| Konturek, PC | 1 |
| Bielański, W | 2 |
| Kwiecień, N | 1 |
| Konturek, SJ | 1 |
| Baniukiewicz, A | 1 |
| Jedynak, M | 1 |
| Gabryelewicz, A | 1 |
| Hahn, EG | 2 |
| van Etten, RJ | 1 |
| Schade, RW | 1 |
| Ouwehand, ME | 1 |
| Schneeberger, PM | 1 |
| Tytgat, GN | 3 |
| Avsar, E | 1 |
| Kalayci, C | 1 |
| Tözün, N | 1 |
| Lawrence, R | 1 |
| Kiziltas, S | 1 |
| Gültekin, O | 1 |
| Ulusoy, NB | 1 |
| Phull, PS | 1 |
| Griffiths, AE | 1 |
| Halliday, D | 1 |
| Jacyna, MR | 1 |
| Goenka, MK | 1 |
| Das, K | 1 |
| Vaiphei, K | 1 |
| Nijhawan, R | 1 |
| Kocbhar, R | 1 |
| Martin, JL | 1 |
| Richardson, PD | 1 |
| Yousfi, MM | 1 |
| El-Zimaity, HM | 1 |
| Cole, RA | 1 |
| Park, SM | 1 |
| Park, J | 1 |
| Chang, SK | 1 |
| Yoo, BC | 1 |
| Kawano, S | 1 |
| Murakami, M | 1 |
| Saita, H | 1 |
| Tsuji, S | 1 |
| Brill, S | 1 |
| Sheu, BS | 1 |
| Yang, HB | 1 |
| Su, IJ | 1 |
| Shiesh, SC | 1 |
| Chi, CH | 1 |
| Lin, XZ | 1 |
| Goh, KL | 2 |
| Navaratnam, P | 1 |
| Peh, SC | 1 |
| Jiménez, I | 1 |
| Pérez García, JI | 1 |
| Bruno, M | 1 |
| Peyre, S | 1 |
| Grosso, S | 1 |
| Rizzi, R | 1 |
| Sategna-Guidetti, C | 1 |
| Paar, D | 1 |
| Terjung, B | 1 |
| Sauerbruch, T | 1 |
| Caselli, M | 1 |
| Trevisani, L | 1 |
| Tursi, A | 1 |
| Sartori, S | 1 |
| Ruina, M | 1 |
| Luzzi, I | 1 |
| Gaudenzi, P | 1 |
| Alvisi, V | 1 |
| Gasbarrini, G | 1 |
| Dohil, R | 1 |
| Israel, DM | 1 |
| Hassall, E | 1 |
| Lerang, F | 1 |
| Moum, B | 1 |
| Haug, JB | 1 |
| Tolås, P | 1 |
| Breder, O | 1 |
| Aubert, E | 1 |
| Høie, O | 1 |
| Søberg, T | 1 |
| Flaaten, B | 1 |
| Farup, P | 1 |
| Berge, T | 1 |
| Idström, JP | 2 |
| Kung, NN | 2 |
| Yuen, NW | 1 |
| Ng, PW | 1 |
| Wong, KC | 1 |
| Chung, EC | 1 |
| Lim, BH | 1 |
| Choi, CH | 1 |
| Li, TH | 1 |
| Ma, HC | 1 |
| Kwok, SP | 1 |
| Dayal, VM | 1 |
| Kumar, P | 1 |
| Kamal, J | 1 |
| Shahi, SK | 1 |
| Agrawal, BK | 1 |
| Kimura, M | 1 |
| Seki, H | 1 |
| Nakao, K | 1 |
| Imoto, I | 1 |
| Ikemura, N | 1 |
| Shibata, T | 1 |
| Takaji, S | 1 |
| Taguchi, Y | 1 |
| Misaki, M | 1 |
| Yamauchi, K | 1 |
| Yamazaki, N | 1 |
| Harris, A | 1 |
| Lo, WC | 1 |
| Lin, HJ | 1 |
| Wang, K | 1 |
| Perng, CL | 1 |
| Vcev, A | 3 |
| Vuković, D | 2 |
| Ivandić, A | 2 |
| Vceva, A | 3 |
| Dmitrović, B | 3 |
| Kovacić, D | 1 |
| Volaric, M | 1 |
| Paulini, D | 1 |
| Mićunović, N | 2 |
| Horvat, D | 1 |
| Mihaljević, S | 2 |
| Popiela, T | 1 |
| Kulig, J | 1 |
| Karcz, D | 1 |
| Tabor, J | 1 |
| Torres, J | 1 |
| Márquez, M | 1 |
| Fillat, O | 1 |
| Herrero, E | 1 |
| Ortiz, JA | 1 |
| Abraira, V | 2 |
| Ching, CK | 3 |
| Lai, CL | 2 |
| Ong, L | 1 |
| Rudnicka, L | 1 |
| Bobrzyński, A | 2 |
| Stachura, J | 2 |
| Tan, WC | 1 |
| Hogan, J | 1 |
| Purkayastha, SK | 1 |
| Lombard, M | 1 |
| Krasner, N | 1 |
| Kobler, E | 1 |
| Werth, B | 1 |
| Wüst, W | 1 |
| Reinhart, WH | 1 |
| Chan, FK | 1 |
| To, KF | 1 |
| Lee, YT | 1 |
| Chan, CS | 1 |
| Li, EK | 1 |
| Woo, J | 1 |
| Cottrill, MR | 1 |
| McKinnon, C | 1 |
| Mason, I | 1 |
| Chesters, SA | 1 |
| Slatcher, G | 1 |
| Copeman, MB | 1 |
| Turbitt, ML | 1 |
| Rodrigo, L | 1 |
| Stamler, D | 1 |
| Archambault, A | 1 |
| Rokkas, T | 1 |
| Skandalis, N | 2 |
| Fedorak, R | 1 |
| Bazzoli, F | 1 |
| Mora, P | 1 |
| Megraud, F | 1 |
| Buckley, MJ | 1 |
| Hyde, DM | 1 |
| Harford, W | 1 |
| Lanza, F | 1 |
| Arora, A | 1 |
| Graham, D | 1 |
| Haber, M | 1 |
| Weissfeld, A | 1 |
| Rose, P | 1 |
| Siepman, N | 1 |
| Lind, T | 2 |
| Veldhuyzen van Zanten, S | 1 |
| Unge, P | 2 |
| Spiller, R | 1 |
| Bayerdörffer, E | 3 |
| Bardhan, KD | 4 |
| Bradette, M | 2 |
| Chiba, N | 1 |
| Wrangstadh, M | 2 |
| Cederberg, C | 1 |
| Suriani, R | 1 |
| Ravizza, M | 1 |
| Pallante, C | 1 |
| Mazzucco, D | 1 |
| Cardesi, E | 1 |
| Colozza, M | 1 |
| Malandrino, M | 1 |
| Oneglio, R | 1 |
| Orso Giacone, G | 1 |
| Dusio, P | 1 |
| Vajo, M | 1 |
| Loane, J | 1 |
| Bindel, H | 1 |
| Gedliczka, O | 1 |
| Konturek, S | 1 |
| Budzyński, A | 1 |
| Harris, AW | 2 |
| Levi, S | 5 |
| Cooper, BT | 2 |
| Langworthy, H | 2 |
| Piper, D | 2 |
| Loo, VG | 2 |
| Fallone, CA | 4 |
| De Souza, E | 1 |
| Lavallée, J | 1 |
| Barkun, AN | 4 |
| Tzivras, M | 2 |
| Souyioultzis, S | 2 |
| Kanellopoulou, E | 1 |
| Manika, Z | 1 |
| Davaris, P | 1 |
| Takac, B | 2 |
| Gardasanić, J | 1 |
| Horonitz, M | 1 |
| Karner, I | 1 |
| Marcelino, M | 1 |
| Jahnsen, J | 1 |
| Lotay, N | 1 |
| Roberts, PM | 1 |
| Berquist, WE | 1 |
| Moreno, L | 1 |
| Glaser, J | 1 |
| Hein, J | 1 |
| Daikeler, R | 1 |
| Weithofer, G | 1 |
| Vieth, M | 2 |
| Schmidt, M | 1 |
| Carnicer, J | 1 |
| Koizumi, W | 1 |
| Tanabe, S | 1 |
| Hibi, K | 1 |
| Imaizumi, H | 1 |
| Ohida, M | 1 |
| Okabe, H | 1 |
| Saigenji, K | 1 |
| Okayasu, I | 1 |
| Katsorida, M | 1 |
| Stimac, D | 1 |
| Kovac, D | 1 |
| Dore, MP | 1 |
| Osato, MS | 1 |
| Kwon, DH | 1 |
| el-Zaatari, FA | 1 |
| Ahuja, V | 1 |
| Dhar, A | 1 |
| Bal, C | 1 |
| Sharma, MP | 1 |
| Ihm, P | 1 |
| Koch, HK | 1 |
| Lokhvitskiĭ, SV | 1 |
| Darvin, VV | 1 |
| Proshin, AV | 1 |
| Bashirova, ES | 1 |
| Butorov, IL | 1 |
| Przytulski, K | 1 |
| Regula, J | 1 |
| Dziurkowska-Marek, A | 1 |
| Kohut, M | 1 |
| Hennig, E | 1 |
| Marek, T | 1 |
| Ostrowski, J | 1 |
| Nowak, A | 1 |
| Butruk, E | 1 |
| Ellenrieder, V | 1 |
| Fensterer, H | 1 |
| Waurick, M | 1 |
| Adler, G | 1 |
| Glasbrenner, B | 1 |
| Huang, WH | 1 |
| Ho, AS | 1 |
| Shyu, RY | 1 |
| Lee, SC | 1 |
| Lee, MM | 1 |
| Hsu, CT | 2 |
| Bethke, TD | 1 |
| Kashifard, M | 1 |
| Siavoshi, F | 2 |
| Huang, FC | 1 |
| Chang, MH | 1 |
| Hsu, HY | 1 |
| Lee, PI | 1 |
| Shun, CT | 1 |
| Cutler, A | 1 |
| Chua, AB | 1 |
| Ding, RP | 1 |
| Kandasami, P | 1 |
| Mazlam, MZ | 1 |
| Raj, SM | 1 |
| Nilsson, F | 1 |
| Walder, M | 1 |
| Petsch, B | 1 |
| Kabala, A | 1 |
| Pawłowski, W | 1 |
| Zanten, SJ | 1 |
| Farley, A | 1 |
| Leddin, D | 1 |
| Spiller, RC | 2 |
| Sipponen, P | 1 |
| Zeijlon, L | 1 |
| Sinclair, P | 1 |
| Ho, J | 2 |
| Yuen, ST | 1 |
| Lau, GK | 2 |
| Van der Wouden, EJ | 1 |
| Zwet, AA | 1 |
| Kooy, A | 1 |
| Kleibeuker, JH | 1 |
| Marshall, JB | 1 |
| Goggin, N | 1 |
| Rowland, M | 2 |
| Imrie, C | 2 |
| Walsh, D | 1 |
| van der Hulst, RW | 1 |
| van 't Hoff, BW | 1 |
| van der Ende, A | 1 |
| Goddard, AF | 1 |
| Lawes, S | 1 |
| Nie, Y | 1 |
| Wu, H | 1 |
| Sha, W | 1 |
| Du, H | 1 |
| Dai, S | 1 |
| Li, Q | 1 |
| Kavcic, B | 1 |
| Zaletel, LK | 1 |
| Gubina, M | 1 |
| Ihan, A | 1 |
| Poljak, M | 1 |
| Krizman, I | 1 |
| Bourke, B | 1 |
| Chen, SY | 1 |
| Wang, JY | 1 |
| Chen, J | 1 |
| Zhang, XD | 1 |
| Zhang, SS | 1 |
| Adeyemi, EO | 1 |
| Danial, MF | 1 |
| Helal, T | 1 |
| Benedict, S | 1 |
| Abdulle, AM | 1 |
| Mach, T | 1 |
| Zahradnik-Bilska, J | 1 |
| Loo, V | 2 |
| Joseph, L | 2 |
| Barkun, J | 1 |
| Kostyk, R | 1 |
| Martino, G | 1 |
| Paoletti, M | 1 |
| Marcheggiano, A | 1 |
| D'Ambra, G | 1 |
| Delle Fave, G | 1 |
| Annibale, B | 1 |
| Rollan, A | 1 |
| Giancaspero, R | 1 |
| Fuster, F | 1 |
| Acevedo, C | 1 |
| Figueroa, C | 1 |
| Hola, K | 1 |
| Schulz, M | 1 |
| Duarte, I | 1 |
| Hu, FL | 2 |
| Qian, SC | 1 |
| Huang, NX | 1 |
| Li, YY | 1 |
| Manan, C | 1 |
| Lesmana, L | 1 |
| Carpio, RE | 1 |
| Perez, JY | 1 |
| Fock, KM | 2 |
| Kachintorn, U | 1 |
| Phornphutkul, K | 1 |
| Kullavanijaya, P | 1 |
| Chelvam, P | 1 |
| Lim, SG | 1 |
| Dammann, HG | 1 |
| Fölsch, UR | 1 |
| von Kleist, DH | 1 |
| Klör, HU | 1 |
| Kirchner, T | 1 |
| Strobel, S | 1 |
| Kist, M | 1 |
| Maev, IV | 2 |
| Andreev, NG | 1 |
| Val'tsova, ED | 1 |
| Romashkina, MA | 1 |
| Ismailova, MZ | 1 |
| Ansari, R | 1 |
| Alizadeh, BZ | 2 |
| Eshraghian, MR | 1 |
| Vakili, A | 1 |
| Saghari, M | 1 |
| Friedman, G | 1 |
| Mayrand, S | 1 |
| Beech, R | 1 |
| Best, L | 1 |
| Michopoulos, S | 1 |
| Tsibouris, P | 1 |
| Bouzakis, H | 1 |
| Balta, A | 1 |
| Vougadiotis, J | 1 |
| Broutet, N | 1 |
| Kralios, N | 1 |
| Katelaris, PH | 1 |
| Adamthwaite, D | 1 |
| Midolo, P | 1 |
| Yeomans, ND | 1 |
| Davidson, G | 1 |
| Lambert, J | 1 |
| Vukobrat-Bijedić, Z | 1 |
| Lacević, N | 1 |
| Bratović, I | 1 |
| Gribajcević, M | 2 |
| Gogov, B | 1 |
| Radović, S | 1 |
| Mansurova, FKh | 1 |
| Kadyrov, DM | 1 |
| Odinaev, RI | 1 |
| Ishankulova, DM | 1 |
| Vanis, N | 1 |
| Salaka, U | 1 |
| Pasalić, G | 1 |
| Gomollón, F | 2 |
| Valdepérez, J | 1 |
| Garuz, R | 1 |
| Fuentes, J | 1 |
| Barrera, F | 1 |
| Malo, J | 1 |
| Tirado, M | 1 |
| Simón, MA | 1 |
| Frevel, M | 1 |
| Daake, H | 1 |
| Janisch, HD | 1 |
| Kellner, HU | 1 |
| Krezdorn, HG | 1 |
| Tanneberger, D | 1 |
| Wack, R | 1 |
| Buzás György, M | 1 |
| Székely, E | 1 |
| Illyés, G | 1 |
| Széles, I | 1 |
| Bytzer, P | 1 |
| Aalykke, C | 1 |
| Rune, S | 1 |
| Weywadt, L | 1 |
| Gjørup, T | 1 |
| Eriksen, J | 1 |
| Bonnevie, O | 1 |
| Bekker, C | 1 |
| Kromann-Andersen, H | 1 |
| Kjaergaard, J | 1 |
| Rask-Madsen, J | 1 |
| Vilien, M | 1 |
| Hansen, J | 1 |
| Justesen, T | 1 |
| Vyberg, M | 1 |
| Teglbjaerg, PS | 1 |
| Sicilia, B | 1 |
| Sierra, E | 1 |
| Lago, A | 1 |
| Villar, M | 1 |
| García, S | 1 |
| Fakheri, H | 1 |
| Merat, S | 1 |
| Fazel, A | 1 |
| Konorev, MR | 1 |
| Della Libera, E | 1 |
| Rohr, MR | 1 |
| Moraes, M | 1 |
| Siqueira, ES | 1 |
| Ferrari, AP | 1 |
| Chu, KM | 1 |
| Liu, XG | 1 |
| Hopkins, RJ | 1 |
| Bateson, MC | 1 |
| Ell, C | 1 |
| Schoerner, C | 1 |
| Solbach, W | 1 |
| Ridl, W | 1 |
| Moser, W | 1 |
| Kate, V | 1 |
| Ananthakrishnan, N | 1 |
| Badrinath, S | 1 |
| Sazhin, VP | 1 |
| Fedorov, AV | 1 |
| V'iuchnova, ES | 1 |
| Lebedev, EG | 1 |
| Dicheva, DT | 1 |
| Ovsiannikova, EV | 1 |
| Antonenko, OM | 1 |
| Shchekina, MI | 1 |
| Kamberoglou, D | 1 |
| Polymeros, D | 1 |
| Sanidas, I | 1 |
| Doulgeroglou, V | 1 |
| Savva, S | 1 |
| Patra, E | 1 |
| Tzias, V | 1 |
| Yang, KC | 1 |
| Wang, CS | 1 |
| Kuo, CF | 1 |
| Vichev, E | 1 |
| Krŭstev, N | 1 |
| Krŭstev, D | 1 |
| Baeva, N | 1 |
| Kiselova, A | 1 |
| Ianev, N | 1 |
| Fujimura, S | 1 |
| Kato, S | 1 |
| Kawamura, T | 1 |
| Watanabe, A | 1 |
| Mansour-Ghanaei, F | 1 |
| Fallah, MS | 1 |
| Shafaghi, A | 1 |
| Skornetskiĭ, BD | 1 |
| Gavrilenko, IaV | 1 |
| Papikian, MKh | 1 |
| Vaĭstukh, SI | 1 |
| Cheng, A | 1 |
| Leung, JW | 1 |
| Zak, J | 1 |
| Lucke, W | 1 |
| Le Roux, E | 1 |
| Winter, T | 1 |
| Lastovica, A | 1 |
| Borody, TJ | 3 |
| George, LL | 3 |
| Brandl, S | 3 |
| Andrews, P | 2 |
| Jankiewicz, E | 1 |
| Ostapowicz, N | 1 |
| Goggin, PM | 1 |
| Spychal, RT | 1 |
| Jackson, PA | 1 |
| Corbishley, CM | 1 |
| Howie, CA | 1 |
| Playford, RJ | 2 |
| Ayesu, K | 1 |
| Li, SK | 1 |
| Hundal, O | 1 |
| Burridge, SM | 2 |
| Spencer, G | 1 |
| Bolton, G | 1 |
| Purser, K | 1 |
| Brooks, S | 1 |
| Prosser, S | 1 |
| Harrison, G | 2 |
| Gant, PW | 2 |
| Neithercut, WD | 1 |
| Chausson, Y | 2 |
| Costa, EL | 1 |
| Maia, AF | 1 |
| Brandao, MJ | 1 |
| Rodrigues, DC | 1 |
| Patchett, S | 1 |
| Keane, C | 2 |
| Evans, DG | 4 |
| Evans, DJ | 4 |
| Saeed, ZA | 1 |
| Heatley, RV | 1 |
| Powell, K | 1 |
| Weil, J | 1 |
| Jones, PH | 1 |
| Trowell, JE | 1 |
| Beardshall, K | 2 |
| Moss, S | 1 |
| Gill, J | 1 |
| Ghosh, P | 2 |
| Hirschl, A | 1 |
| Alpert, LC | 1 |
| Dorval, ED | 1 |
| Loulergue, J | 1 |
| Barbieux, JP | 1 |
| Metman, EH | 1 |
| de Muret, A | 1 |
| Fullarton, GM | 1 |
| Chittajalu, R | 1 |
| el Nujumi, AM | 1 |
| MacDonald, AM | 1 |
| Dahill, SW | 1 |
| Hilditch, TE | 1 |
| Castro, Lde P | 1 |
| Prewett, EJ | 1 |
| Smith, JT | 1 |
| Nwokolo, CU | 1 |
| Hudson, M | 1 |
| Sawyerr, AM | 1 |
| Lind, CD | 1 |
| Nakshabendi, IM | 1 |
| Peebles, SE | 1 |
| Lee, FD | 1 |
| Russell, RI | 1 |
| Rauws, EA | 1 |
| Devine, M | 1 |
| Moore-Jones, D | 1 |
| Walton, M | 1 |
| Elta, GH | 1 |
| O'Riordan, T | 1 |
| Mathai, E | 1 |
| Tobin, E | 1 |
| McKenna, D | 1 |
| Sweeney, E | 1 |
| Opekun, A | 1 |
| de Leeuw, P | 1 |
| de Mot, H | 1 |
| Dugernier, T | 1 |
| Wautelet, J | 1 |
| Bohy, E | 1 |
| Delmée, M | 1 |
| Dollery, CT | 1 |
| Bloom, SR | 1 |
| Cox, TM | 1 |
| Hodgson, HJ | 1 |
| Losowsky, MS | 1 |
| Pepys, MB | 1 |
| Wright, NA | 1 |
| Wrong, OM | 1 |
| Swift, I | 1 |
| Foulkes, W | 1 |
| Playford, R | 1 |
| Cole, P | 1 |
| Noonan, S | 1 |
| Morgan, A | 1 |
| Lenne, J | 1 |
| Hyland, L | 1 |
| Borody, EG | 1 |
| Allard, JC | 1 |
| Kuligowska, E | 1 |
| Kvasz, L | 1 |
| Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
|---|---|---|---|---|---|---|---|
| Evaluation of the Efficacy of Concomitant Therapy for Eradication of Helicobacter Pylori[NCT01922765] | Phase 4 | 540 participants (Anticipated) | Interventional | 2013-08-31 | Recruiting | ||
| Rifaximin Associated With Classic Triple Therapy (Inhibitor of Proton Pump, Amoxicillin and Clarithromycin) for the Eradication of Helicobacter Pylori Infection[NCT03124199] | Phase 3 | 40 participants (Actual) | Interventional | 2014-02-28 | Completed | ||
| The Phase 2 Study of FP-10, the Food Ingredient Derived From Milk Casein, on the Eradication Rates of Helicobacter Pylori by a Triple Therapy With Lansoprazole, Amoxicillin, and Clarithromycin[NCT00281047] | Phase 2/Phase 3 | 138 participants | Interventional | 2006-01-31 | Recruiting | ||
| Comparing the Efficacy and Impact on Gastrointestinal Microbiome of Reverse Hybrid Therapy and Bismuth Quadruple Therapy in Helicobacter Pylori Eradication[NCT02547038] | 352 participants (Actual) | Interventional | 2015-02-28 | Completed | |||
| A Prospective Randomized Trial of Levofloxacin-amoxicillin Triple Therapy vs. Levofloxacin-tetracycline Quadruple Therapy in Second-line Helicobacter Pylori Treatment[NCT02978157] | 102 participants (Actual) | Interventional | 2015-02-28 | Completed | |||
| Comparison of Hybrid and Bismuth Containing Quadruple Therapies for Helicobacter Pylori Eradication: a Randomized Controlled Trial[NCT02541864] | 330 participants (Actual) | Interventional | 2013-07-31 | Completed | |||
| Comparison of Two Rescue Therapies for Helicobacter Pylori Infection - A Multicenter Randomized Controlled Trial[NCT02547012] | 51 participants (Actual) | Interventional | 2013-11-30 | Completed | |||
| Comparison of 12-day Reverse Hybrid Therapy and 12-day Standard Triple Therapy for Helicobacter Pylori Infection - a Randomized Controlled Trial (REHYTRI Study)[NCT02359435] | 440 participants (Actual) | Interventional | 2012-10-31 | Completed | |||
| [information is prepared from clinicaltrials.gov, extracted Sep-2024] | |||||||
Percentage of patients that has comply with treatment, considered as intake of more than 90% of study drugs in patients who attended the post-treatment visit. (NCT03124199)
Timeframe: 1 month
| Intervention | percentage of participants (Number) |
|---|---|
| Rifaximin | 100 |
Percentage of Participants with H.Pylori Infection Eradication confirmed with urea breath test at least 4 weeks after the end of treatment (NCT03124199)
Timeframe: 1 month
| Intervention | percentage of participants (Number) |
|---|---|
| Rifaximin | 61 |
Patients with side effects present during treatment and in the 4 weeks after end of treatment (NCT03124199)
Timeframe: 1 month
| Intervention | participants (Number) | ||||
|---|---|---|---|---|---|
| with diarrhea | with metallic taste | headache | nausea | abdominal pain | |
| Rifaximin | 13 | 9 | 5 | 5 | 1 |
Evaluate eradication outcome by endoscopy urease test and histology or urea breath test (Number of Participants With Complete Eradication of Helicobacter Pylori) (NCT02547038)
Timeframe: sixth week after the end of anti- H. pylori therapy
| Intervention | participants (Number) |
|---|---|
| Pantoprazole+Bismuth+Tetra+Metro | 169 |
| (Panto+Amox+Clar+Metr)+(Panto+Amox) | 170 |
Number of participants with negative H pylori status in follow-up tests as a measure of successful eradication (NCT02978157)
Timeframe: six weeks after the end of anti-H pylori therapy.
| Intervention | participants (Number) |
|---|---|
| Esomeprazole+Amox+Levo | 36 |
| Esomeprazole+Bismuth+Tetra+Levo | 49 |
Repeated endoscopy with rapid urease test, histological examination and culture or urea breath tests are conducted to assess H. pylori status. (NCT02541864)
Timeframe: at the 6th week after the end of anti- H. pylori therapy
| Intervention | participants (Number) |
|---|---|
| Pantoprazole+Bismuth+Tetra+Metro | 154 |
| Hybrid Therapy | 154 |
Evaluate eradication outcome by endoscopy urease test and histology or urea breath test (NCT02547012)
Timeframe: six weeks after the end of anti-H pylori therapy.
| Intervention | participants (Number) |
|---|---|
| Esomeprazole+Amox+Levo+Tetra | 13 |
| Esomeprazole+Amox+Levo | 21 |
Evaluate eradication outcome by endoscopy urease test and histology or urea breath test (NCT02359435)
Timeframe: at the 6th week after the end of anti- H. pylori therapy
| Intervention | participants (Number) |
|---|---|
| Reverse Hybrid Therapy | 206 |
| Standard Triple Therapy | 191 |
15 reviews available for metronidazole and Duodenal Ulcer
| Article | Year |
|---|---|
[Helicobacter pylori. Update 2002].
Topics: Adenocarcinoma; Amoxicillin; Anti-Bacterial Agents; Clarithromycin; Drug Therapy, Combination; Duode | 2002 |
Is it time for quadruple therapy to be first line?
Topics: Amoxicillin; Antacids; Anti-Infective Agents; Bismuth; Clarithromycin; Clinical Trials as Topic; Dru | 2003 |
[Eradication of Helicobacter pylori].
Topics: Amoxicillin; Anti-Bacterial Agents; Clarithromycin; Drug Therapy, Combination; Duodenal Ulcer; Enzym | 2003 |
[Guidelines for the diagnosis and treatment of H. pylori infection].
Topics: Adult; Anti-Bacterial Agents; Anti-Infective Agents; Drug Therapy, Combination; Duodenal Ulcer; Dysp | 2003 |
Treatment strategies for symptom resolution, healing, and Helicobacter pylori eradication in duodenal ulcer patients.
Topics: Anti-Bacterial Agents; Bismuth; Drug Therapy, Combination; Duodenal Ulcer; Helicobacter Infections; | 1994 |
Duodenal ulcer treatment: progress from pH to HP.
Topics: Amoxicillin; Bismuth; Drug Therapy, Combination; Duodenal Ulcer; Gastric Mucosa; Helicobacter Infect | 1994 |
Helicobacter pylori infection.
Topics: Bismuth; Drug Therapy, Combination; Duodenal Ulcer; Helicobacter Infections; Helicobacter pylori; Hu | 1993 |
Triple therapy and Helicobacter pylori.
Topics: Amoxicillin; Antacids; Anti-Bacterial Agents; Anti-Ulcer Agents; Bismuth; Drug Therapy, Combination; | 1996 |
[Antibiotic resistance of Helicobacter pylori in Malmö. Therapeutic success in spite of antibiotic resistance].
Topics: Anti-Bacterial Agents; Anti-Ulcer Agents; Clarithromycin; Drug Resistance, Microbial; Drug Therapy, | 1999 |
[Treatment of Helicobacter pylori infections].
Topics: Clarithromycin; Clinical Protocols; Drug Resistance; Drug Therapy, Combination; Duodenal Ulcer; Fema | 1999 |
How should Helicobacter pylori infected children be managed?
Topics: Anti-Bacterial Agents; Child; Duodenal Ulcer; Helicobacter Infections; Helicobacter pylori; Humans; | 1999 |
[Experience in the use of losek (omeprazole) in gastroenterology].
Topics: Amoxicillin; Anti-Bacterial Agents; Anti-Infective Agents; Anti-Ulcer Agents; Clarithromycin; Double | 2001 |
Helicobacter pylori therapy: first-line options and rescue regimen.
Topics: Amoxicillin; Anti-Bacterial Agents; Clarithromycin; Drug Resistance, Microbial; Drug Therapy, Combin | 2001 |
Review article: the treatment of Helicobacter pylori infection.
Topics: Amoxicillin; Anti-Ulcer Agents; Drug Therapy, Combination; Duodenal Ulcer; Dyspepsia; Gastritis; Hel | 1992 |
Helicobacter pylori and duodenal ulceration.
Topics: Cimetidine; Duodenal Ulcer; Gastrins; Gastritis; Helicobacter Infections; Helicobacter pylori; Human | 1991 |
156 trials available for metronidazole and Duodenal Ulcer
| Article | Year |
|---|---|
New single capsule of bismuth, metronidazole and tetracycline given with omeprazole versus quadruple therapy consisting of bismuth, omeprazole, amoxicillin and clarithromycin for eradication of Helicobacter pylori in duodenal ulcer patients: a Chinese pro
Topics: Adolescent; Adult; Aged; Amoxicillin; Antacids; Anti-Bacterial Agents; Bismuth; Capsules; China; Cla | 2018 |
Efficacy and Tolerability of Two Quadruple Regimens: Bismuth, Omeprazole, Metronidazole with Amoxicillin or Tetracycline as First-Line Treatment for Eradication of Helicobacter Pylori in Patients with Duodenal Ulcer: A Randomized Clinical Trial.
Topics: Adolescent; Adult; Aged; Amoxicillin; Bismuth; Drug Therapy, Combination; Duodenal Ulcer; Female; He | 2018 |
Concomitant therapy achieved the best eradication rate for Helicobacter pylori among various treatment strategies.
Topics: Adult; Aged; Amoxicillin; Anti-Bacterial Agents; Breath Tests; Clarithromycin; Drug Therapy, Combina | 2015 |
Randomized clinical trial comparing 10-day sequential, 7-day concomitant and 7-day standard triple therapies for Helicobacter pylori eradication.
Topics: Adolescent; Adult; Aged; Amoxicillin; Anti-Bacterial Agents; Clarithromycin; Drug Administration Sch | 2016 |
Effect of Helicobacter pylori eradication on ulcer recurrence after simple closure of perforated duodenal ulcer.
Topics: Adult; Amoxicillin; Anti-Infective Agents; Anti-Ulcer Agents; Drug Therapy, Combination; Duodenal Ul | 2009 |
Safety and efficacy of 1-week levofloxacin-based triple therapy in first-line treatment for Helicobacter pylori-related peptic ulcer disease in Kashmir, India.
Topics: Adolescent; Adult; Aged; Anti-Bacterial Agents; Anti-Ulcer Agents; Drug Administration Schedule; Dru | 2013 |
Furazolidone-based triple 'rescue therapy' vs. quadruple 'rescue therapy' for the eradication of Helicobacter pylori resistant to metronidazole.
Topics: Adolescent; Adult; Anti-Bacterial Agents; Anti-Ulcer Agents; Drug Resistance, Bacterial; Drug Therap | 2002 |
[Fromilid (clarithromycin) in eradication patients in patients with duodenal ulcer associated with Helicobacter pylori (comparison of two treatment variations)].
Topics: Adolescent; Adult; Aged; Anti-Bacterial Agents; Clarithromycin; Drug Therapy, Combination; Duodenal | 2002 |
[Fromilide (clarithromycin) in eradication of Helicobacter pylori in patients with duodenal ulcer].
Topics: Adolescent; Adult; Aged; Anti-Bacterial Agents; Anti-Ulcer Agents; Clarithromycin; Drug Therapy, Com | 2002 |
Azithromycin in a triple therapy for H.pylori eradication in active duodenal ulcer.
Topics: Adolescent; Adult; Aged; Amoxicillin; Anti-Bacterial Agents; Anti-Ulcer Agents; Azithromycin; Drug T | 2002 |
Omeprazole triple therapy versus omeprazole quadruple therapy for healing duodenal ulcer and eradication of Helicobacter pylori infection: a 24-month follow-up study.
Topics: Adolescent; Adult; Aged; Amoxicillin; Anti-Bacterial Agents; Anti-Ulcer Agents; Clarithromycin; Drug | 2002 |
One-week ranitidine bismuth citrate, amoxicillin and metronidazole triple therapy for the treatment of Helicobacter pylori infection in Chinese.
Topics: Adult; Aged; Amoxicillin; Anti-Bacterial Agents; Anti-Ulcer Agents; Bismuth; Drug Therapy, Combinati | 2002 |
Efficacy of triple therapy comprising rabeprazole, amoxicillin and metronidazole for second-line Helicobacter pylori eradication in Japan, and the influence of metronidazole resistance.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Adult; Aged; Amoxicillin; Anti-Bacterial Agents; Anti-Ulcer | 2003 |
Effect of treatment of Helicobacter pylori on the prevention of gastroduodenal ulcers in patients receiving long-term NSAIDs: a double-blind, placebo-controlled trial.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Amoxicillin; Anti-Inflammatory Agents, Non-Steroidal; Cl | 2003 |
Bismuth-based quadruple therapy using a single capsule of bismuth biskalcitrate, metronidazole, and tetracycline given with omeprazole versus omeprazole, amoxicillin, and clarithromycin for eradication of Helicobacter pylori in duodenal ulcer patients: a
Topics: Administration, Oral; Adult; Aged; Amoxicillin; Anti-Bacterial Agents; Anti-Ulcer Agents; Capsules; | 2003 |
Diagnosis and eradication of Helicobacter pylori in patients with duodenal ulceration in the community.
Topics: Adult; Aged; Anti-Bacterial Agents; Breath Tests; Drug Therapy, Combination; Duodenal Ulcer; Female; | 2003 |
[Efficacy of omeprazole in the treatment of Helicobacter pylori-associated duodenal ulcers... in children].
Topics: Adolescent; Amoxicillin; Anti-Bacterial Agents; Anti-Infective Agents; Anti-Ulcer Agents; Child; Dru | 2003 |
Low eradication rate of Helicobacter pylori with triple 7-14 days and quadriple therapy in Turkey.
Topics: Adolescent; Adult; Aged; Amoxicillin; Anti-Bacterial Agents; Anti-Infective Agents; Anti-Ulcer Agent | 2004 |
Low eradication rate of Helicobacter pylori with triple 7-14 days and quadriple therapy in Turkey.
Topics: Adolescent; Adult; Aged; Amoxicillin; Anti-Bacterial Agents; Anti-Infective Agents; Anti-Ulcer Agent | 2004 |
Low eradication rate of Helicobacter pylori with triple 7-14 days and quadriple therapy in Turkey.
Topics: Adolescent; Adult; Aged; Amoxicillin; Anti-Bacterial Agents; Anti-Infective Agents; Anti-Ulcer Agent | 2004 |
Low eradication rate of Helicobacter pylori with triple 7-14 days and quadriple therapy in Turkey.
Topics: Adolescent; Adult; Aged; Amoxicillin; Anti-Bacterial Agents; Anti-Infective Agents; Anti-Ulcer Agent | 2004 |
Low eradication rate of Helicobacter pylori with triple 7-14 days and quadriple therapy in Turkey.
Topics: Adolescent; Adult; Aged; Amoxicillin; Anti-Bacterial Agents; Anti-Infective Agents; Anti-Ulcer Agent | 2004 |
Low eradication rate of Helicobacter pylori with triple 7-14 days and quadriple therapy in Turkey.
Topics: Adolescent; Adult; Aged; Amoxicillin; Anti-Bacterial Agents; Anti-Infective Agents; Anti-Ulcer Agent | 2004 |
Low eradication rate of Helicobacter pylori with triple 7-14 days and quadriple therapy in Turkey.
Topics: Adolescent; Adult; Aged; Amoxicillin; Anti-Bacterial Agents; Anti-Infective Agents; Anti-Ulcer Agent | 2004 |
Low eradication rate of Helicobacter pylori with triple 7-14 days and quadriple therapy in Turkey.
Topics: Adolescent; Adult; Aged; Amoxicillin; Anti-Bacterial Agents; Anti-Infective Agents; Anti-Ulcer Agent | 2004 |
Low eradication rate of Helicobacter pylori with triple 7-14 days and quadriple therapy in Turkey.
Topics: Adolescent; Adult; Aged; Amoxicillin; Anti-Bacterial Agents; Anti-Infective Agents; Anti-Ulcer Agent | 2004 |
Low eradication rate of Helicobacter pylori with triple 7-14 days and quadriple therapy in Turkey.
Topics: Adolescent; Adult; Aged; Amoxicillin; Anti-Bacterial Agents; Anti-Infective Agents; Anti-Ulcer Agent | 2004 |
Low eradication rate of Helicobacter pylori with triple 7-14 days and quadriple therapy in Turkey.
Topics: Adolescent; Adult; Aged; Amoxicillin; Anti-Bacterial Agents; Anti-Infective Agents; Anti-Ulcer Agent | 2004 |
Low eradication rate of Helicobacter pylori with triple 7-14 days and quadriple therapy in Turkey.
Topics: Adolescent; Adult; Aged; Amoxicillin; Anti-Bacterial Agents; Anti-Infective Agents; Anti-Ulcer Agent | 2004 |
Low eradication rate of Helicobacter pylori with triple 7-14 days and quadriple therapy in Turkey.
Topics: Adolescent; Adult; Aged; Amoxicillin; Anti-Bacterial Agents; Anti-Infective Agents; Anti-Ulcer Agent | 2004 |
Low eradication rate of Helicobacter pylori with triple 7-14 days and quadriple therapy in Turkey.
Topics: Adolescent; Adult; Aged; Amoxicillin; Anti-Bacterial Agents; Anti-Infective Agents; Anti-Ulcer Agent | 2004 |
Low eradication rate of Helicobacter pylori with triple 7-14 days and quadriple therapy in Turkey.
Topics: Adolescent; Adult; Aged; Amoxicillin; Anti-Bacterial Agents; Anti-Infective Agents; Anti-Ulcer Agent | 2004 |
Low eradication rate of Helicobacter pylori with triple 7-14 days and quadriple therapy in Turkey.
Topics: Adolescent; Adult; Aged; Amoxicillin; Anti-Bacterial Agents; Anti-Infective Agents; Anti-Ulcer Agent | 2004 |
Low eradication rate of Helicobacter pylori with triple 7-14 days and quadriple therapy in Turkey.
Topics: Adolescent; Adult; Aged; Amoxicillin; Anti-Bacterial Agents; Anti-Infective Agents; Anti-Ulcer Agent | 2004 |
Low eradication rate of Helicobacter pylori with triple 7-14 days and quadriple therapy in Turkey.
Topics: Adolescent; Adult; Aged; Amoxicillin; Anti-Bacterial Agents; Anti-Infective Agents; Anti-Ulcer Agent | 2004 |
Low eradication rate of Helicobacter pylori with triple 7-14 days and quadriple therapy in Turkey.
Topics: Adolescent; Adult; Aged; Amoxicillin; Anti-Bacterial Agents; Anti-Infective Agents; Anti-Ulcer Agent | 2004 |
Low eradication rate of Helicobacter pylori with triple 7-14 days and quadriple therapy in Turkey.
Topics: Adolescent; Adult; Aged; Amoxicillin; Anti-Bacterial Agents; Anti-Infective Agents; Anti-Ulcer Agent | 2004 |
Low eradication rate of Helicobacter pylori with triple 7-14 days and quadriple therapy in Turkey.
Topics: Adolescent; Adult; Aged; Amoxicillin; Anti-Bacterial Agents; Anti-Infective Agents; Anti-Ulcer Agent | 2004 |
Low eradication rate of Helicobacter pylori with triple 7-14 days and quadriple therapy in Turkey.
Topics: Adolescent; Adult; Aged; Amoxicillin; Anti-Bacterial Agents; Anti-Infective Agents; Anti-Ulcer Agent | 2004 |
Low eradication rate of Helicobacter pylori with triple 7-14 days and quadriple therapy in Turkey.
Topics: Adolescent; Adult; Aged; Amoxicillin; Anti-Bacterial Agents; Anti-Infective Agents; Anti-Ulcer Agent | 2004 |
Low eradication rate of Helicobacter pylori with triple 7-14 days and quadriple therapy in Turkey.
Topics: Adolescent; Adult; Aged; Amoxicillin; Anti-Bacterial Agents; Anti-Infective Agents; Anti-Ulcer Agent | 2004 |
Low eradication rate of Helicobacter pylori with triple 7-14 days and quadriple therapy in Turkey.
Topics: Adolescent; Adult; Aged; Amoxicillin; Anti-Bacterial Agents; Anti-Infective Agents; Anti-Ulcer Agent | 2004 |
Low eradication rate of Helicobacter pylori with triple 7-14 days and quadriple therapy in Turkey.
Topics: Adolescent; Adult; Aged; Amoxicillin; Anti-Bacterial Agents; Anti-Infective Agents; Anti-Ulcer Agent | 2004 |
Low eradication rate of Helicobacter pylori with triple 7-14 days and quadriple therapy in Turkey.
Topics: Adolescent; Adult; Aged; Amoxicillin; Anti-Bacterial Agents; Anti-Infective Agents; Anti-Ulcer Agent | 2004 |
Low eradication rate of Helicobacter pylori with triple 7-14 days and quadriple therapy in Turkey.
Topics: Adolescent; Adult; Aged; Amoxicillin; Anti-Bacterial Agents; Anti-Infective Agents; Anti-Ulcer Agent | 2004 |
Low eradication rate of Helicobacter pylori with triple 7-14 days and quadriple therapy in Turkey.
Topics: Adolescent; Adult; Aged; Amoxicillin; Anti-Bacterial Agents; Anti-Infective Agents; Anti-Ulcer Agent | 2004 |
Low eradication rate of Helicobacter pylori with triple 7-14 days and quadriple therapy in Turkey.
Topics: Adolescent; Adult; Aged; Amoxicillin; Anti-Bacterial Agents; Anti-Infective Agents; Anti-Ulcer Agent | 2004 |
Low eradication rate of Helicobacter pylori with triple 7-14 days and quadriple therapy in Turkey.
Topics: Adolescent; Adult; Aged; Amoxicillin; Anti-Bacterial Agents; Anti-Infective Agents; Anti-Ulcer Agent | 2004 |
Low eradication rate of Helicobacter pylori with triple 7-14 days and quadriple therapy in Turkey.
Topics: Adolescent; Adult; Aged; Amoxicillin; Anti-Bacterial Agents; Anti-Infective Agents; Anti-Ulcer Agent | 2004 |
Low eradication rate of Helicobacter pylori with triple 7-14 days and quadriple therapy in Turkey.
Topics: Adolescent; Adult; Aged; Amoxicillin; Anti-Bacterial Agents; Anti-Infective Agents; Anti-Ulcer Agent | 2004 |
Low eradication rate of Helicobacter pylori with triple 7-14 days and quadriple therapy in Turkey.
Topics: Adolescent; Adult; Aged; Amoxicillin; Anti-Bacterial Agents; Anti-Infective Agents; Anti-Ulcer Agent | 2004 |
Low eradication rate of Helicobacter pylori with triple 7-14 days and quadriple therapy in Turkey.
Topics: Adolescent; Adult; Aged; Amoxicillin; Anti-Bacterial Agents; Anti-Infective Agents; Anti-Ulcer Agent | 2004 |
Low eradication rate of Helicobacter pylori with triple 7-14 days and quadriple therapy in Turkey.
Topics: Adolescent; Adult; Aged; Amoxicillin; Anti-Bacterial Agents; Anti-Infective Agents; Anti-Ulcer Agent | 2004 |
[Efficacy of different schemes of anti-helicobacter therapy in duodenal ulcer].
Topics: Adult; Anti-Infective Agents; Anti-Ulcer Agents; Clarithromycin; Drug Administration Schedule; Drug | 2004 |
[Effects of different triple therapies on duodenal ulcer-associated Helicobacter pylori infection and a one-year follow-up study].
Topics: Amoxicillin; Clarithromycin; Drug Therapy, Combination; Duodenal Ulcer; Female; Follow-Up Studies; H | 2004 |
Response of blood endothelin-1 and nitric oxide activity in duodenal ulcer patients undergoing Helicobacter pylori eradication.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Adult; Aged; Aged, 80 and over; Amoxicillin; Anti-Bacterial | 2005 |
High eradication rates of Helicobacter pylori infection with first- and second-line combination of esomeprazole, tetracycline, and metronidazole in patients allergic to penicillin.
Topics: Anti-Bacterial Agents; Anti-Infective Agents; Anti-Ulcer Agents; Drug Hypersensitivity; Drug Therapy | 2005 |
Furazolidone-based, metronidazole-based, or a combination regimen for eradication of Helicobacter pylori in peptic ulcer disease.
Topics: Adult; Amoxicillin; Anti-Bacterial Agents; Anti-Infective Agents, Local; Drug Therapy, Combination; | 2007 |
Omeprazole/amoxicillin versus triple therapy for Helicobacter pylori in duodenal ulcer disease: two-year follow-up of a prospective randomized study.
Topics: Adult; Aged; Amoxicillin; Anti-Bacterial Agents; Anti-Ulcer Agents; Bismuth; Duodenal Ulcer; Female; | 1995 |
[Comparison of 2 treatment schemes to eradicate Helicobacter pylori].
Topics: Adolescent; Adult; Aged; Amoxicillin; Anti-Ulcer Agents; Bismuth; Duodenal Ulcer; Dyspepsia; Endosco | 1995 |
Recrudescence of Helicobacter pylori infection in patients with healed duodenal ulcer after treatment with different regimens.
Topics: Adult; Amoxicillin; Anti-Bacterial Agents; Bismuth; Drug Administration Schedule; Drug Therapy, Comb | 1995 |
Effect of triple therapy or amoxycillin plus omeprazole or amoxycillin plus tinidazole plus omeprazole on duodenal ulcer healing, eradication of Helicobacter pylori, and prevention of ulcer relapse over a 1-year follow-up period: a prospective, randomized
Topics: Adult; Amoxicillin; Bismuth; Drug Administration Schedule; Drug Therapy, Combination; Duodenal Ulcer | 1995 |
Triple therapy with sucralfate, tetracycline, and metronidazole for Helicobacter pylori-associated duodenal ulcers.
Topics: Adult; Bismuth; Drug Administration Schedule; Drug Therapy, Combination; Duodenal Ulcer; Female; Hel | 1995 |
Efficacy of omeprazole combined with antibiotics for Helicobacter pylori eradication and duodenal ulcer recurrence.
Topics: Adult; Aged; Amoxicillin; Double-Blind Method; Drug Therapy, Combination; Duodenal Ulcer; Female; Fo | 1995 |
Helicobacter pylori clearance and eradication with triple therapy in duodenal ulcer patients.
Topics: Adult; Amoxicillin; Drug Therapy, Combination; Duodenal Ulcer; Female; Follow-Up Studies; Helicobact | 1995 |
Pharmacological effects of metronidazole+tetracycline+bismuth subcitrate versus omeprazole+amoxycillin+bismuth subcitrate in Helicobacter pylori-related gastritis and peptic ulcer disease.
Topics: Adult; Amoxicillin; Anti-Bacterial Agents; Anti-Ulcer Agents; Double-Blind Method; Drug Therapy, Com | 1994 |
Association of symptoms with Helicobacter pylori infection in children.
Topics: Adolescent; Biopsy; Bismuth; Child; Chronic Disease; Drug Therapy, Combination; Duodenal Ulcer; Duod | 1995 |
Quality of life and relapse of duodenal ulcer before and after eradication of Helicobacter pylori.
Topics: Adolescent; Adult; Antacids; Bismuth; Cognitive Behavioral Therapy; Combined Modality Therapy; Drug | 1994 |
The effect of eradication of Helicobacter pylori upon the duodenal ulcer recurrence--a 24 month follow-up study.
Topics: Adolescent; Adult; Aged; Amoxicillin; Anti-Ulcer Agents; Drug Therapy, Combination; Duodenal Ulcer; | 1994 |
Effects of omeprazole and eradication of Helicobacter pylori on gastric and duodenal mucosal enzyme activities and DNA in duodenal ulcer patients.
Topics: Antacids; Biopsy; Bismuth; DNA; Drug Therapy, Combination; Duodenal Ulcer; Duodenum; Female; Gastric | 1994 |
Triple therapy eradicated H. pylori equally in patients pretreated with omeprazole or ranitidine. A 12-month follow-up.
Topics: Adolescent; Adult; Aged; Anti-Ulcer Agents; Chi-Square Distribution; Confidence Intervals; Drug Ther | 1995 |
[Short-term triple therapy with pantoprazole, clarithromycin and metronidazole for the healing of Helicobacter pylori infection].
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Aged; Aged, 80 and over; Benzimidazoles; Biopsy; Clarithrom | 1995 |
Eradication of Helicobacter pylori infection and the recurrence of duodenal ulcers.
Topics: Adolescent; Adult; Aged; Drug Therapy, Combination; Duodenal Ulcer; Female; Follow-Up Studies; Helic | 1993 |
Duodenal ulcer healing by eradication of Helicobacter pylori without anti-acid treatment: randomised controlled trial.
Topics: Adult; Aged; Antacids; Biopsy; Drug Resistance, Microbial; Drug Therapy, Combination; Duodenal Ulcer | 1994 |
Prospective, randomized study of H2-blocker and triple therapy for duodenal ulcer treatment and the eradication of Helicobacter pylori.
Topics: Adult; Amoxicillin; Bismuth; Drug Therapy, Combination; Duodenal Ulcer; Famotidine; Female; Helicoba | 1994 |
Selection of patients for treatment of duodenal ulcer infected with Helicobacter pylori.
Topics: Adult; Amoxicillin; Anti-Bacterial Agents; Cimetidine; Drug Therapy, Combination; Duodenal Ulcer; Fe | 1994 |
[H. pylori and chronic duodenal ulcer: eradication therapy with ranitidine-antibiotic combination and follow-up of ulcer disease].
Topics: Amoxicillin; Double-Blind Method; Drug Therapy, Combination; Duodenal Ulcer; Follow-Up Studies; Heli | 1994 |
Effects of eradication of Helicobacter pylori on gastritis in duodenal ulcer patients.
Topics: Amoxicillin; Double-Blind Method; Drug Therapy, Combination; Duodenal Ulcer; Gastric Mucosa; Gastrit | 1994 |
Effectiveness of a five times daily triple therapy regimen against Helicobacter pylori.
Topics: Anti-Ulcer Agents; Drug Resistance, Microbial; Drug Therapy, Combination; Duodenal Ulcer; Gastroscop | 1994 |
Evaluation of two therapeutic regimens for the treatment of Helicobacter pylori infection.
Topics: Adult; Amoxicillin; Anti-Ulcer Agents; Bismuth; Drug Administration Schedule; Drug Therapy, Combinat | 1994 |
Helicobacter pylori and refractory duodenal ulcers: cross-over comparison of continued cimetidine with cimetidine plus antimicrobials.
Topics: Adult; Amoxicillin; Cimetidine; Drug Administration Schedule; Drug Therapy, Combination; Duodenal Ul | 1994 |
Effect of eradication of Helicobacter pylori on gastric juice ascorbic acid concentrations.
Topics: Aged; Ampicillin; Anti-Ulcer Agents; Ascorbic Acid; Drug Therapy, Combination; Duodenal Ulcer; Fasti | 1993 |
Eradicating Helicobacter pylori infection lowers gastrin mediated acid secretion by two thirds in patients with duodenal ulcer.
Topics: Amoxicillin; Anti-Bacterial Agents; Basal Metabolism; Breath Tests; Carbon Radioisotopes; Duodenal U | 1993 |
[The effect of the eradication of H. pylori on the intractable ulcer].
Topics: Ampicillin; Bismuth; Drug Therapy, Combination; Duodenal Ulcer; Helicobacter Infections; Helicobacte | 1993 |
Efficacy and side effects of a triple drug regimen for the eradication of Helicobacter pylori.
Topics: Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Drug Administration Schedule; Drug Therapy, C | 1993 |
One-year follow-up of duodenal ulcers after 1-wk triple therapy for Helicobacter pylori.
Topics: Anti-Bacterial Agents; Anti-Ulcer Agents; Drug Therapy, Combination; Duodenal Ulcer; Follow-Up Studi | 1994 |
Kinetics of specific IgG antibodies for monitoring the effect of anti-Helicobacter pylori chemotherapy.
Topics: Amoxicillin; Antibodies, Bacterial; Double-Blind Method; Drug Therapy, Combination; Duodenal Ulcer; | 1993 |
Colloidal bismuth subcitrate, ranitidine, and ranitidine plus metronidazole in the treatment of duodenal ulcer and Helicobacter pylori infection: a controlled and prospective study.
Topics: Adult; Anti-Ulcer Agents; Colloids; Drug Therapy, Combination; Duodenal Ulcer; Helicobacter Infectio | 1993 |
Effect of ranitidine and amoxicillin plus metronidazole on the eradication of Helicobacter pylori and the recurrence of duodenal ulcer.
Topics: Adult; Aged; Amoxicillin; Drug Administration Schedule; Drug Therapy, Combination; Duodenal Ulcer; F | 1993 |
Short report: a non-metronidazole triple therapy for eradication of Helicobacter pylori infection--tetracycline, amoxicillin, bismuth.
Topics: Adult; Aged; Amoxicillin; Bismuth; Drug Therapy, Combination; Duodenal Ulcer; Helicobacter Infection | 1993 |
Patient factors affecting Helicobacter pylori eradication with triple therapy.
Topics: Adult; Age Factors; Bismuth; Drug Administration Schedule; Drug Therapy, Combination; Duodenal Ulcer | 1993 |
Prospective, randomized, investigator-blind trial of Helicobacter pylori infection treatment in patients with refractory duodenal ulcers. Healing and long-term relapse rates.
Topics: Adolescent; Adult; Aged; Anti-Ulcer Agents; Chi-Square Distribution; Colloids; Drug Therapy, Combina | 1993 |
[Ulcer healing through the elimination of Helicobacter pylori: is a week of therapy enough?].
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Amoxicillin; Anti-Ulcer Agents; Clarithromycin; Drug The | 1996 |
Pathogenesis of gastric metaplasia of the human duodenum: role of Helicobacter pylori, gastric acid, and ulceration.
Topics: Adult; Aged; Amoxicillin; Antacids; Anti-Ulcer Agents; Drug Therapy, Combination; Duodenal Ulcer; Du | 1996 |
Addition of metronidazole to omeprazole/amoxycillin dual therapy increases the rate of Helicobacter pylori eradication: a double-blind, randomized trial.
Topics: Administration, Oral; Adolescent; Adult; Aged; Aged, 80 and over; Amoxicillin; Anti-Ulcer Agents; An | 1995 |
Dual therapy versus triple therapy for Helicobacter pylori-associated duodenal ulcers.
Topics: Adolescent; Adult; Aged; Amoxicillin; Anti-Bacterial Agents; Anti-Ulcer Agents; Chi-Square Distribut | 1996 |
Omeprazole coupled with two antibiotics for Helicobacter pylori eradication and prevention of ulcer recurrence.
Topics: Adult; Amoxicillin; Anti-Bacterial Agents; Anti-Ulcer Agents; Double-Blind Method; Drug Therapy, Com | 1996 |
Low H. pylori reinfection rate after triple therapy in Chilean duodenal ulcer patients.
Topics: Adolescent; Adult; Aged; Amoxicillin; Anti-Ulcer Agents; Bismuth; Chile; Drug Therapy, Combination; | 1996 |
Effect of the eradication of Helicobacter pylori on duodenal ulcer healing and ulcer relapse: randomized controlled study in Japan.
Topics: Adult; Amoxicillin; Anti-Bacterial Agents; Anti-Ulcer Agents; Cimetidine; Drug Administration Schedu | 1996 |
Antimicrobial therapy for Helicobacter pylori infection versus long-term maintenance antisecretion treatment in the prevention of recurrent hemorrhage from peptic ulcer: prospective nonrandomized trial on 125 patients.
Topics: Amoxicillin; Anti-Bacterial Agents; Anti-Ulcer Agents; Clarithromycin; Drug Therapy, Combination; Du | 1996 |
One week treatment with omeprazole, clarithromycin and tinidazole or lansoprazole, amoxicillin and metronidazole for cure of Helicobacter pylori infection in duodenal ulcer patients.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Adult; Amoxicillin; Anti-Bacterial Agents; Anti-Ulcer Agent | 1996 |
4-day lansoprazole quadruple therapy: a highly effective cure for Helicobacter pylori infection.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Anti-Bacterial Agents; Bismuth; Drug Therapy, Combination; | 1996 |
Refractory duodenal ulcer healing and relapse: comparison of omeprazole with Helicobacter pylori eradication.
Topics: Adult; Anti-Bacterial Agents; Anti-Infective Agents; Anti-Ulcer Agents; Antitrichomonal Agents; Duod | 1996 |
One week treatment for Helicobacter pylori infection: a randomised study of quadruple therapy versus triple therapy.
Topics: Adult; Aged; Anti-Bacterial Agents; Anti-Ulcer Agents; Drug Administration Schedule; Drug Therapy, C | 1995 |
Helicobacter pylori eradication--evaluation of triple therapy containing omeprazole.
Topics: Adult; Amoxicillin; Anti-Bacterial Agents; Anti-Ulcer Agents; Drug Therapy, Combination; Duodenal Ul | 1996 |
Symptomatic and endoscopic duodenal ulcer relapse rates 12 months following Helicobacter pylori eradication treatment with omeprazole and amoxycillin with or without metronidazole.
Topics: Adult; Amoxicillin; Anti-Ulcer Agents; Drug Therapy, Combination; Duodenal Ulcer; Gastroscopy; Helic | 1996 |
Helicobacter pylori infection and serum pepsinogen I concentration in peptic ulcer patients: effect of bacterial eradication.
Topics: Adult; Antacids; Anti-Ulcer Agents; Antitrichomonal Agents; Duodenal Ulcer; Female; Helicobacter Inf | 1996 |
One week triple therapy with omeprazole, clarithromycin and tinidazole for Helicobacter pylori: differing efficacy in previously treated and untreated patients.
Topics: Adolescent; Adult; Aged; Anti-Bacterial Agents; Anti-Ulcer Agents; Child; Clarithromycin; Drug Admin | 1996 |
Reinfection and duodenal ulcer relapse in south-east Asian patients following successful Helicobacter pylori eradication: results of a 2-year follow-up.
Topics: Amoxicillin; Anti-Ulcer Agents; Bismuth; Drug Therapy, Combination; Duodenal Ulcer; Female; Follow-U | 1996 |
A twelve-month follow-up after Helicobacter pylori eradication. A clinical and histological evaluation.
Topics: Adolescent; Adult; Aged; Amoxicillin; Anti-Bacterial Agents; Anti-Ulcer Agents; Duodenal Ulcer; Fema | 1996 |
Short-term low-dose triple therapy with azithromycin, metronidazole and lansoprazole appears highly effective for the eradication of Helicobacter pylori.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Administration, Oral; Adult; Aged; Anti-Bacterial Agents; A | 1997 |
Highly effective twice-daily triple therapies for Helicobacter pylori infection and peptic ulcer disease: does in vitro metronidazole resistance have any clinical relevance?
Topics: Adult; Aged; Aged, 80 and over; Amoxicillin; Anti-Bacterial Agents; Anti-Ulcer Agents; Clarithromyci | 1997 |
One-week low-dose triple therapy for Helicobacter pylori is sufficient for relief from symptoms and healing of duodenal ulcers.
Topics: Anti-Bacterial Agents; Anti-Ulcer Agents; Clarithromycin; Double-Blind Method; Drug Therapy, Combina | 1997 |
Anti-Helicobacter pylori treatment in bleeding ulcers: randomized controlled trial comparing 2-day versus 7-day bismuth quadruple therapy.
Topics: Activities of Daily Living; Adult; Aged; Anti-Bacterial Agents; Anti-Ulcer Agents; Bismuth; Drug Adm | 1997 |
Triple therapy with ranitidine or lansoprazole in the treatment of Helicobacter pylori-associated duodenal ulcer.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Adult; Aged; Anti-Bacterial Agents; Anti-Ulcer Agents; Clar | 1997 |
Clarithromycin in the combination therapy for the eradication of Helicobacter pylori in peptic ulcer disease.
Topics: Adult; Aged; Amoxicillin; Anti-Bacterial Agents; Bismuth; Clarithromycin; Drug Therapy, Combination; | 1997 |
Another therapeutic schedule in eradication of Helicobacter pylori.
Topics: Adult; Aged; Amoxicillin; Amoxicillin-Potassium Clavulanate Combination; Anti-Bacterial Agents; Anti | 1997 |
Efficacy of ebrotidine and ranitidine combined with amoxicillin and metronidazole in the eradication of Helicobacter pylori in patients with duodenal ulcer.
Topics: Adult; Amoxicillin; Benzenesulfonates; Double-Blind Method; Duodenal Ulcer; Female; Gastritis; Helic | 1997 |
Does treatment of Helicobacter pylori with antibiotics alone heal duodenal ulcer? A randomised double blind placebo controlled study.
Topics: Adult; Aged; Amoxicillin; Clarithromycin; Double-Blind Method; Drug Administration Schedule; Drug Th | 1997 |
Helicobacter pylori eradication--comparison of three drug regimens and symptomatic assessment in duodenitis and antral gastritis.
Topics: Adult; Aged; Amoxicillin; Anti-Bacterial Agents; Bismuth; Clarithromycin; Drug Therapy, Combination; | 1997 |
Randomised trial of eradication of Helicobacter pylori before non-steroidal anti-inflammatory drug therapy to prevent peptic ulcers.
Topics: Anti-Bacterial Agents; Anti-Inflammatory Agents, Non-Steroidal; Bismuth; Drug Administration Schedul | 1997 |
Two omeprazole-based Helicobacter pylori eradication regimens for the treatment of duodenal ulcer disease in general practice.
Topics: Adult; Amoxicillin; Anti-Bacterial Agents; Double-Blind Method; Drug Therapy, Combination; Duodenal | 1997 |
Short-course therapy with amoxycillin-clarithromycin triple therapy for 10 days (ACT-10) eradicates Helicobacter pylori and heals duodenal ulcer. ACT-10 Study Group.
Topics: Adult; Amoxicillin; Anti-Bacterial Agents; Canada; Clarithromycin; Double-Blind Method; Drug Resista | 1997 |
Double-blind, multicenter evaluation of lansoprazole and amoxicillin dual therapy for the cure of Helicobacter pylori infection.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Adult; Amoxicillin; Anti-Ulcer Agents; Clarithromycin; Diar | 1996 |
Eradication of Helicobacter pylori using one-week triple therapies combining omeprazole with two antimicrobials: the MACH I Study.
Topics: Amoxicillin; Anti-Ulcer Agents; Clarithromycin; Double-Blind Method; Drug Administration Schedule; D | 1996 |
Helicobacter pylori-positive duodenal ulcer: a long-term double-blind randomized study in patients healed with H2-receptor antagonists.
Topics: Adult; Aged; Antacids; Anti-Ulcer Agents; Disease-Free Survival; Double-Blind Method; Doxycycline; D | 1996 |
One week triple therapy for Helicobacter pylori: does high-dose clarithromycin confer additional benefit?
Topics: Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Anti-Ulcer Agents; Antitrichomonal Agents; Cl | 1997 |
[Hormonal changes and secretion and stomach mucosal microstructure in the course of H. pylori in patients with duodenal ulcer].
Topics: Amoxicillin; Anti-Ulcer Agents; Bismuth; Duodenal Ulcer; Epidermal Growth Factor; Gastric Juice; Gas | 1997 |
One week triple therapy for Helicobacter pylori: a multicentre comparative study. Lansoprazole Helicobacter Study Group.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Adult; Aged; Aged, 80 and over; Amoxicillin; Anti-Ulcer Age | 1997 |
One-week therapy with omeprazole, clarithromycin and metronidazole or ornidazole, followed by 3 weeks' treatment with omeprazole, eradicates Helicobacter pylori equally and heals duodenal ulcer.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Anti-Ulcer Agents; Antitrichomona | 1997 |
[Omeprazole and azithromycin with and without metronidazole in the eradication of Helicobacter pylori in duodenal ulcer disease].
Topics: Adult; Anti-Bacterial Agents; Anti-Ulcer Agents; Azithromycin; Drug Therapy, Combination; Duodenal U | 1997 |
Ranitidine bismuth citrate with clarithromycin given twice daily effectively eradicates Helicobacter pylori and heals duodenal ulcers.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Antitrichomonal Agents; Bismuth; | 1998 |
[new one-week triple therapies with metronidazole for the eradication of Helicobacter pylori: clarithromycin or amoxycillin as the second antibiotic].
Topics: Adult; Amoxicillin; Anti-Bacterial Agents; Anti-Ulcer Agents; Clarithromycin; Drug Therapy, Combinat | 1998 |
Utility of serology in determining Helicobacter pylori eradication after therapy.
Topics: Adult; Amoxicillin; Anti-Bacterial Agents; Anti-Ulcer Agents; Antibodies, Bacterial; Double-Blind Me | 1998 |
A prospective randomized study of amoxycillin and omeprazole with and without metronidazole in the eradication treatment of Helicobacter pylori.
Topics: Adult; Aged; Aged, 80 and over; Amoxicillin; Drug Therapy, Combination; Duodenal Ulcer; Female; Heli | 1998 |
Omeprazole, azithromycin and either amoxycillin or metronidazole in eradication of Helicobacter pylori in duodenal ulcer patients.
Topics: Adult; Aged; Aged, 80 and over; Amoxicillin; Anti-Bacterial Agents; Anti-Ulcer Agents; Azithromycin; | 1998 |
Lansoprazole and secnidazole with clarithromycin, amoxycillin or pefloxacin in the eradication of Helicobacter pylori in a developing country.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Adult; Aged; Amoxicillin; Anti-Bacterial Agents; Anti-Ulcer | 1998 |
Efficacy of tetracycline and metronidazole alone or with ranitidine on the healing of duodenal ulcer and eradication of Helicobacter pylori. A randomized controlled multicenter study. Tetra-Metro-Ran Study Group.
Topics: Anti-Bacterial Agents; Anti-Ulcer Agents; Drug Combinations; Duodenal Ulcer; Female; Helicobacter In | 1998 |
Randomized comparison of 1-hour topical method vs. amoxycillin plus omeprazole for eradication of Helicobacter pylori in duodenal ulcer patients.
Topics: Adult; Amoxicillin; Anti-Ulcer Agents; Bismuth; Clinical Protocols; Drug Therapy, Combination; Duode | 1998 |
Influence of clarithromycin dosage on pantoprazole combined triple therapy for eradication of Helicobacter pylori.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Anti | 1998 |
Incidence of duodenal ulcer healing after 1 week of proton pump inhibitor triple therapy for eradication of Helicobacter pylori. The Lansoprazole Helicobacter Study Group.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Adult; Aged; Amoxicillin; Anti-Bacterial Agents; Anti-Ulcer | 1998 |
New one-week, low-dose triple therapy for the treatment of duodenal ulcer with Helicobacter pylori infection.
Topics: Adult; Aged; Clarithromycin; Drug Therapy, Combination; Duodenal Ulcer; Female; Helicobacter Infecti | 1998 |
Cure of Helicobacter pylori infection and healing of duodenal ulcer: comparison of pantoprazole-based one-week modified triple therapy versus two-week dual therapy. The International Pantoprazole HP Study Group.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Adolescent; Adult; Aged; Aged, 80 and over; Anti-Bacterial | 1998 |
Continuous and more effective duodenal ulcer healing under therapy with bismuth and two antibiotics than with dual therapy comprising omeprazole and amoxicillin.
Topics: Adult; Amoxicillin; Antacids; Anti-Bacterial Agents; Anti-Ulcer Agents; Bismuth; Drug Therapy, Combi | 1998 |
[Previous treatment with omeprazole and H. pylori: does it diminish the eradication efficacy of the "new" triple therapies of one week's duration?].
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Adult; Amoxicillin; Anti-Bacterial Agents; Anti-Ulcer Agent | 1998 |
[The treatment of chronic duodenal ulcer with accompanying Helicobacter pylori infection].
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Amoxicillin; Antacids; Anti-Infective Agents; Bismuth; C | 1998 |
The DU-MACH study: eradication of Helicobacter pylori and ulcer healing in patients with acute duodenal ulcer using omeprazole based triple therapy.
Topics: Acute Disease; Aged; Amoxicillin; Anti-Bacterial Agents; Anti-Ulcer Agents; Clarithromycin; Double-B | 1999 |
Triple therapy for Helicobacter pylori eradication is more effective than long-term maintenance antisecretory treatment in the prevention of recurrence of duodenal ulcer: a prospective long-term follow-up study.
Topics: Adult; Anti-Bacterial Agents; Anti-Ulcer Agents; Breath Tests; Clarithromycin; Drug Therapy, Combina | 1999 |
The influence of metronidazole resistance on the efficacy of ranitidine bismuth citrate triple therapy regimens for Helicobacter pylori infection.
Topics: Adult; Amoxicillin; Anti-Bacterial Agents; Anti-Ulcer Agents; Bismuth; Clarithromycin; Drug Resistan | 1999 |
Randomized controlled comparison of nitroimidazoles for the eradication of Helicobacter pylori and relief of ulcer-associated and non-ulcer dyspepsia.
Topics: Adult; Aged; Clarithromycin; Double-Blind Method; Drug Therapy, Combination; Duodenal Ulcer; Dyspeps | 1999 |
Colloidal bismuth pectin: an alternative to bismuth subcitrate for the treatment of Helicobacter pylori--positive duodenal ulcer.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Amoxicillin; Anti-Bacterial Agents; Anti-Ulcer Agents; B | 1999 |
Assessment of decisions in the treatment of Helicobacter pylori-related duodenal ulcer: a cost-effectiveness study.
Topics: Adolescent; Adult; Amoxicillin; Anti-Infective Agents; Anti-Ulcer Agents; China; Cimetidine; Cost-Be | 1999 |
The outcome of a 2-week treatment of Helicobacter pylori-positive duodenal ulcer with omeprazole-based antibiotic regimen in a region with high metronidazole resistance rate.
Topics: Adolescent; Adult; Amoxicillin; Anti-Bacterial Agents; Biopsy; Clarithromycin; Contraindications; Dr | 1999 |
[Reinfection with Helicobacter pylori in patients with duodenal ulcer after successful eradication].
Topics: Adult; Amoxicillin; Bismuth; Chronic Disease; Clarithromycin; Drug Therapy, Combination; Duodenal Ul | 1999 |
Predictors of failure of Helicobacter pylori eradication and predictors of ulcer recurrence: a randomized controlled trial.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Amoxicillin; Anti-Bacterial Agents; Anti-Ulcer Agents; D | 1999 |
Comparison of lansoprazole-based triple and dual therapy for treatment of Helicobacter pylori-related duodenal ulcer: an Asian multicentre double-blind randomized placebo controlled study.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Adolescent; Adult; Aged; Aged, 80 and over; Amoxicillin; An | 2000 |
Triple therapy in the eradication of Helicobacter pylori in patients with duodenal ulcer disease: results of a multicentre study in South-East Asia. South-East Asia Multicenter Study Group.
Topics: Adolescent; Adult; Aged; Amoxicillin; Anti-Bacterial Agents; Anti-Ulcer Agents; Asia, Southeastern; | 2000 |
Eradication of H. pylori with pantoprazole, clarithromycin, and metronidazole in duodenal ulcer patients: a head-to-head comparison between two regimens of different duration.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Abdominal Pain; Adult; Aged; Anti-Bacterial Agents; Anti-Ul | 2000 |
[The MACH2 Study: value of inhibiting gastric acid secretion in eradication of Helicobacter pylori with a one week triple therapy protocol].
Topics: Amoxicillin; Anti-Ulcer Agents; Clarithromycin; Dose-Response Relationship, Drug; Double-Blind Metho | 2000 |
Furazolidone versus metronidazole in quadruple therapy for eradication of Helicobacter pylori in duodenal ulcer disease.
Topics: Adult; Anti-Bacterial Agents; Drug Combinations; Duodenal Ulcer; Female; Furazolidone; Helicobacter | 2000 |
Is Helicobacter pylori eradication associated with gastroesophageal reflux disease?
Topics: Adolescent; Adult; Aged; Amoxicillin; Anti-Ulcer Agents; Bismuth; Double-Blind Method; Drug Therapy, | 2000 |
Randomized study comparing omeprazole with ranitidine as anti-secretory agents combined in quadruple second-line Helicobacter pylori eradication regimens.
Topics: Administration, Oral; Adult; Anti-Bacterial Agents; Anti-Ulcer Agents; Drug Administration Schedule; | 2000 |
Randomized trial of omeprazole and metronidazole with amoxycillin or clarithromycin for Helicobacter pylori eradication, in a region of high primary metronidazole resistance: the HERO study.
Topics: Adolescent; Adult; Aged; Amoxicillin; Anti-Bacterial Agents; Clarithromycin; Drug Resistance; Drug T | 2000 |
[Effect of pantoprazole, amoxicillin and metronidazole treatment on the level of H. pylori eradication and the histological image of antral gastritis in patients with duodenal ulcer].
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Adult; Amoxicillin; Anti-Bacterial Agents; Anti-Ulcer Agent | 2000 |
[Cost-effectiveness analysis of 2 strategies of Helicobacter pylori eradication: results of a prospective and randomized study in primary care].
Topics: Adolescent; Adult; Amoxicillin; Anti-Bacterial Agents; Anti-Ulcer Agents; Clarithromycin; Cost-Benef | 2000 |
Eradication of Helicobacter pylori with pantoprazole and two antibiotics: a comparison of two short-term regimens.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Adult; Amoxicillin; Anti-Bacterial Agents; Anti-Ulcer Agent | 2000 |
[Lansoprazole versus ranitidine bismuth citrate containing triple regimens for Helicobacter pylori eradication in patients with duodenal ulcer].
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Adult; Anti-Bacterial Agents; Anti-Ulcer Agents; Bismuth; C | 2000 |
Treatment of Helicobacter pylori in patients with duodenal ulcer hemorrhage--a long-term randomized, controlled study.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Amoxicillin; Antacids; Anti-Bacterial Agents; Bismuth; D | 2000 |
Eradication of Helicobacter pylori compared with long-term acid suppression in duodenal ulcer disease. A randomized trial with 2-year follow-up. The Danish Ulcer Study Group.
Topics: Amoxicillin; Anti-Ulcer Agents; Double-Blind Method; Duodenal Ulcer; Female; Follow-Up Studies; Gast | 2000 |
Clarithromycin vs. furazolidone in quadruple therapy regimens for the treatment of Helicobacter pylori in a population with a high metronidazole resistance rate.
Topics: Adult; Amoxicillin; Anti-Bacterial Agents; Anti-Infective Agents, Local; Anti-Ulcer Agents; Clarithr | 2001 |
Eradication of Helicobacter pylori infection in patients with duodenal ulcer and non-ulcer dyspepsia and analysis of one-year reinfection rates.
Topics: Adolescent; Adult; Aged; Anti-Bacterial Agents; Anti-Ulcer Agents; Drug Therapy, Combination; Duoden | 2001 |
Three-day lansoprazole quadruple therapy for Helicobacter pylori-positive duodenal ulcers: a randomized controlled study.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Administration, Oral; Adolescent; Adult; Aged; Antacids; An | 2001 |
Quadruple therapy for symptomatic spontaneous duodenal ulcer disease.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Adult; Aged; Aged, 80 and over; Anti-Ulcer Agents; Clarithr | 2001 |
The AMOR study: a randomized, double-blinded trial of omeprazole versus ranitidine together with amoxycillin and metronidazole for eradication of Helicobacter pylori.
Topics: Adolescent; Aged; Aged, 80 and over; Amoxicillin; Dose-Response Relationship, Drug; Double-Blind Met | 2001 |
Effect of Helicobacter pylori eradication on the ulcer recurrence rate after simple closure of perforated duodenal ulcer: retrospective and prospective randomized controlled studies.
Topics: Adolescent; Adult; Aged; Antacids; Anti-Bacterial Agents; Anti-Ulcer Agents; Bismuth; Duodenal Ulcer | 2001 |
Comparison of 1-week vs. 2- or 4-week therapy regimens with ranitidine bismuth citrate plus two antibiotics for Helicobacter pylori eradication.
Topics: Adult; Aged; Anti-Bacterial Agents; Anti-Ulcer Agents; Bismuth; Clarithromycin; Dose-Response Relati | 2001 |
A multicenter study on eradication of Helicobacter pylori infection in patients with duodenal ulcer by lansoprazole-antibiotics combined therapy.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Adult; Aged; Amoxicillin; Anti-Bacterial Agents; Clarithrom | 1999 |
Eradication of Helicobacter pylori in duodenal ulcer disease tetracycline & furazolidone vs. metronidazole & amoxicillin in omeprazole based triple therapy.
Topics: Amoxicillin; Anti-Bacterial Agents; Anti-Infective Agents, Local; Drug Therapy, Combination; Duodena | 2002 |
[Treatment of patients with ulcer associated with Helicobacter pylori (experience with a triple therapy regimen].
Topics: Adult; Aged; Anti-Bacterial Agents; Anti-Ulcer Agents; Clarithromycin; Drug Therapy, Combination; Du | 2002 |
[Treatment of duodenal peptic ulcer with metronidazole].
Topics: Adolescent; Adult; Clinical Trials as Topic; Drug Evaluation; Drug Therapy, Combination; Duodenal Ul | 1977 |
Randomised controlled trial of short term treatment to eradicate Helicobacter pylori in patients with duodenal ulcer.
Topics: Bismuth; Drug Therapy, Combination; Duodenal Ulcer; Duodenum; Helicobacter Infections; Helicobacter | 1992 |
Triple therapy with sucralfate is as effective as triple therapy containing bismuth in eradicating Helicobacter pylori and reducing duodenal ulcer relapse rates.
Topics: Bismuth; Drug Therapy, Combination; Duodenal Ulcer; Helicobacter pylori; Humans; Metronidazole; Omep | 1992 |
Surface hydrophobicity of gastric mucosa in Helicobacter pylori infection: effect of clearance and eradication.
Topics: Adult; Aged; Amoxicillin; Analysis of Variance; Bismuth; Duodenal Ulcer; Endoscopy, Digestive System | 1992 |
Effect of Helicobacter pylori on parietal cell sensitivity to pentagastrin in duodenal ulcer subjects.
Topics: Adult; Amoxicillin; Anti-Ulcer Agents; Drug Therapy, Combination; Duodenal Ulcer; Gastric Acidity De | 1992 |
Short report: omeprazole plus antibiotic combinations for the eradication of metronidazole-resistant Helicobacter pylori.
Topics: Adult; Aged; Bismuth; Circadian Rhythm; Drug Administration Schedule; Drug Resistance, Microbial; Dr | 1992 |
Effect of treatment of Helicobacter pylori infection on the long-term recurrence of gastric or duodenal ulcer. A randomized, controlled study.
Topics: Adult; Aged; Aged, 80 and over; Bismuth; Drug Therapy, Combination; Duodenal Ulcer; Female; Helicoba | 1992 |
Effect of treatment of Helicobacter pylori infection on the long-term recurrence of gastric or duodenal ulcer. A randomized, controlled study.
Topics: Adult; Aged; Aged, 80 and over; Bismuth; Drug Therapy, Combination; Duodenal Ulcer; Female; Helicoba | 1992 |
Effect of treatment of Helicobacter pylori infection on the long-term recurrence of gastric or duodenal ulcer. A randomized, controlled study.
Topics: Adult; Aged; Aged, 80 and over; Bismuth; Drug Therapy, Combination; Duodenal Ulcer; Female; Helicoba | 1992 |
Effect of treatment of Helicobacter pylori infection on the long-term recurrence of gastric or duodenal ulcer. A randomized, controlled study.
Topics: Adult; Aged; Aged, 80 and over; Bismuth; Drug Therapy, Combination; Duodenal Ulcer; Female; Helicoba | 1992 |
Duodenal ulcer recurrence and Helicobacter pylori.
Topics: Amoxicillin; Duodenal Ulcer; Follow-Up Studies; Helicobacter pylori; Humans; Metronidazole; Recurren | 1991 |
Effect of triple therapy (antibiotics plus bismuth) on duodenal ulcer healing. A randomized controlled trial.
Topics: Adult; Aged; Aged, 80 and over; Anti-Inflammatory Agents, Non-Steroidal; Anti-Ulcer Agents; Bismuth; | 1991 |
Cure of duodenal ulcer associated with eradication of Helicobacter pylori.
Topics: Administration, Oral; Amoxicillin; Anti-Ulcer Agents; Campylobacter; Campylobacter Infections; Drug | 1990 |
Duodenal ulcer disease--to heal or to cure?
Topics: Amoxicillin; Antacids; Anti-Ulcer Agents; Drug Therapy, Combination; Duodenal Ulcer; Helicobacter In | 1991 |
Recurrence of duodenal ulcer and Campylobacter pylori infection after eradication.
Topics: Administration, Oral; Adult; Aged; Campylobacter Infections; Clinical Trials as Topic; Drug Administ | 1989 |
131 other studies available for metronidazole and Duodenal Ulcer
| Article | Year |
|---|---|
Development of bacterial transglycosylase inhibitors as new antibiotics: moenomycin A treatment for drug-resistant Helicobacter pylori.
Topics: Anti-Bacterial Agents; Bambermycins; Drug Design; Drug Resistance, Multiple, Bacterial; Duodenal Ulc | 2014 |
Antibiotic Resistance of
Topics: Adolescent; Adult; Amoxicillin; Anti-Bacterial Agents; Clarithromycin; Cross-Sectional Studies; Drug | 2022 |
In vitro characterization of the anti-bacterial activity of SQ109 against Helicobacter pylori.
Topics: Adamantane; Amoxicillin; Antitubercular Agents; Cell Membrane; Chloramphenicol; Clarithromycin; Drug | 2013 |
Ten-year trend of the cumulative Helicobacter pylori eradication rate for the 'Japanese eradication strategy'.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Amoxicillin; Anti-Bacterial Agents; Clarithromycin; Dise | 2013 |
Nationwide survey of Helicobacter pylori treatment for children and adolescents in Japan.
Topics: Adolescent; Amoxicillin; Anemia, Iron-Deficiency; Anti-Bacterial Agents; Child; Clarithromycin; Drug | 2017 |
[Perforation and haemorrhage duodenal bulbar ulcers in a child: a case report].
Topics: Adrenergic Agonists; Amoxicillin; Anti-Bacterial Agents; Anti-Infective Agents; Child; Drug Therapy, | 2008 |
A case of duodenal Entamoeba histolytica.
Topics: Adult; AIDS-Related Opportunistic Infections; Amebicides; Animals; Biopsy; Drug Administration Sched | 2009 |
Antibiotic susceptibility of Helicobacter pylori isolates in Dakar, Senegal.
Topics: Adult; Amoxicillin; Anti-Bacterial Agents; Ciprofloxacin; Drug Resistance, Bacterial; Duodenal Ulcer | 2009 |
De novo erosive esophagitis in duodenal ulcer patients related to pre-existing reflux symptoms, smoking, and patient age, but not to Helicobacter pylori eradication: a one-year follow-up study.
Topics: Adult; Age Factors; Amoxicillin; Anti-Bacterial Agents; Anti-Infective Agents; Anti-Ulcer Agents; Cl | 2010 |
Antibiotic susceptibility patterns of Helicobacter pylori and triple therapy in a high-prevalence area.
Topics: Adolescent; Adult; Age Factors; Aged; Amoxicillin; Anti-Bacterial Agents; Clarithromycin; Drug Resis | 2010 |
[Zantac (ranitidine) in treating duodenal ulcers].
Topics: Adult; Amoxicillin; Anti-Ulcer Agents; Drug Therapy, Combination; Duodenal Ulcer; Female; Helicobact | 2002 |
[Long-term curative effects of suture plus proximal gastric vagotomy or triad-therapy for duodenal ulcer with acute perforation].
Topics: Acute Disease; Adolescent; Adult; Aged; Amoxicillin; Drug Therapy, Combination; Duodenal Ulcer; Fema | 2002 |
Long-term follow-up of gastric metaplasia after eradication of Helicobacter pylori.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Adult; Aged; Amoxicillin; Cicatrix; Convalescence; Drug The | 2003 |
[Effectiveness of eradication anti-helicobacter therapy in patients with duodenal ulcer in different drug dosage regimens].
Topics: Adolescent; Adult; Anti-Bacterial Agents; Anti-Ulcer Agents; Bismuth; Drug Administration Schedule; | 2003 |
[Pharmacotherapy in complex treatment of ulcerous stenosis].
Topics: Amoxicillin; Antacids; Anti-Infective Agents; Anti-Ulcer Agents; Cimetidine; Drug Therapy, Combinati | 2003 |
Long-term persistence of resistant Enterococcus species after antibiotics to eradicate Helicobacter pylori.
Topics: Aged; Aged, 80 and over; Anti-Bacterial Agents; Anti-Ulcer Agents; Clarithromycin; Drug Resistance, | 2003 |
Summaries for patients. Effects of antibiotic treatment for Helicobacter pylori on normal bowel bacteria.
Topics: Aged; Aged, 80 and over; Anti-Bacterial Agents; Anti-Ulcer Agents; Clarithromycin; Drug Resistance, | 2003 |
[Level of Helicobacter pylori infection of the gastric mucosa in the optimization of a daily dose of antihelicobacter drugs].
Topics: Adolescent; Adult; Anti-Bacterial Agents; Anti-Ulcer Agents; Dose-Response Relationship, Drug; Drug | 2003 |
Standard treatment for Helicobacter pylori infection is suboptimal in non-ulcer dyspepsia compared with duodenal ulcer in Chinese.
Topics: Adolescent; Adult; Aged; Amoxicillin; Anti-Ulcer Agents; Asian People; Clarithromycin; Drug Resistan | 2005 |
Pneumatosis cystoides intestinalis associated with perforated chronic duodenal ulcer and Meckel's diverticulum.
Topics: Abdominal Pain; Adult; Anti-Infective Agents; Ceftriaxone; Chronic Disease; Duodenal Ulcer; Humans; | 2005 |
[Prospective study of 420 biopsies realised in patients with duodenal ulcer with positive Helicobacter pylori].
Topics: Adult; Aged; Amoxicillin; Anti-Bacterial Agents; Anti-Infective Agents; Anti-Ulcer Agents; Biopsy; D | 2006 |
Chest pain during triple therapy for duodenal ulcer.
Topics: Adult; Anti-Bacterial Agents; Anti-Infective Agents; Anti-Ulcer Agents; Chest Pain; Clarithromycin; | 2007 |
[Cyclic nucleotides, acid formation and the endoscopic picture in duodenal peptic ulcer patients].
Topics: Adolescent; Adult; Cyclic AMP; Cyclic GMP; Duodenal Ulcer; Duodenoscopy; Gastric Acid; Gastroscopy; | 1984 |
Metronidazole kinetics and bioavailability in patients undergoing gastrointestinal surgery.
Topics: Administration, Oral; Adolescent; Adult; Aged; Biological Availability; Duodenal Ulcer; Female; Huma | 1984 |
[Metronidazole in the treatment of peptic ulcer].
Topics: Adolescent; Adult; Aged; Duodenal Ulcer; Female; Humans; Male; Metronidazole; Middle Aged; Peptic Ul | 1981 |
[Is measurement of basal levels of serum pepsinogen II useful in proving the eradication of Helicobacter pylori by treatment?].
Topics: Adult; Aged; Antacids; Anti-Bacterial Agents; Bismuth; Drug Therapy, Combination; Duodenal Ulcer; Fe | 1995 |
[The importance of obtaining biopsies of the gastric body in the follow-up after eradicating treatment of Helicobacter pylori].
Topics: Adult; Aged; Amoxicillin; Antacids; Anti-Bacterial Agents; Biopsy; Bismuth; Clavulanic Acid; Clavula | 1995 |
[Omeprazole + clarithromycin + metronidazole--a new standard for eradication of Helicobacter pylori].
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Anti-Ulcer Agents; Clarithromycin | 1995 |
High Helicobacter pylori numbers are associated with low eradication rate after triple therapy.
Topics: Amoxicillin; Anti-Bacterial Agents; Anti-Ulcer Agents; Breath Tests; Chronic Disease; Colony Count, | 1995 |
Helicobacter pylori infection in recurrent abdominal pain in childhood: comparison of diagnostic tests and therapy.
Topics: Abdominal Pain; Adolescent; Amoxicillin; Antibodies, Bacterial; Bismuth; Child; Child, Preschool; Du | 1995 |
Helicobacter pylori eradication and reinfection.
Topics: Anti-Ulcer Agents; Breath Tests; Drug Administration Schedule; Drug Resistance, Microbial; Drug Ther | 1995 |
"Cure" of Helicobacter pylori and "cure" of peptic ulcer: do they mean the same thing?
Topics: Anti-Bacterial Agents; Bismuth; Drug Therapy, Combination; Duodenal Ulcer; Follow-Up Studies; Helico | 1995 |
Helicobacter pylori infection and abnormalities of acid secretion in patients with duodenal ulcer disease.
Topics: Amoxicillin; Antacids; Anti-Bacterial Agents; Anti-Ulcer Agents; Drug Therapy, Combination; Duodenal | 1995 |
Effect of Helicobacter pylori eradication on peptic ulcer healing.
Topics: Adult; Aged; Drug Therapy, Combination; Duodenal Ulcer; Female; Helicobacter Infections; Helicobacte | 1995 |
[The effect of "triple therapy" on the eradicating of H. pylori and the healing of a duodenal ulcer. The initial study and 6 months later].
Topics: Adult; Aged; Anti-Ulcer Agents; Drug Evaluation; Drug Therapy, Combination; Duodenal Ulcer; Female; | 1995 |
Low dose, short duration therapy for the eradication of Helicobacter pylori in patients with duodenal ulcer.
Topics: Adult; Aged; Anti-Ulcer Agents; Drug Administration Schedule; Drug Therapy, Combination; Duodenal Ul | 1994 |
Duodenal ulcer healing drugs.
Topics: Amoxicillin; Bismuth; Drug Therapy, Combination; Duodenal Ulcer; Gastric Acid; Gastrin-Releasing Pep | 1994 |
Effect of eradication of Helicobacter pylori on gastric epithelial cell proliferation.
Topics: Adult; Aged; Bismuth; Cell Division; Drug Therapy, Combination; Duodenal Ulcer; Female; Gastric Muco | 1994 |
Long-term follow-up and serological study after triple therapy of Helicobacter pylori-associated duodenal ulcer.
Topics: Anti-Ulcer Agents; Antibodies, Bacterial; Drug Therapy, Combination; Duodenal Ulcer; Enzyme-Linked I | 1994 |
[Eradication of Helicobacter pylori. Effectiveness of a combination of ranitidine and metronidazole/roxithromycin].
Topics: Dose-Response Relationship, Drug; Drug Administration Schedule; Drug Therapy, Combination; Duodenal | 1994 |
Phospholipase A2 activity in gastric juice from patients with active and H. pylori-eradicated healed duodenal ulcer.
Topics: Adult; Aged; Bile Acids and Salts; Bismuth; Choline; Drug Therapy, Combination; Duodenal Ulcer; Fema | 1994 |
Effect of eradication of Helicobacter pylori on serum pepsinogen I, gastrin, and insulin in duodenal ulcer patients: a 12-month follow-up study.
Topics: Amoxicillin; Anti-Ulcer Agents; Bismuth; Drug Therapy, Combination; Duodenal Ulcer; Female; Follow-U | 1994 |
Role of Helicobacter pylori eradication in the prevention of peptic ulcer bleeding relapse.
Topics: Adult; Aged; Aged, 80 and over; Amoxicillin; Bismuth; Drug Therapy, Combination; Duodenal Ulcer; Fem | 1994 |
Histology of the mucosa of gastric antrum and body before and after eradication of Helicobacter pylori.
Topics: Adult; Amoxicillin; Drug Therapy, Combination; Duodenal Ulcer; Female; Furazolidone; Gastric Mucosa; | 1993 |
Omeprazole/amoxicillin versus ranitidine/triple therapy for duodenal ulcer: when is the "same" the same?
Topics: Amoxicillin; Bismuth; Drug Therapy, Combination; Duodenal Ulcer; Helicobacter Infections; Helicobact | 1994 |
Short report: treatment of Helicobacter pylori-associated duodenal ulcer with omeprazole plus antibiotics.
Topics: Adult; Aged; Drug Therapy, Combination; Duodenal Ulcer; Female; Follow-Up Studies; Helicobacter Infe | 1993 |
One week's anti-Helicobacter pylori treatment for duodenal ulcer.
Topics: Adolescent; Adult; Aged; Antacids; Anti-Ulcer Agents; Breath Tests; Drug Administration Schedule; Dr | 1994 |
[Oral triple therapy for eradication of Helicobacter pylori in duodenal ulcer disease].
Topics: Administration, Oral; Adult; Aged; Bismuth; Drug Administration Schedule; Drug Therapy, Combination; | 1993 |
Antibiotic therapy alone eradicates Helicobacter pylori and prevents duodenal ulcer recurrence.
Topics: Amoxicillin; Anti-Bacterial Agents; Drug Therapy, Combination; Duodenal Ulcer; Helicobacter pylori; | 1993 |
Histamine content of the oxyntic mucosa from duodenal ulcer patients: effect of Helicobacter pylori eradication.
Topics: Adult; Amoxicillin; Drug Therapy, Combination; Duodenal Ulcer; Female; Furazolidone; Gastric Mucosa; | 1993 |
Acid secretion and sensitivity to gastrin in patients with duodenal ulcer: effect of eradication of Helicobacter pylori.
Topics: Acute Disease; Adult; Aged; Bismuth; Drug Therapy, Combination; Duodenal Ulcer; Gastric Acid; Gastri | 1993 |
Eradication of Helicobacter pylori in recurrent duodenal ulcer.
Topics: Amoxicillin; Duodenal Ulcer; Helicobacter Infections; Helicobacter pylori; Humans; Metronidazole; Re | 1993 |
The role of Helicobacter pylori in peptic ulcer disease.
Topics: Amoxicillin; Antacids; Bismuth; Drug Therapy, Combination; Duodenal Ulcer; Gastric Mucosa; Helicobac | 1993 |
Eradication of Helicobacter pylori normalizes serum gastrin concentration and antral gastrin cell number in a patient with primary gastrin cell hyperplasia.
Topics: Bismuth; Drug Therapy, Combination; Duodenal Ulcer; Enterochromaffin Cells; Gastric Mucosa; Gastrins | 1993 |
Local cellular and immune response by antral mucosa in patients undergoing treatment for eradication of Helicobacter pylori.
Topics: Adolescent; Adult; Aged; Bismuth; Drug Therapy, Combination; Duodenal Ulcer; Female; Gastric Mucosa; | 1993 |
[Eradication of Helicobacter pylori and hemorrhagic recurrence of duodenal ulcer].
Topics: Antacids; Anti-Bacterial Agents; Bismuth; Duodenal Ulcer; Follow-Up Studies; Helicobacter Infections | 1995 |
[One week triple therapy for eradication of Helicobacter pylori infection: simple and effective].
Topics: Anti-Bacterial Agents; Anti-Ulcer Agents; Clarithromycin; Dose-Response Relationship, Drug; Drug Adm | 1995 |
Resolution of gastric outlet obstruction after eradication of Helicobacter pylori.
Topics: Aged; Anti-Bacterial Agents; Anti-Ulcer Agents; Drug Therapy, Combination; Duodenal Ulcer; Female; G | 1995 |
Cost-effectiveness of treatment regimens for the eradication of Helicobacter pylori in duodenal ulcer.
Topics: Amoxicillin; Antacids; Anti-Bacterial Agents; Anti-Ulcer Agents; Bismuth; Clarithromycin; Cost-Benef | 1996 |
Factors affecting growth and antibiotic susceptibility of Helicobacter pylori: effect of pH and urea on the survival of a wild-type strain and a urease-deficient mutant.
Topics: Amoxicillin; Anti-Bacterial Agents; Anti-Ulcer Agents; Benzamides; Clarithromycin; Drug Interactions | 1996 |
[What factors influence healing of duodenal ulcer when Helicobacter pylori eradication treatment is used?].
Topics: Adult; Age Factors; Aged; Amoxicillin; Antacids; Anti-Bacterial Agents; Anti-Ulcer Agents; Bismuth; | 1996 |
Verification of decreased basal and stimulated serum pepsinogen-I levels is a useful non-invasive method for determining the success of eradication therapy for Helicobacter pylori.
Topics: Adult; Aged; Anti-Bacterial Agents; Anti-Ulcer Agents; Biopsy; Drug Therapy, Combination; Duodenal U | 1996 |
Helicobacter pylori reinfection after apparent eradication--the Ipswich experience.
Topics: Adult; Anti-Bacterial Agents; Anti-Ulcer Agents; Bismuth; Breath Tests; Case-Control Studies; Drug T | 1996 |
Triple therapy with sucralfate, amoxycillin and metronidazole for healing duodenal ulcer and eradicating Helicobacter pylori infection.
Topics: Adult; Aged; Aged, 80 and over; Amoxicillin; Anti-Ulcer Agents; Antitrichomonal Agents; Drug Therapy | 1996 |
The role of screening for Helicobacter pylori in patients with duodenal ulceration in the primary health care setting.
Topics: Adult; Aged; Aged, 80 and over; Amoxicillin; Anti-Ulcer Agents; Antibodies, Bacterial; Drug Therapy, | 1996 |
[Which factors influence the success of the classical triple therapy in the eradication of Helicobacter pylori?].
Topics: Adult; Amoxicillin; Antacids; Anti-Bacterial Agents; Anti-Ulcer Agents; Bismuth; Drug Therapy, Combi | 1996 |
[The validation and effect of the prophylactic (antirelapse) treatment of peptic ulcer patients with chlorozil and metronidazole].
Topics: Adult; Anti-Ulcer Agents; Choline; Drug Evaluation; Duodenal Ulcer; Female; Follow-Up Studies; Human | 1996 |
Metronidazole, ranitidine and clarithromycin combination for treatment of Helicobacter pylori infection (modified Bazzoli's triple therapy).
Topics: Adult; Aged; Anti-Bacterial Agents; Anti-Ulcer Agents; Antitrichomonal Agents; Clarithromycin; Drug | 1996 |
Triple therapy in duodenal ulcer healing--a follow up study.
Topics: Adult; Amoxicillin; Anti-Ulcer Agents; Chronic Disease; Drug Therapy, Combination; Duodenal Ulcer; F | 1996 |
Effect of lansoprazole in mono-, dual-, or triple therapy on Helicobacter pylori eradication.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Amoxicillin; Anti-Ulcer Agents; Drug Therapy, Combination; | 1996 |
Bacterial density of Helicobacter pylori predicts the success of triple therapy in bleeding duodenal ulcer.
Topics: Adult; Amoxicillin; Anti-Ulcer Agents; Biopsy; Drug Therapy, Combination; Duodenal Ulcer; Female; Ga | 1996 |
Drugs for treatment of peptic ulcers.
Topics: Amoxicillin; Antacids; Anti-Bacterial Agents; Anti-Ulcer Agents; Clarithromycin; Diarrhea; Drug Inte | 1997 |
[Breath test in the diagnosis of Helicobacter pylori infection: concordance with histological methods and correlation with anatomopathological lesions of the gastric mucosa].
Topics: Adult; Amoxicillin; Antacids; Anti-Bacterial Agents; Anti-Ulcer Agents; Biopsy; Breath Tests; Drug T | 1996 |
Life-threatening interaction between clarithromycin and disopyramide.
Topics: Aged; Anti-Arrhythmia Agents; Anti-Bacterial Agents; Anti-Ulcer Agents; Clarithromycin; Disopyramide | 1997 |
Effective 2-wk therapy for Helicobacter pylori disease in children.
Topics: Adolescent; Anti-Bacterial Agents; Anti-Ulcer Agents; Child; Clarithromycin; Drug Evaluation; Drug T | 1997 |
Triple-drug therapy of Helicobacter pylori infection in duodenal ulcer disease.
Topics: Adult; Anti-Bacterial Agents; Anti-Ulcer Agents; Bismuth; Drug Therapy, Combination; Duodenal Ulcer; | 1997 |
Gastric metaplasia and Helicobacter pylori.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Adult; Aged; Amoxicillin; Anti-Infective Agents; Anti-Ulcer | 1997 |
Relation of lactoferrin levels in gastric mucosa with Helicobacter pylori infection and with the degree of gastric inflammation.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Ammonia; Anti-Bacterial Agents; Anti-Ulcer Agents; Biomarke | 1997 |
Ranitidine in a twice daily triple therapy regimen for the eradication of Helicobacter pylori.
Topics: Amoxicillin; Antitrichomonal Agents; Drug Administration Schedule; Drug Therapy, Combination; Duoden | 1997 |
Unhealed duodenal ulcers despite Helicobacter pylori eradication.
Topics: Amoxicillin; Anti-Bacterial Agents; Anti-Ulcer Agents; Case-Control Studies; Clarithromycin; Drug Ad | 1997 |
Short-term eradication therapy for Helicobacter pylori does not reduce the incidence of gastric metaplasia in duodenal ulcer patients.
Topics: Adult; Aged; Amoxicillin; Anti-Ulcer Agents; Drug Therapy, Combination; Duodenal Ulcer; Female; Heli | 1997 |
[Effectiveness of short-term triple therapy for healing Helicobacter pylori infection in ulcer disease].
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Anti-Ulcer Agents; Clarithromycin | 1997 |
Metronidazole resistance reduces efficacy of triple therapy and leads to secondary clarithromycin resistance.
Topics: Adult; Aged; Anti-Bacterial Agents; Anti-Ulcer Agents; Clarithromycin; Drug Resistance, Microbial; D | 1997 |
In-vitro susceptibility of Helicobacter pylori to ampicillin, clarithromycin, metronidazole and omeprazole.
Topics: Ampicillin; Anti-Bacterial Agents; Clarithromycin; Duodenal Ulcer; Helicobacter pylori; Humans; Metr | 1997 |
New, improved Helicobacter pylori eradication therapy in children.
Topics: Adolescent; Anti-Bacterial Agents; Anti-Ulcer Agents; Child; Clarithromycin; Drug Therapy, Combinati | 1998 |
[Short-term triple therapy with pantoprazole, amoxicillin and metronidazole in Helicobacter pylori infection].
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Adolescent; Adult; Aged; Aged, 80 and over; Amoxicillin; An | 1998 |
[Helicobacter pylori infection and recurrent abdominal pain in children. A proved relationship?].
Topics: Abdominal Pain; Adolescent; Adult; Age Factors; Amoxicillin; Antacids; Anti-Bacterial Agents; Anti-U | 1998 |
Clostridium difficile colitis associated with a 'triple' regimen, containing clarithromycin and metronidazole, to eradicate Helicobacter pylori.
Topics: Anti-Ulcer Agents; Clarithromycin; Drug Therapy, Combination; Duodenal Ulcer; Enterocolitis, Pseudom | 1998 |
Demonstration of unexpected antibiotic resistance of genotypically identical Helicobacter pylori isolates.
Topics: Amoxicillin; Anti-Bacterial Agents; Clarithromycin; DNA, Bacterial; Drug Resistance, Microbial; Duod | 1998 |
[Evaluation of results of surgical treatment of peptic ulcer associated with Helicobacter pylori].
Topics: Adult; Antacids; Anti-Bacterial Agents; Anti-Ulcer Agents; Bismuth; Duodenal Ulcer; Evaluation Studi | 1998 |
Long-term follow-up of duodenal ulcer in children before and after eradication of Helicobacter pylori.
Topics: Adolescent; Amoxicillin; Anti-Bacterial Agents; Biopsy; Bismuth; Child; Disease Progression; Drug Th | 1999 |
Optimal treatment for duodenal ulcer disease: a cost-decision analysis in Malaysian patients.
Topics: Amoxicillin; Anti-Bacterial Agents; Anti-Infective Agents; Anti-Ulcer Agents; Bismuth; Clarithromyci | 1999 |
Duodenal ulcer disease: to treat H. pylori infection or not?
Topics: Bismuth; Drug Therapy, Combination; Duodenal Ulcer; Helicobacter Infections; Helicobacter pylori; Hu | 1992 |
Effect of Helicobacter pylori eradication on the natural history of duodenal ulcer disease.
Topics: Adolescent; Amoxicillin; Anti-Bacterial Agents; Child; Drug Therapy, Combination; Duodenal Ulcer; Fo | 1998 |
Two- to four-year histological follow-up of gastric mucosa after Helicobacter pylori eradication.
Topics: Adult; Aged; Amoxicillin; Drug Therapy, Combination; Duodenal Ulcer; Female; Follow-Up Studies; Gast | 1999 |
Duodenal ulcer relapse is not always associated with recurrence of H. pylori infection: a prospective three-year follow-up study.
Topics: Adolescent; Adult; Aged; Amoxicillin; Anti-Ulcer Agents; Drug Therapy, Combination; Duodenal Ulcer; | 1999 |
The long-term reinfection rate and the course of duodenal ulcer disease after eradication of Helicobacter pylori in a developing country.
Topics: Adolescent; Adult; Aged; Amoxicillin; Anti-Ulcer Agents; Chile; Developing Countries; Drug Therapy, | 2000 |
[24-hour monitoring of gastric juice pH in assessment of anti-ulcer treatment].
Topics: Adult; Amoxicillin; Anti-Infective Agents; Anti-Ulcer Agents; Biopsy; Circadian Rhythm; Drug Therapy | 2000 |
[Quamatel application in three-drug eradication therapy of duodenal ulcer and gastroduodenal ulcerations associated with helicobacter pylori infection].
Topics: Adolescent; Adult; Amoxicillin; Anti-Bacterial Agents; Drug Therapy, Combination; Duodenal Ulcer; Fa | 2000 |
[The role of omeprazole in the eradication of Helicobacter pylori in patients with duodenal ulcers].
Topics: Adolescent; Adult; Aged; Amoxicillin; Anti-Bacterial Agents; Anti-Ulcer Agents; Drug Therapy, Combin | 2000 |
[High eradication rates in Helicobacter pylori infection in patients with duodenal ulcer who failed previous eradication therapy].
Topics: Adult; Aged; Amoxicillin; Anti-Ulcer Agents; Clarithromycin; Drug Therapy, Combination; Duodenal Ulc | 2000 |
Eradication of Helicobacter pylori from the stomach and duodenum of patients with duodenal ulcers.
Topics: Adult; Amoxicillin; Anti-Ulcer Agents; Duodenal Ulcer; Duodenum; Enzyme-Linked Immunosorbent Assay; | 2001 |
In search of the Holy Grail of Heliocobacter pylori remedies.
Topics: Amoxicillin; Anti-Bacterial Agents; Anti-Infective Agents; Anti-Ulcer Agents; Bismuth; Clarithromyci | 2001 |
[Current principles of the use of laparoscopic surgery in gastroduodenal ulcer].
Topics: Antacids; Anti-Bacterial Agents; Anti-Ulcer Agents; Clarithromycin; Drug Therapy, Combination; Duode | 2001 |
[Gastroduodenitis and ulcers--statistical study for 1998].
Topics: Anti-Bacterial Agents; Anti-Infective Agents; Anti-Ulcer Agents; Bulgaria; Clarithromycin; Drug Ther | 2000 |
In vitro activity of rifampicin against Helicobacter pylori isolated from children and adults.
Topics: Adolescent; Adult; Amoxicillin; Biopsy; Child; Child, Preschool; Clarithromycin; Drug Resistance, Mu | 2002 |
[Clinical evaluation of some modern anti-ulcer drugs].
Topics: Adult; Alloxan; Anti-Ulcer Agents; Biological Products; Drug Combinations; Duodenal Ulcer; Gefarnate | 1979 |
Smoking does not contribute to duodenal ulcer relapse after Helicobacter pylori eradication.
Topics: Anti-Ulcer Agents; Duodenal Ulcer; Female; Follow-Up Studies; Helicobacter Infections; Helicobacter | 1992 |
pH-dependent secretion of gastrin in duodenal ulcer disease: effect of suppressing Helicobacter pylori.
Topics: Amoxicillin; Anti-Ulcer Agents; Duodenal Ulcer; Female; Gastric Acid; Gastrins; Helicobacter Infecti | 1992 |
[Treatment of stomach ulcer with bismuth subnitrate, oxytetracycline and metronidazole].
Topics: Adult; Bismuth; Drug Therapy, Combination; Duodenal Ulcer; Female; Helicobacter pylori; Humans; Male | 1992 |
Eradicating Helicobacter pylori in patients with duodenal ulcer.
Topics: Drug Resistance, Microbial; Duodenal Ulcer; Helicobacter Infections; Helicobacter pylori; Humans; Me | 1992 |
Helicobacter pylori-related hypergastrinaemia is not due to elevated antral surface pH. Studies with antral alkalinisation.
Topics: Adult; Amoxicillin; Antacids; Duodenal Ulcer; Female; Gastrins; Helicobacter Infections; Helicobacte | 1992 |
Duodenal ulcer and eradication of Helicobacter pylori in a developing country. An 18-month follow-up study.
Topics: Amoxicillin; Brazil; Developing Countries; Drug Therapy, Combination; Duodenal Ulcer; Duodenoscopy; | 1992 |
Short report: short-term triple therapy for H. pylori-associated duodenal ulcer disease.
Topics: Adult; Anti-Ulcer Agents; Bismuth; Drug Therapy, Combination; Duodenal Ulcer; Female; Helicobacter I | 1992 |
Does a previous course of tripotassium dicitrato bismuthate affect the subsequent chances of successful Helicobacter pylori eradication?
Topics: Adult; Aged; Drug Administration Schedule; Drug Resistance, Microbial; Duodenal Ulcer; Dyspepsia; Fe | 1992 |
[Helicobacter pylori: from harmless commensal to clinically significant disease factor].
Topics: Amoxicillin; Bismuth; Drug Therapy, Combination; Duodenal Ulcer; Dyspepsia; Gastritis; Helicobacter | 1992 |
Suppression of Helicobacter pylori reduces gastrin releasing peptide stimulated gastrin release in duodenal ulcer patients.
Topics: Adult; Duodenal Ulcer; Female; Gastrin-Releasing Peptide; Gastrins; Helicobacter Infections; Helicob | 1992 |
Factors influencing the eradication of Helicobacter pylori with triple therapy.
Topics: Adult; Aged; Aged, 80 and over; Bismuth; Drug Therapy, Combination; Duodenal Ulcer; Female; Gastriti | 1992 |
[Helicobacter pylori and duodenal ulcer. Long-term results of triple sucralfate antibiotic therapy].
Topics: Adult; Aged; Amoxicillin; Drug Therapy, Combination; Duodenal Ulcer; Helicobacter Infections; Helico | 1991 |
Plasma gastrin, daytime intragastric pH, and nocturnal acid output before and at 1 and 7 months after eradication of Helicobacter pylori in duodenal ulcer subjects.
Topics: Adult; Aged; Amoxicillin; Anti-Ulcer Agents; Bismuth; Circadian Rhythm; Duodenal Ulcer; Female; Gast | 1991 |
Five-day bismuth-free triple therapy for the eradication of Helicobacter pylori and reduction of duodenal ulcer relapse.
Topics: Adult; Amoxicillin; Breath Tests; Carbon Radioisotopes; Drug Administration Schedule; Drug Therapy, | 1991 |
Eradication of Helicobacter pylori abolishes 24-hour hypergastrinaemia: a prospective study in healthy subjects.
Topics: Adult; Amoxicillin; Circadian Rhythm; Duodenal Ulcer; Female; Gastric Acidity Determination; Gastrin | 1991 |
Spiral shaped microorganisms in the human duodenal mucosa.
Topics: Adult; Amoxicillin; Anti-Ulcer Agents; Bismuth; Drug Therapy, Combination; Duodenal Ulcer; Duodenum; | 1991 |
Cure of duodenal ulcer after eradication of Helicobacter pylori.
Topics: Adult; Aged; Anti-Ulcer Agents; Campylobacter Infections; Duodenal Ulcer; Duodenitis; Duodenum; Fema | 1990 |
Adjuvant antibiotic therapy in duodenal ulcers treated with colloidal bismuth subcitrate.
Topics: Amoxicillin; Anti-Ulcer Agents; Bismuth; Campylobacter Infections; Drug Resistance, Microbial; Drug | 1990 |
Ablation of exaggerated meal-stimulated gastrin release in duodenal ulcer patients after clearance of Helicobacter (Campylobacter) pylori infection.
Topics: Bismuth; Campylobacter Infections; Drug Therapy, Combination; Duodenal Ulcer; Female; Food; Gastrins | 1990 |
Primary infection of ascitic fluid with Clostridium difficile.
Topics: Ascites; Clostridium; Clostridium Infections; Duodenal Ulcer; Female; Gastrointestinal Hemorrhage; H | 1990 |
Campylobacter pylori, duodenal ulcer disease, and gastrin.
Topics: Adult; Antacids; Anti-Ulcer Agents; Campylobacter Infections; Duodenal Ulcer; Gastrins; Humans; Male | 1989 |
Antral Helicobacter pylori, hypergastrinaemia, and duodenal ulcers: effect of eradicating the organism.
Topics: Antacids; Campylobacter; Campylobacter Infections; Duodenal Ulcer; Gastrins; Gastritis; Humans; Metr | 1989 |
Percutaneous treatment of an intrahepatic abscess caused by a penetrating duodenal ulcer.
Topics: Combined Modality Therapy; Drainage; Duodenal Ulcer; Gentamicins; Histamine H2 Antagonists; Humans; | 1987 |
[Relation of lambliasis and duodenal ulcer. Preliminary report].
Topics: Adolescent; Child; Child, Preschool; Duodenal Ulcer; Giardiasis; Humans; Infant; Metronidazole | 1971 |